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Chapter I 
 
HEMOZOI: A CASE OF HEME CRYSTAL EGIEERIG  
 
Nature provides numerous examples of organic-inorganic interactions that produce 
precisely controlled biominerals in which structural morphologies are reproducible in size, shape 
and orientation (1). This process by which living organisms produce minerals is referred to as 
biomineralization. For example, many multicellular organisms produce hard tissues such as 
bones, teeth, shells, skeletal units, and spicules. These minerals can serve as mechanical devices 
(e.g., skeletal support, cutting, grinding) or physical function (e.g., magnetic and optical) (2, 3). 
The detailed mechanism of biomineralization is far from complete; however, current 
understanding points to mediation by organic molecules. Organic macromolecules may act as 
nucleators, growth modifiers, anchoring units, compartments, or scaffold in mineral growth (4).  
These roles can be achieved through templating (1, 5, 6) or enzymatic (7) effects. As a template, 
macromolecules can provide stereochemistry and physisorption for the inorganic assembly (1). 
In contrast, as an enzyme, the macromolecule could regulate inorganic phase synthesis by 
controlling local chemistry (3). While biominerals can provide mechanical support, their 
presence in human can indicate medical complications. Despite the practical functionality of 
calcium oxalate monohydrate as mechanical support in plants (8), their presence in humans, 
better known as kidney stone, can cause painful inflammation. While considerable advances 
have been made in understanding how the organic components of organisms (proteins(9) and 
lipids(10)) direct the formation for some biominerals, in many cases their role remains unclear. 
This is especially with hemozoin, a dark, crystalline heme pigment (11, 12). Heme or 
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Fe(III)PPIX is the precursor of hemozoin and its potential role in a number of pathogenic 
conditions has produced a surge of research interest in hemozoin formation. Blood feeding 
organisms implicated in malaria (11), schistosomiasis (13), and Chagas’ disease (14) , namely, 
the malaria parasite Plasmodium falciparum, the worm Schistosoma mansoni, and the kissing 
bug Rhodnius Prolixus, produces hemozoin to circumvent heme toxicity associated with 
hemoglobin degradation (15). A better understanding of hemozoin and its formation will shed 
new light on these diseases and drug designs to combat them. 
 
Malaria Review 
 
Malaria is a disease that is rooted in human history, having been clinically described as 
early as the fourth century B.C by Hippocrates. However, it wasn’t until the 19th century that 
Charles Laveran established a causal relationship of pigmentation to the malaria parasite (1880) 
(16), through his observation of moving bodies from blood samples of patients suspected of 
having malaria. And a decade later, Sir Ronald Ross linked the transmission of the disease to 
mosquitoes and reported the life cycle of the parasite. Despite its rich history, molecular 
understanding of the disease is still incomplete. Today, malaria is classified as a protozoan 
parasitic disease that is a leading public health and economic burden. The disease infects 300-
500 million children annually and is endemic in over 100 countries (17). The majority of these 
cases occur in Sub-Sahara Africa (17). With the recent increase in parasite resistance to 
traditional antimalarial drugs and vector resistance to insecticides, an in-depth understanding of 
the disease is crucial for the future treatment of this disease. 
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Malaria is caused by parasites belonging to the genus Plasmodium. Four species have been 
shown to infect humans: Plasmodium falciparum, Plasmodium ovale, Plasmodium malariae and 
Plasmodium vivax. Plasmodium falciparum, the most prevalent species is often fatal to humans.  
  The life cycle of Plasmodium Falciparum is divided into three stages: vector (mosquito), 
liver (host), and blood (host) stages. Briefly, the life cycle of P. falciparum begins when a female 
mosquito transfers the malaria parasite to her human host (Scheme 1). The sporozoite travels 
through the bloodstream and invades the liver cells where it develops for 5-10 days. During the 
liver stage the sporozoite undergoes asexual reproduction to form tissue schizont which then 
develops to form merozoite. The end of the liver stage is signified by merozoites rupturing the 
liver cells and invading red blood cells (RBC). In the RBC, the merozoite matures into 
trophozoite which develops further to form schizont. These schizonts develop, divide, and then 
rupture from the RBC, releasing additional merozoites ready to begin another cycle by invading 
another RBC. The RBC cycle is associated with symptoms of clinical malaria such as chills, 
fever, and anemia. If left untreated, these symptoms may escalate to death. Some merozoites 
develop into sexual forms called gametocyctes which can be taken up by another mosquito 
during its feeding. In the gut, these gametocyctes matures into oocysts and then into sporozoites. 
The sporozoites then travel to the salivary gland where it waits to be injected into the next host. 
 
Hemoglobin Degradation 
 
The malaria parasite has a limited capacity to synthesize amino acids de novo, and 
consequently, must scavenge nutrient exogenously by catabolizing the host’s supply. Within the 
RBC, P. falciparum attains nutrients by degrading hemoglobin (Hb), a protein responsible for the 
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host’s oxygen transport (18). Hb is transported into the acidic digestive food vacuole (pH 4.8 
±0.4) (19, 20) via transport vesicles known as cytostome. During the intraerythrocytic stage, the 
malaria parasite can degrade up to 80% of the host’s hemoglobin (21). To illustrate this 
phenomenon, in an average patient with 750 g of health hemoglobin and a 20% parasitemia, as 
much as 100 g of hemoglobin can be degraded during this cycle (11).These peptides are further 
hydrolyzed into amino acid in the parasite cytosol. As a consequence of Hb degradation, heme is 
released. In the “free” state, heme induces oxygen dependent free radical formation, lipid 
peroxidation and protein and DNA oxidation.  P. falciparum has evolved efficient adaptations to 
circumvent the toxic effects of “free” heme. This process involves the crystallization of heme 
into hemozoin which is nontoxic to the parasite.  
Inside the parasite, the degradation of hemoglobin takes place within the acidic lysosomal 
organelle called the digestive food vacuole (22). Within this compartment, a suite of Plasmodial 
proteinases, including two aspartic proteases, plasmepsin I and II, and one cysteine protease, 
falcipain, breaks down the hemoglobin protein (18). This process begins with a cleavage 
between residues α33Phe and α34Leu by an aspartic protease (23). This site of cleavage is 
critical for securing the hemoglobin tetramer together when oxygen is bound (24). Plasmepsin I 
and II further cleave the fragment at secondary sites.  These fragments are substrates for the 
cysteine protease falcipain (25), which continues to break down the fragments into smaller units.  
Inhibition of Plasmepsin I/II and cysteine protease falcipain results in parasite death. 
Metalloprotease found in the digestive vacuole are the final enzyme that acts on the fragments 
prior to transport of the small peptides from the digestive vacuole into the cytoplasm where they 
are further degraded to amino acids (26). 
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Scheme 1. Life cycle of the Plasmodium falciparum within the human host (27).  
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Heme Metabolism 
 
 Iron protoporphyrin IX or heme is a ubiquitous molecule that is essential for the function 
of all aerobic cells (i.e. biological processes, including oxygen transport, respiration 
photosynthesis, drug detoxification, and signal transduction) (28). Despite the necessity of heme 
for biological functions, free heme can generate reactive oxygen species that can damage 
biological molecules. The root of free heme cytotoxicity involves its highly hydrophobic nature 
which allows the iron contained within its protoporphyrin IX ring to enter and cross cell 
membranes (29). Its amphiphilic nature favors its association with phospholipid bilayers,  
interfering with the physical integrity (30). As a consequence, the toxic effect of heme is 
associated with diverse pathologies such as inflammation, atherosclerosis, Alzheimer’s and 
Parkinson’s diseases.  It is not surprising that evolution has developed many adaptations to 
protect organisms against the detrimental consequences of free heme (31).   
Heme oxygenase -1 (HO-1) is an essential enzyme in the heme breakdown (32). To date, 
two isozymes of HO are known, HO-1 and HO-2 (33), and a possibility of a third, HO-3, 
remains debatable (34). HO activity is higher in tissues (spleen, liver, and bone marrow) where 
senescent erythrocytes are sequestered and degraded (35). Characteristically, HO-1 and HO-2 are 
highly induced by its substrate heme (35-37) and binds to heme in an equimolar ratio using the 
reduced form of nicotinamide-adenin dinucleotide phosphate (NADPH), three molecules of 
oxygen and at least seven electrons provided by NADPH-cytochrome P450 reductase (38). Both 
HO isoforms can cleave the protoporphyrin IX ring of free heme, releasing Fe from its inner core 
and generating carbon monoxide. The remaining protoporphyrin structure gives rise to 
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biliverdine which is reduced to bilirubin, transported to the liver conjugated with glucuronic acid 
and excreted into bile (39). 
Plasmodium, the causative agent of malaria, lacks the enzyme heme oxygenase to 
catabolize the porphyrin moiety, and must address heme toxicity by converting heme to 
hemozoin. Interestingly, mouse strain that expresses high level of HO-1 in response to 
Plasmodium infection do not succumb to severe and/or cerebral malaria, while those that express 
low level of HO-1 do so (40).  
 
Hemozoin Characterization 
 
Hemozoin was first observed as the discoloration in organs of malaria patient, and was 
later reported as a byproduct of hemoglobin degradation. It is a microcrystalline cyclic dimer of 
ferriprotoporphyrin IX (Fe(III)PPIX) in which the propionate side chain of one protoporphyrin 
coordinates to the iron(III) centre of the other. The dimers hydrogen bond to their neighbours via 
the second propionic acid group, forming extended chains through the macroscopic crystal (41, 
42). Hemozoin is chemically and structurally similar to a distinctive hematin pigment, called 
beta-hematin (Figure 1) (43).  Today, all synthetic hematin-crystals with iron of one hematin 
bound to the propionic acid group of another hematin are called beta-hematin. It should be noted 
that this terminology does not convey possible variations in three-dimensional structure. 
Chemically, hemozoin and its synthetic counterpart can be identified by Fourier 
transform infrared spectroscopy with intense absorbance at 1664 cm-1, corresponding to the C=O 
stretching vibration, and at 1210 cm-1, corresponding to the C-O stretching vibration (Figure 2d) 
(42). These peaks were absent from the spectra of the synthetic substrates hemin chloride and  
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Figure 1. Hemozoin’s chemical structure.  Hemozoin is a crystalline dimer which is composed of 
direct a coordination between a propionate group of one Fe(III)PPIX and the iron of another 
heme dimer unit . The dimers hydrogen bond to form an extended network, making up the 
macroscopic crystal. 
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hematin, suggesting a direct coordination between the carboxylate of one heme monomer and the 
iron center of another. The presence of these peaks signifies the formation of precursor 
Fe(III)PPIX dimers.  Structurally, hemozoin and beta-hematin are identical at the atomic level 
with distinct powder x-ray diffraction peaks at 7, 22, and 24 2Theta (ɵ) (Figure 2e). These 
structures were determined using simulated annealing techniques on the diffraction data, which 
includes the use of Le Bail algorithm to compare integrated peak intensities, the Rievtveld 
refinement of the structure’s molecular bonding geometry and Fourier difference calculations of 
atomic positions (41). The diffraction pattern proposed a triclinic unit cell with a space group of 
P-1, indicating an inversion of symmetry between the unit cells of the Fe(III)PPIX dimer. This 
pattern suggests a five-coordinate Fe(III)PPIX dimer bound by reciprocal monodentate 
carboxylate interactions with the propionic side chains of each PPIX (41).  
Morphologically, scanning electron microscopy analysis show hemozoin from P. 
falciparum from human have a regular, flat-faced, needle-like structure (Figure 2 b,c) (44). 
These structures are micron-size crystals with three dominant side faces: {100}, {010}, and 
{001}. This morphology is determined by the relative growth rate of its various faces. Briefly, 
the morphological properties of a crystal depends on the relationship between the layer energy, 
E1, the energy released when a layer is formed, and the attachment energy, Eatt, the energy per 
molecule released when a new layer is attached to the crystal face. Eatt regulates the growth rate 
perpendicular to the layer, while E1 controls the stability of the layer. The morphological 
importance of crystal face is inversely proportional to its attachment energy. Generally, the face 
that grows slowest is expressed in the crystal habit. Values for E1 and Eatt of hemozoin were 
calculated by Buller et al (45) via computational modeling of atom-atom potential energy 
functions. These calculations predicted low Eatt for {001} (-101.5 kcal/mol) and larger values  
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Figure 2. Characterization of hemozoin and beta-hematin. Morphologically, both hemozoin(c) 
and beta-hematin (b) are needle-like in structure. FT-IR analysis (d) of both samples revealed 
characteristic peaks at 1664 cm-1 and 1210 cm-1, indicating the presence of a heme dimer.  X-ray 
diffraction patterns of hemozoin and beta-hematin exhibit characteristic peaks at 7, 22, and 24 2ɵ 
(e). 
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for {100} (-30.6 kcal/mol) and {010} (-27.7 kcal/mol) side faces.  From these predictions, the 
authors proposed that the fastest growing face of hemozoin is likely to be the {001}. Thus, 
stabilization of dominate crystal faces, {010} and {100} may promote crystal nucleation; and 
binding onto the fastest growing face, {001}, may inhibit crystal growth. 
 
Biological Mediator of Hemozoin Formation 
 
Nearly 95% of the heme released from hemoglobin degradation is converted into the 
malaria pigment in Plasmodium Falciparum (46); however, the molecular understanding of this 
process remains unclear.  The history of hemozoin research comprises of three main hypotheses 
for hemozoin formation: enzymatic mediated, protein mediated, and lipid mediated. Initially, 
Slater and Cerami (47) observed that extracts of P. Falciparum  trophozoites incubated with 
heme in sodium acetate at physiological conditions was sufficient in converting hematin to beta-
hematin. This conversion was inhibited by the addition of quinoline-containing drugs (47). This 
observation led them to propose that the formation of hemozoin was catalyzed by a heme 
polymerase enzyme.  Dorn et al. refuted the “heme polymerase” proposal by demonstrating that 
the same catalytic property was conserved in parasitic extract that were subjected to heat 
treatment (48). They concluded that hemozoin formation is a chemical process rather than an 
enzymatic process. 
Another spotlight in the search for a mediator of hemozoin formation was the histidine-
rich protein (HRP). Sullivan et al. identified two proteins, HRPII and HRPIII, that were 
sufficient at mediating beta-hematin formation (49). HRP II contains 51 repeats of the sequence 
Ala-His-His, making up 76% of the mature protein (50). HRPIII contains 28 Ala-His-His 
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sequences, making up 56% of its mature protein (51). Functionalized nanoparticles containing 
HRP epitope promoted beta-hematin in a pH dependent manner with optimal conversion at pH4, 
similar to that of the digestive food vacuole of Plasmodium falciparum. However, reports of 
HRP’s location outside the digestive vacuole (52) and P. falciparum clone that lack the genes for 
both HRP II and HRPIII still retain hemozoin production (53) made the first proposal unlikely. 
Currently, research in hemozoin formation is focused on lipids. The role of neutral lipids 
on hemozoin crystallization was initially proposed by Fitch et al. (54) and was later identified as 
composing of di- and triacyl- glycerols (55). Most importantly, Sullivan and coworkers reported 
the presence of neutral lipid bodies enveloping hemozoin crystals inside P. Falciparum digestive 
vacuoles (56). These lipid bodies were identified as a mixture of mono and di-glycerides (57). 
Recently, Egan and colleagues (58) demonstrated the beta-hematin formation occurs at the lipid-
water interface and that the rate of heme conversion can account for heme toxicity. However, the 
details of this mechanism are unknown. 
 
Antimalarials 
The quinoline family of drugs has served as the primary treatment for malaria for over 
300 years (11). Chloroquine (CQ), a synthetic analogue of the oldest known antimalarial, 
quinine, was extensively used for half a century as the major antimalarial throughout the world. 
Its popularity stemmed from its being an effective antimalarial and inexpensive. Chloroquine 
exist in the neutral form within the body (pKa1=8.1 and pKa2 = 10.2), allowing it to passively 
transport through cell membranes. However, within the digestive food vacuole of P. falciparum 
(pH 4.8 ±0.4) parasite the drug is doubly protonated (45), explaining its accumulation within the 
vacuole up to millimolar concentration (59-63). The extensive use of chloroquine and surging 
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resistance have encouraged production of other effect quinoline analogues that includes the 
bicyclic quinoline skeleton and a flexible amine moiety(64, 65). There is an abundance of 
evidence that suggests chloroquine and related aminoquinoline compounds stems from their 
ability to complex with free heme released during hemoglobin degradation (Figure 3) (66-68). 
Likewise, computational models reveal that this crystal “capping” effect is brought about when 
CQ blocks the {001} and {010} crystal face, preventing growth.  
 Growing parasite’s resistance to chloroquine and many of the quinoline based anti-
malarial drugs has paved way for the resurface of the malaria disease. It is believed that the 
parasite acquires resistance through an efflux mechanism which prevents the accumulation of 
drugs within the digestive food vacuole, the site of hemozoin formation, in the parasite (20, 69). 
Because the mechanism of drug resistance does not disrupt the heme conversion, the conversion 
of heme to hemozoin remains a potential target for therapeutic treatments. Thus, a more detailed 
understanding of hemozoin formation will shed new light on malaria treatments.  
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Figure 3. Hemozoin-chloroquine interaction model.  Current understanding of Chloroquine mode 
of action centers on its interaction to the { }001  and { }011  faces of heme as well as π-π stacking at 
the { }010  face.(45)  A chloroquine molecule complex to each axial face of a Fe(III)PPIX 
molecule, preventing crystal extension.   
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Chapter II 
 
EUTRAL LIPID MEDIATIO OF HEMOZOI FORMATIO 
 
  Lipids have been implicated in the formation of hemozoin. Bendrat and colleagues 
initially speculated that this process is mediated by lipids when they observed that an acetonitrile 
extract of P. falciparum promoted the formation of beta-hematin. The dramatic increase in lipid 
content of the infected erythrocyte (70-74) and observations of hemozoin localization in close 
proximity to neutral lipid bodies (NLBs) (57, 75) have directed investigations of hemozoin 
formation towards neutral lipids. Specifically, triacylglycerol (TAG) and diacylglycerol (DAG), 
lipids traditionally important for membrane biogenesis and energy storage, are synthesized by 
Plasmodium falciparum and packaged into NLBs in a stage-specific manner within the DV (72, 
73, 76). In contrast, these lipids are barely detectable in uninfected erythrocytes(70, 74). This 
observation was corroborated by recent finding in helminth Schistosoma mansoni that hemozoin 
are localized at neutral lipid droplets (13, 14, 77). However, the function of NLBs during parasite 
growth remains unclear.  Two popular hypotheses include NLBs functioning as a depot of lipid 
intermediates that are generated during digestion of phospholipids (76) and NLBs serving as a 
deposit of lipid components that can be quickly mobilized to supply the growing parasite with 
fatty acids and acylglycerols for membrane generation (73). Of significance, the P. falciparum 
NLB composition was reported as a specific blend of mono- di- and triacylglycerols present in 
the DV is sufficient for mediating hemozoin formation. Mass spectrometry identified the 
components of these lipids to be the monoglycerides monostearoylglycerol (MSG) and 
monopalmitoylglycerol (MPG) and the diglycerides 1,3-dioleoylglycerol (DOG), 1,3-
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dipalmitoylglycerol (DPG) and 1,3-dilinoleoylglycerol (DLG) in a 4:2:1:1:1 ratio(57). This 
biological composition is referred to as the “lipid blend.” 
Recently, biologically realistic half-lives of about 5 minutes at 37 °C were reported for 
beta-hematin formation in a lipid-water interface model (58), suggesting that the interface may 
play an essential role during heme crystallization. The question remains, how does the lipid-
water interface facilitate hemozoin formation? In an attempt to address this question, we 
evaluated the hypothesis that neutral lipid bodies are the biological mediator of hemozoin 
formation within the digestive food vacuole of the parasite. In part I of this chapter will 
investigate the organization of model neural lipid (MSG and MPG). In addition, the ability of 
MSG/MPG lipid bodies to facilitate beta-hematin formation was examined.  
In the second part, synthetic neutral lipid bodies (SNLB) composed of the lipid blend were 
utilized to investigate the localization and partitioning of heme into the lipid bodies. Differential 
scanning calorimetry and kinetic measurements demonstrate that the lipid blend provides a 
unique environment for hemozoin formation. By observing the collisional (Stern-Volmer) 
quenching of Nile Red (NR) fluorescence, confocal microscopy  and conventional fluorescence 
spectroscopy reveal that soluble Fe(III)PPIX spontaneously localizes to the SNLBs and 
partitions into SNLBs in a pH-dependent manner. In conjunction with the known pattern of LB 
proliferation, it is speculated that NLBs within the DV are not only the location of in vivo 
hemozoin formation, but are also essential for the survival of the parasite by functioning as a 
time and site specific mediator for heme detoxification. The work presented in this chapter is the 
result of collaborative work with Dr. Timothy Egan (University of Cape Town(UCT), South 
Africa), Dr. Katherine De Villiers (University of Stellenbosch, South Africa), Dr. Kanyile 
Ncokazi (UCT), Rebecca Sandlin (Vander 
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Experimental Methods 
 
Materials 
All materials used were of analytical grade or of the highest grade of purity available 
from commercial suppliers. Stock solutions made from citric acid purchased from Merck were 
used to prepare citrate buffer (50 mM) and pH adjusted to 4.8 using a slurry of sodium hydroxide 
(NaOH). A stock solution (3.2 mM) of hematin was formed by dissolving 2 mg of hematin in 0.4 
mL NaOH (0.1 M) followed by the addition of 0.6 mL of 1:9 acetone/methanol. The following 
lipids were used in this study: monoglyceride lipids rac 1-monopalmitoylglycerol (MPG), rac 1-
monostearoylglycerol (MSG), rac 1-monomyristoylglycerol (MMG) and rac 1-
monooleoylglycerol (MOG); diglycerides 1,3-dioleoylglycerol (DOG), 1,3-dipalmitoylglycerol 
(DPG) and 1,3-dilinoleoylglycerol (DLG); triglycerides trioleoylglycerol (TOG) and 
trimyristoylglycerol (TMG); and cholesterol (CHL). All lipids used in this study were obtained 
from Sigma-Aldrich South Africa. 3.3 mM solutions of lipids were prepared in 1:9 acetone/ 
methanol solvent. In order to carry out a reaction, 200 µL of lipid solution was pre-mixed with 2 
µL of hematin solution and was layered on the surface of the citrate buffer (5 mL) which was 
pre-incubated at 37 °C.   
The lipid blend refers to the established biological ratio of 4:2:1:1:1 of 
MSG:MPG:DOG:DLG:DPG  reported by the Sullivan group.  Each lipid was dissolved in a 9:1 
ratio of methanol: acetone to promote lipid solubility.  Stock solutions of lipids for lipid blend 
experiments were prepared at 16.2 mM.   A 20 µM stock solution of Nile Red (MP Biomedicals, 
LLC or Sigma-Aldrich South Africa) was prepared in acetone and used immediately.  
 
 
 
 
18 
 
Characterization of neutral lipid bodies 
When a solution of neutral lipid is deposited onto an aqueous surface, a monolayer of 
lipid is formed at the surface. The selectively fluorescent, hydrophobic phenoxazone dye, Nile 
Red(78) was used to characterize the organization of lipid molecules dispersed in the solution 
beneath this surface monolayer. 200 µL of stock MPG solution was layered on top of a 5 mL 
solution of citrate buffer (50 mM, 37 °C) drop-wise using a microsyringe. After 5 min. 
incubation, 2 µL of a 500 µg/mL Nile Red stock solution was introduced to the surface. Samples 
were then withdrawn from beneath the surface and placed on a glass slide for imaging by a 
Nikon Epifluorescent microscope and a Zeiss LSM 510 meta inverted confocal microscope. 
Confocal imaging was performed using a 488 nm argon laser with 505-550 nm band pass filter. 
Confocal orthogonal projection was produced using Zeiss LSM Image Browser software. 
Another 2 µL of the sample was stained with a 2 % solution of uranyl acetate for imaging using a 
JEM 1200EXII TEM operated at 120 kV. The same experiment was repeated for the lipid blend. 
The size distribution of the lipid (MPG) emulsions were measured using two Malvern particle 
sizing systems: The Malvern Zetasizer with a lower limit of 0.1 nm and an upper limit of 6 µm 
and the Malvern Mastersizer with a lower limit of 50 nm and upper limit of 800 µm. 1 mL of 
MPG stock solution was deposited onto surface of citric acid buffer (50 mL, 50 mM, pH 4.8) and 
0.5 mL samples extracted from below the surface were used for Zetasizer measurements while 2 
mL samples were used for the Mastersizer. Three measurements were taken for each sample at 0, 
20, 40, and 60 minutes after the lipids were deposited to determine the stability of the size 
distribution of the lipid bodies in these emulsions with time. 
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Localization of heme (Fe (III)PPIX) 
Hematin was dissolved in 0.1 M NaOH and then mixed with an acetone/methanol (1:9 
v/v) solution to form a 2 mg/mL stock solution (3.2 mM) of Fe(III)PPIX (from here on 
generically referred to as heme).  3.3 mM lipid solutions of MPG and MSG were prepared as 
described above, except that the ratio of acetone (acetone/methanol) was increased for MSG to 
ensure that the lipid had dissolved completely. 2 µL solution of heme and 200 µL of lipid were 
mixed. This premixed solution was introduced, as previously described, onto the surface of citric 
acid buffer solution (5 mL, 37 °C, pH 4.8) in a 15 mL conical tube (Falcon, diameter = 46.87  
mm). To determine the localization of heme with respect to the lipid bodies, samples were taken 
immediately from beneath the layered surface and prepared for transmission electron microscopy 
imaging using a LEO 912 transmission electron microscope. Additional samples were withdrawn 
after ten minutes of incubation at 37 °C. Iron distribution was measured from the latter sample 
on objects that mirrored the structures of beta-hematin crystals using TEM electron spectroscopic 
imaging (ESI) for elemental analysis of iron. 
 
Characterization of beta-hematin 
A scale up version of the above setup was performed 24 times using MPG and MSG for 
product characterization. Beta-hematin formed in the lipid-water system was characterized by 
Fourier transformed infrared (FTIR) spectroscopy of undried material as Nujol mulls. Powder X-
ray diffraction (XRD) of the extensively washed (5% pyridine solution) dried product, and 
transmission electron microscopy imaging of samples removed directly from MSG-lipid 
interface were also performed.  XRD was carried out using Cu Kα radiation (λ=1.541 Å), with 
data collection on a Philips PW1050/80 vertical goniometer in the 2θ range 5 – 40° using an Al 
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sample holder. TEM images were obtained using the LEO 912. Heme incubated in the aqueous 
medium alone served as control. Lattice spacings were measured from images obtained from a 
Philips CM20 transmission electron microscope (TEM). 
 
The role of OH and C=O groups in nucleating beta-hematin. 
Experiments at pentanol and octanol/aqueous interfaces were carried out exactly as 
described previously (58) using 10 mL of the solvent. The experiment with toluene was 
conducted in the same way except that toluene was substituted for pentanol or octanol.  In the 
case of docosane a 1.9 mg/mL stock solution was prepared by dissolving 1.9 mg in 1.0 mL of a 
solution containing 1:3:6 acetone:chloroform:methanol (v/v), while for methyl laurate a 2.61 
mg/mL stock solution was prepared to volume in a 1.0 mL volumetric flask by dissolving 3 µL 
of neat methyl laurate (0.869 g/mL) in 1:9 acetone:methanol solution. 2.0 mg hematin was 
dissolved in 1.2 mL of 0.1 M NaOH in a 10 mL glass vial. After complete dissolution of the 
solid, 1.8 mL of the 1:9 acetone:methanol solution was added and the new solution was 
thoroughly mixed to give a final concentration of 0.67 mg/mL. This solution was prepared fresh 
for each individual experiment. 
Experiments were carried out in Schott Duran crystallising dishes with an internal 
diameter of 5 cm in the case of pentanol, octanol and toluene and 9 cm in the case of docosane 
and methyl laurate. 50.0 mL of citrate buffer was measured into each vessel and incubated with a 
pentanol, octanol or toluene layer on top of the aqueous solution. In the case of the other two, the 
aqueous layer was pre-incubated at 37°C while docosane, methyl laurate and heme solutions 
were prepared. On average this process took 15 – 20 minutes. These organic liquids are all 
largely insoluble in aqueous medium and the solvent system used to dissolve docosane showed a 
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tendency to precipitate heme at high concentrations. Thus it was reasoned that premixing any of 
them with the heme/NaOH solution would not produce a sensible result and so the interface was 
prepared with no premixing. The non-aqueous layer was spread over the surface of the citrate 
buffer. Subsequently, 0.5 mL (0.33 mg) of heme solution was added drop-wise to the pre-
incubated interface using a syringe with a needle diameter of 0.5 mm. Once heme had been 
delivered to the interface, the experiments were left to incubate for 30 minutes. Control 
experiments in the presence and absence of MMG were carried out at the same time. At the end 
of the incubation period the surface was agitated to force all the heme products (both 
unconverted heme and beta-hematin) to precipitate into the acidic bulk medium. The total 
volume of solvents and precipitate (~ 50.5 mL) was transferred to an 85 mL Nalgene centrifuge 
tube and centrifuged at 10,000 rpm for 10 minutes. The clear supernatant was discarded and the 
pellet kept for further analysis. 1.0 mL of a pyridine:water:acetone solution (1:17.9:5.5 pH 7.5) 
was added to wash the pellet. In the case of methyl laurate, the supernatant remaining after a 
second centrifugation was subsequently diluted (40:1960 µL) and the absorbance measured at 
405 nm to quantify the unreacted hematin. The remaining pellet from docosane and methyl 
laurate experiments was analysed as a nujol mull by FT-IR. 
 
Beta-hematin formation via methods of extrusion 
A premixed solution of MPG (1 mL, 3.3 mM) and hematin (10 µL, 3.2 mM)) was 
adjusted to pH 7.0 with 0.01 M hydrochloric acid (HCl). Citric acid buffer (~300 µL, 50 mM, pH 
7.0) was carefully added to this solution, to avoid precipitation of the lipid solution. MPG/heme 
vesicles were formed by extrusion through Nucleopore track-etch polycarbonate membranes 
(Avanti Polar Lipids Inc.) 19 times at temperature above the Tc. The newly formed heme-MPG 
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lipid emulsions were introduced into an aqueous solution buffered at pH 4.8 containing 50 mM 
citrate. The mixture was incubated at 37 °C for about 10 minutes and TEM imaging of 3 µL of 
samples was taken using the LEO 912 electron microscope. This experiment was repeated for 
MSG.  
 
Kinetic studies of beta-hematin formation 
Kinetics for the following lipids were examined: monoglycerides MPG, MSG, and MOG; 
diglycerides DOG, DPG, and DLG; triglycerides TOG and TMG; and CHL. The experimental 
setup was as described above. Briefly, premixed solution was formed using 2 µL of heme and 
200 µL of lipid stock solutions and was layered onto citric acid buffer. The mixture was 
incubated at 37 °C for 0, 1, 3, 5, 15, 30, 45 and 60 minutes. Each time point was performed in 
triplicate. The reaction was quenched with the addition of 1 mL of an aqueous solution 
containing 30% pyridine, 10% HEPES buffer (2.0 M, pH 7.5), and 40% acetone (v/v). The 
sample was immediately centrifuged for 10 minutes at 4,000 rpm. The percentage of 
unconverted heme was determined by performing colorimetric measurements at 405 nm on the 
supernatant of quenched and centrifuged samples. This is a modification of an assay published 
and confirmed by Ncokazi and Egan (58, 79).  
 
The effect of temperature on kinetics of beta-hematin formation  
For temperature analysis of beta-hematin formation in the lipid-water system, 
measurements of percentage of heme conversion were conducted at 25, 30, 40, and 50 °C. A 
premixed solution of 200 µL MSG and 2 µL heme stock solution was deposited onto a citric acid 
buffer (50 mM, pH 4.8) sub-phase at designated temperatures. The reaction was quenched and 
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colorimetric measurements were performed as described above at various time points. Half life, 
t1/2 was calculated using Prism 4©. Rate constants were calculated from t1/2 values and were 
applied to the Arrhenius plot to determine activation energy, Ae using the Arrhenius equation. 
                                     k = Ae-Ea/RT  
where k is the rate constant, A is the pre-exponential factor, T is the temperature (Kelvin), and 
R is the gas constant.  
 
The effect of pH on kinetics of beta-hematin formation 
In order to examine the effect of pH on beta-hematin formation at the lipid-water interface, the 
pH of the aqueous solution on which the lipid solution was deposited was adjusted to 0.5, 1.0, 
2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 4.8, 5.0, 5.5, 6.0, 6.5 and 7.0 at 37 °C. The method is as described 
previously. After 1 hr of incubation the reaction was quenched with pyridine solution and the 
beta-hematin percentage yield was recorded by means of colorimetric measurements at 405 nm. 
 
Fe(III)PPIX localization and partitioning into SLB 
Fluorescence spectra of NR were recorded in acetone as a function of concentration in order to 
determine the linear range of intensity versus concentration. A series of fluorescence spectra 
were also recorded in different solvents so as to observe the dependence of λem (max) on 
polarity. To observe the effects of Fe(III)PPIX on NR fluorescence, a 100:1 solution of lipid: NR 
was prepared with a final concentration in buffer at the desired pH of 100 µM lipid and 1.0 µM 
NR.  Buffers used were 0.020 M HEPES (pH 6.0 – 8.0) or citric acid/citrate (pH 2.8 – 5.5). A 1 
mL aliquot of NR-labeled SNLB dispersed in aqueous medium was placed in a quartz 
fluorescence cuvette and titrated with Fe(III)PPIX prepared by dissolving hematin in 0.1 M 
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NaOH.  The fluorescence spectrum was measured on a Varian Cary Eclipse fluorescence 
spectrophotometer.  Both excitation and emission slit width’s were set to 5 nm with a medium 
scan control and medium PMT detector voltage.  The sample was excited at 540 nm and the 
emission spectrum was recorded from 560-800 nm. 
Data were analyzed according to the Stern-Volmer equation (equation 1): 


= 1 + 	
  (1) 
where I0 is λem(max) in the absence of the quencher, I is the observed λem(max) in the presence 
of a given concentration of quencher, KSV is the Stern-Volmer quenching constant and [Q] is the 
concentration of the quencher, in this case Fe(III)PPIX. 
Partitioning of Fe(III)PPIX between aqueous solution and octanol was measured at pH 
7.51 using HEPES buffered aqueous solution (0.020 M). Fe(III)PPIX was prepared from hematin 
in 0.1 M NaOH and then introduced into the buffer at a final concentration of 57.8 µM. This was 
shaken and equilibrated for 6 h at 37 °C with an equal volume of octanol. At the end, the UV-
visible spectra of the aqueous and octanol layers were measured on a Varian Cary 100 
spectrophotometer at 403 nm. 
 
Confocal imaging of heme localization 
For confocal microscopy measurements, the 16.2 mM lipid blend solution was prepared 
using stocks in a 4:2:1:1:1 volume ratio.  A 100:1 solution of lipid: NR was prepared by 
combining 150 µL NR stock with 18.5 µL of lipid blend stock.  This solution was briefly 
vortexed and diluted with a 50 mM solution of citric buffer (pH 4.8) to give a final volume of 1 
mL.  This solution was again briefly vortexed, giving a final lipid concentration of 300 µM and 
Nile Red of 3 µM.  A lipid volume of 180 µL was imaged in a glass bottom microwell dish 
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(35mm Petri dish and 14 mm microwell dish, MatTek Corporation). A 500 µM Fe(III)PPIX 
solution was prepared for quenching of the NR signal as described above. Quenching was 
performed by sequentially adding 20 µL of the Fe(III)PPIX solution every ~30 seconds, starting 
10 seconds into imaging, until complete quenching was observed. Great care was taken to not 
displace the lipid bodies. Measurements were made using a Zeiss LSM 510META upright 
confocal microscope (VUMC Cell Imaging Shared Resource) using the time series application 
with 63× oil (1.4) immersion objectives. Z-stacking was performed before and after quenching to 
ensure lipid bodies were not displaced during the experiment.  The quenching experiment was 
repeated with the exception of introducing 400 µL of 250 µM Fe(III)PPIX at once (10 seconds 
into imaging).  The quenching experiments were repeated for citric buffer adjusted to pH 1.3, 
2.3, 4.8, 5.5, 6.7, 7.3, and 8.1. The rate of photobleaching was measured by imaging the 
fluorescence intensity of NR-labeled SNLBs without the presence of heme for 200 seconds. The 
experiment was repeated for pH 4.8 with the addition of 140 µL Fe(III)PPIX. 
 
Differential scanning calorimetry (DSC) 
Thermal analysis (TA) of neutral lipid samples encapsulated in sealed aluminum capsules 
were conducted with a TA instrument DSC Q200.  Approximately 2.4-3.2 mg samples of each 
lipid were weighed with a microbalance and analyzed from a temperature of 80°C to -80°C at a 
cooling rate of 10°C/min and a heating rate of 15°C/min.  The exothermic and endothermic 
peaks were determined by plotting heat flow (adjusted for weight) vs. temperature. 
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Results and Discussion 
 
 
Part I: Beta-Hematin Formation at the Interface of MSG/MPG Model Lipid Bodies 
Part II: Heme Partitioning into Synthetic eutral Lipid Bodies (SLB) and the Mediation 
of Beta-Hematin Formation by SLB 
 
 
Part I: Beta-Hematin Formation at the Interface of MSG/MPG Model Lipid Bodies 
 
 
Characterization of neutral lipid bodies 
Studies of lipid mediation of beta-hematin formation have demonstrated rapid heme 
conversion when hematin was introduced to a solution of rac 1-monomyristoylglyerol (MMG) 
that was deposited onto an aqueous subphase (58). By contrast, previous crystallization studies 
using only a monolayer of the phospholipid dipalmitoylphosphatidyl-choline (DPPC) reported 
the insufficiency of the lipid monolayer to mediate beta-hematin formation, even after 24 h of 
incubation (80). Instead, when an aged bulk solution of lipid was substituted, beta-hematin 
crystals were detected. Together, these data point to an unknown lipid mediated heme conversion 
process that exists beneath the surface monolayer which produces most if not all of the beta-
hematin. Little is known about the organization of these lipids beneath the surface. To investigate 
the distribution of neutral lipids in this system, transmission electron microscopy (TEM) and 
fluorescent imaging were performed on samples extracted from just beneath the surface. Imaging 
data suggest that lipids spontaneously organize into a lipid emulsion beneath the surface (Figure 
4a, b). Fluorescence imaging of samples stained with the lipophilic stain, Nile Red, and a water  
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Figure 4. Characterization of monopalmitoyl glycerol in acetone/methanol solution after 
deposition onto an aqueous surface. Samples were extracted from just beneath the surface. TEM 
images show lipid bodies in the nanometre size range (a), while fluorescence imaging of samples 
stained with the lipophilic stain, Nile Red (orange), and the water soluble dye, fluorescein 
(green), show bodies in the micrometer size range (b). Measurements of lipid particle size 
distribution reveal two populations, one in the range 50 – 200 nm and the other 1 – 10 µm. This 
size distribution remained stable over a period of an hour (c).  Confocal orthogonal projection 
confirms that lipid bodies are not hollow, but rather continuous throughout their interiors (d). 
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soluble dye, fluorescein, showed lipid bodies in the emulsion layer in the micrometer size range 
(Figure 4b), while TEM imaging showed structures in the nanometre size range (Figure 4a). 
Confocal microscopy of the samples confirmed that the lipid bodies contain a homogeneous core 
(Figure 4d) and are not hollow liposomes. Measurements of the particle size distribution in these 
lipid emulsions revealed two populations. A large population in the 50 to 200 nm diameter range 
(Figure 4c) and a smaller population of lipid bodies in the 1 to 10 µm range. These emulsions 
were stable over time, as little fluctuation in size distribution was observed in four independent 
measurements over a period of an hour.  
Experimental evidence presented here incontrovertibly demonstrates that the remaining 
lipid forms an emulsion in the sub-phase beneath this monolayer. Furthermore, the sizes of the 
lipid bodies in this emulsion fall into two populations, one in the low micrometer range and the 
other in the range 50 – 200 nm. The lipid bodies are not micelles or hollow liposomes, but rather 
have a “solid” core (i.e. are homogeneous through their interiors) as shown by confocal 
microscopy of the larger population of bodies. These lipid bodies, which form spontaneously as 
shown in Scheme 2, are strikingly similar in appearance to neutral lipid bodies reported 
associated with the digestive vacuole of P. falciparum and the gut lumen of S. mansoni and 
which, at least in the case of the former organism have been shown to consist largely of mono-, 
di- and triglycerides (14, 57, 73, 81). Indeed, they appear to be essentially synthetic counterparts 
of these lipid bodies. 
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Scheme 2. Evolution of the lipid emulsion following deposition of a solution on the aqueous 
surface. A sample of lipid dissolved in 1:9 acetone to methanol solution is deposited onto an 
aqueous surface. As the environment surrounding the lipid becomes predominately aqueous, the 
lipids rearrange to form lipid bodies.  
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Localization of heme and product characterization 
TEM imaging showed that when hematin was premixed with MPG and introduced onto 
an aqueous surface, electron dense material, probably heme, rapidly localized around the surface 
of the lipid bodies, apparently at or near the lipid-water interface (Figure 5a). Images of samples 
incubated for 10 minutes showed crystals resembling beta-hematin (Figure 5b). TEM/ESI of iron 
distribution in these samples confirmed the presence of iron in these putative beta-hematin 
crystals (Figure 5b). TEM evidence suggests that the heme accumulates near the surface of the 
lipid bodies. Such accumulation of the amphiphilic heme molecule at the surface of lipid bodies 
in P. falciparum and S. mansoni has previously been proposed (57, 73, 81, 82), but this 
represents the first direct evidence of localization of free heme at the interface of lipid bodies and 
water. Morphologically, these crystals resemble hemozoin in their crystal habit (Fig. 6c, f). 
Infrared spectra and powder diffraction data of the products formed using MSG and MPG clearly 
demonstrates the production of beta-hematin with percentage of product conversion of 75 ± 2 
and 65 ± 4, respectively (Fig. 7a). Prominent IR peaks at 1662 cm-1 and 1210 cm-1 are readily 
discernible indicating significant formation of beta-hematin (Fig. 6a, d). These findings are 
confirmed by XRD (Fig. 6b, e) showing the characteristic diffraction peaks of beta-hematin. The 
diffraction pattern of the product formed with MSG in particular, definitively demonstrates the 
presence of beta-hematin. Subsequent formation of beta-hematin has been unequivocally 
demonstrated in this work by FTIR spectroscopy and powder XRD. TEM also demonstrates the 
formation of crystals identical in habit to hemozoin. In contrast to current results, previous 
studies by Sullivan and co-workers reported MSG as ineffective in promoting beta-hematin (57). 
This result may be owing to its low solubility. By employing a 1:9 acetone/methanol mixture 
pre-incubated at 37 °C, MSG was effectively solubilized. Though this does not directly mimic  
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Figure 5. TEM image of heme localized at or near the lipid-water interface. When hematin was 
premixed with MPG and introduced onto an aqueous surface and immediately imaged using 
TEM, electron dense materials, presumably hematin was localized at or near the lipid-water 
interface (a). Elemental imaging of iron using TEM with electron spectroscopic imaging (ESI) 
conducted on samples reacted for 10 min. confirmed the presence of beta-hematin crystals (b). 
Regions highlighted in red denote the presence of iron (Fe). Scale bar = 50 nm. 
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Figure 6. Infrared (IR), X-ray diffraction (XRD), and transmission electron microscopy (TEM) evidence for the formation of beta-
hematin at the lipid-water interface using MSG (a, b, c), and MPG (d, e, f). Two large Nujol peaks (a, d) obscure the region between 
1550 and 1320 cm-1 but do not interfere with the characteristic beta-hematin IR peaks at 1660 and 1210 cm-1 (42). Both products 
formed under mediation of MSG (a) and MPG (d) show IR characteristics of beta-hematin. XRD of products obtained in presence of 
MSG (b) and MPG (e) show patterns characteristic of beta-hematin (41). TEM images of these products closely resemble hemozoin in 
their crystal habit (c, f). Scale bar = 50nm. 
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the physiological process, it is necessary in order to introduce the lipid and hematin to the 
interface in a soluble form so as to promote beta-hematin crystallization, probably promoting 
lipid droplet formation and preventing precipitation of unconverted heme. 
 
Beta-hematin nucleation and extension 
  To examine the role of the hydrophilic head group during nucleation, percentage heme 
conversion was examined in the presence of various mediators. Octanol and pentanol resemble 
neutral mono- and diglyceride lipids in having OH head groups and aliphatic chains. Docosane, 
CH3(CH2)20CH3, and methyl laurate, (CH3)-O-C(=O)-(CH2)10CH3, lack OH groups while methyl 
laurate, but not docosane, contains C=O groups. Toluene can π-stack with heme, but lacks either 
chains or polar head groups. These solvents were therefore proposed as good substitutes for 
lipids in order to probe the role of the terminal OH groups, C=O groups and π-electron 
containing groups in nucleating beta-hematin. In the presence of the hydroxyl (-OH) group, such 
as in the case of octanol and pentanol, a percentage of beta-hematin formation comparable to that 
mediated by monoglyceride was found, 83% and 95%, respectively (Figure 8b). This percentage 
was reduced by nearly half (40%) when the ester methyl laurate was substituted (Figure 8. 5a). 
However, under the mediation of a long chain alkane, docosane, which mimics the alkyl chain of 
the lipid, but lacks the hydrophilic head group, no product was detected. Interestingly, toluene as 
a mediator produced 42% conversion to beta-hematin (Figure 8a).  
The lipids used in this study all contain carbonyl (C=O) head groups, while mono- and 
diglycerides also contain hydroxyl (OH) head groups. These lipids pack together by virtue of 
interactions between their polar head groups (30). As each additional  is esterified in going from 
mono- to di- to triglycerides the polarity of the head group is reduced (83, 84). In 
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Figure. 7 Beta-Hematin formation using various neutral lipids.  The percentage of beta-hematin formation was measured for premixed 
solutions of hematin and lipid deposited onto an aqueous solution. Mono- and diglycerides exhibited about the same efficiency in 
mediating beta-hematin formation, while the triglyceride mediated reaction resulted in less product. The control reaction in which 
heme was incubated in the aqueous medium alone produced no product (a). No statistically significant difference was observed in the 
rate of beta-hematin formation for these lipids, except for MOG and DOG which are significantly faster than the others (b). This rate 
did not change when the surface area of the experimental vessel was increased for MSG (c); however, a reduction in the percent yield 
was observed in reactions performed in a vessel with a 71 mm2 surface area (t1/2 = 1.63 min; 47% yield) compared with that with a 47 
mm2 surface area (t1/2 = 1.61 min; 63.8 % yield ). 
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Langmuir-Blodgett films in which the alkyl chains are positioned towards the air and the head 
groups interact with the aqueous solution, lateral compression of diglycerides reports a collapse 
pressure of 25 – 35 mN/m, significantly higher than that of triglycerides (12 – 14 mN/m). This 
indicates that the former anchor more strongly in the water phase than triglycerides (85). The 
higher polarity of mono- and diglycerides is likely to contribute to their efficiency in directing 
crystal nucleation. These molecules likely self assemble with their polar head groups facing the 
aqueous layer, presenting OH groups and lone pair electrons which can interact with heme. This 
is supported by observations with other amphiphilies which indicate that oxygen containing head 
groups (OH or –(C=O)-O-) play a crucial role in beta-hematin formation, since pentanol, octanol 
and methyl laurate all promote its formation, while no beta-hematin was formed in the presence 
of docosane. These observations support the proposal of Leiserowitz and colleagues that 
hemozoin formation occurs at lipid-water interfaces through epitaxial growth (80). Indeed, the 
role of amphiphilic molecules orienting nucleation of inorganic crystals through structural 
complementarity and/or lattice epitaxy between head groups of the amphiphile and the later 
arrangement within the crystal is well established in other systems (86). However, it is also the 
case that decreasing surface tension plays a role in crystal nucleation, as has been demonstrated 
by Huy et al. for beta-hematin formation in acidic aqueous alcohol solutions using water 
miscible alcohols (87). The activities of the various amphiphilic solvents used in this study and 
of the lipids could thus alternatively simply reflect their ability to lower surface tension and 
warrants future investigation.  
TEM imaging of extruded samples of both MPG/heme and MSG/heme solutions showed 
beta-hematin formed near the outer region of the lipid bodies (Figure 9). In all observations, 
crystal size did not exceed dimensions of associated lipid bodies. Clusters of beta-hematin  
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Figure 8. Comparison of efficiency of lipids, solvents and amphiphiles in forming beta-hematin 
at the interface with aqueous solution (pH 4.8, 37 °C).  Comparison of MMG, methyl laurate and 
a control in which heme is spread on the surface of the aqueous medium in the absence of an 
amphiphilic molecule, measured at 30 min (a). Comparison of organic solvents pentanol, octanol 
and toluene in a two-phase system with heme introduced at the interface, measured at 30 min (b) 
were performed to evaluate the roles of hydrocarbon chain length and polar head group during 
beta-hematin formation.  
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crystals were observed localized near and aligned parallel to the interface and each other (Figure 
9b, c, f, g). In several images, the beta-hematin crystals were located along the lipid-water 
interface of the lipid bodies (Figure 9a, e). These images closely resemble observations in P. 
falciparum reported by Coppens and Vielemeyer and Pisciotta et al. (57, 88). while images of 
early stages of hemozoin formation in S. mansoni also appear to be similar upon close inspection 
(13). The observations in the current study provide direct evidence that crystal nucleation occurs 
at the lipid-water interface and that crystal elongation occurs parallel to this interface. Based on 
the work of Buller et al.(45) which relates the shape of beta-hematin crystals to the {h,k,l} 
indices of the crystal, it appears likely that crystal extension occurs parallel to the c-axis until its 
growth is limited by the curvature of the lipid particle. Thus, the slowest growing {100} face is 
in contact with the lipid surface and the fastest growing {001} face is approximately 
perpendicular to the interface. This arrangement is in agreement with the findings of the recent 
GIXD and XR study of beta-hematin formation in a premixed MMG/hematin system which 
showed that the {100} face of the crystals is perfectly aligned with the surface of the solution 
(89). However, in the absence of electron diffraction data in the present study, this remains 
somewhat speculative. In part II, a more detailed approach to analyze heme localization will be 
presented. 
 
Kinetic studies of beta-hematin formation 
A premixed lipid-hematin solution was introduced onto the aqueous sub-phase. After the 
designated incubation period, the percentage of beta-hematin formation was measured using a 
pyridine-based assay. This assay has been described and validated elsewhere (79) . Briefly, the 
assay is based on the ability of 5% (v/v)  aqueous pyridine solution (pH 7.5) to react with 
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unconverted heme, but not beta-hematin, resulting in the formation of a low spin pyridine-heme 
complex with a distinctive absorbance at 405 nm and a characteristic orange-pink colour. When 
the percent yield for the 60 minute time point was compared, similar percentages of heme 
conversion were measured for mono- and diglycerides while less product was formed using 
triglycerides (Figure 7a).  Interestingly, cholesterol was found to be inefficient at mediating beta-
hematin formation. Though there are observed differences between mono- and diglycerides on 
the one hand and triglycerides on the other in the percentage of heme conversion, the rates of 
product formation mediated by these lipids were not greatly affected by the lipid. Overall, the 
reaction was completed within five minutes and a significant quantity of product was formed in 
less than one minute (Figure 7b). Interestingly, unsaturated glycerides promoted beta-hematin 
formation more rapidly than saturated glycerides. Nearly a two fold increase in rate was 
observed for formation of beta-hematin with unsaturated glyceride (MOG, DOG, and TOG) 
mediation when compared to the rate calculated from saturated glycerides. In the absence of the 
lipid bodies, no product was formed. Reaction rates were also unaffected by the cross-sectional 
area of the vessel in which the reaction was conducted. 
Model neutral lipid bodies composed of a homogenous sample are competent for the 
detoxification of free heme at a biologically realistic rate under physiological conditions. Indeed, 
the observed rates are the fastest so far reported for beta-hematin formation with half-lives of 
about 0.5 min at 37 °C for the monoglycerides MPG, MMG and MSG and only slightly slower 
for the di- and triglycerides (DLG, DPG and TMG). If hemoglobin degradation occurs at a 
constant rate, lipid-water interface mediated hemozoin formation would be more than sufficient 
to manage the entire flux during the intraerythrocytic stage. The rate of formation is about an  
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Figure 9. TEM of beta-hematin formed at the MSG/water (a – c) and MPG/water (e – g) 
interface through methods of extrusion. A lipid and haematin solution was extruded through a 
fixed membrane filter and then introduced into an aqueous solution containing 50 mM citric acid 
(pH 4.8, 37 °C). Samples were taken for TEM images after 10 min of incubation. beta-hematin 
crystals were observed aligned along the lipid-water interface for both extruded samples of MSG 
(top row) and MPG (bottom row). Clusters of beta-hematin crystals were oriented parallel to 
each other and to the lipid-water interface (MSG, b, c; MPG, f, g). 
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order of magnitude faster than that previously reported with the lipid-water system (58). In these 
previous studies, the heme and lipid solutions were separately introduced to the aqueous 
interface, whereas in the current work they were premixed. This demonstrates that the method by 
which heme is introduced to the interface strongly influences the kinetics, and also suggests that 
the rate of diffusion or transport of heme molecules to the lipid bodies contributes to the efficacy 
of the biological process. The reaction rates for the different lipids do not vary greatly, but the 
unsaturated glycerides (MOG, DOG, TOG) promote crystal formation significantly more rapidly 
than the saturated glycerides. It is possible that unsaturated lipid bodies favor initial interaction 
of heme and lipid via π-stacking. It is interesting in this regard that while the alkane docosane 
does not support beta-hematin formation, the aromatic solvent toluene does, albeit less efficiently 
than octanol and pentanol. This lends support to the notion that a π-system may further promote 
beta-hematin formation at the interface. It is noteworthy that the unsaturated fatty acid linoleic 
acid has been reported to increase 40% in parasitized erythrocytes relative to control (71), raising 
the question of whether it serves as a promoter of hemozoin formation. 
 
 
pH and temperature dependence of beta-hematin formation 
The pH dependence of the percentage of beta-hematin formation at the lipid-water 
interface after 1 h incubation at 37 °C follows a bell-shaped curve (Figure 10b) with maximal 
production at pH 4. As the reaction moves away from this optimal pH, the percentage of heme 
conversion is reduced. No product was detected below pH 2 or above 6. The dependence of yield 
on pH follows a bell shaped curve, with near optimal formation at the physiological pH of the 
malaria parasite digestive vacuole (4.8 – 5.2) (20). This pH dependence can be ascribed to the  
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Figure 10. Temperature and pH dependence of beta-hematin formation at the lipid-water 
interface.  The Arrhenius plot (a) was constructed from rate constants (k) measured in an MSG 
interface system at pH 4.8 and temperatures ranging between 25 and 50 °C. The slope gives an 
activation energy of 76 ± 16 kJ/mol. The effect of pH (b) was measured at 37 °C and using an 
MSG interface system. The solid line fitted through the pH data is a best fit to an equation 
representing two pKa values with, pKa1 = 2.3 ± 0.01 and pKa2 = 5.2 ± 0.01. 
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protonation state of beta-hematin itself, in which one propionic acid group is un-ionized, while 
the other is ionized. At low pH (< 2) both propionic acid groups are un- ionized and beta-hematin 
formation is abolished, while at high pH (> 6) both are ionized and beta-hematin formation is 
similarly abolished. 
The dependence of the rate of beta-hematin formation on temperature in the MSG/water 
emulsion was also determined. The Arrhenius plot of ln(k) vs 1/temperature yielded a negative 
slope (Figure 10a), suggesting that the assembly of heme dimers is a first order reaction. A first 
order reaction indicates that the rate of beta-hematin formation depends on the concentration of 
the reactant. In this case, the rate is likely dependent on the concentration of heme dimers to the 
first power and not the concentration of lipid or Fe(III)PPIX in solution because the product, 
beta-hematin, is the result of heme dimer hydrogen bonding to form the macroscopic crystal. 
Applying the slope of the ln(k) vs 1/temperature to the Arrhenius Equation  resulted in an 
activation energy of 76 ± 16 kJ/mol (Figure 10a). The activation energy obtained in the lipid 
water system is a little lower than that for beta-hematin formation in 4.5 M acetate buffer and 50 
mM benzoic acid buffer (84 ± 4 kJ/mol), but the difference is not statistically significant. The 
activation energy for beta-hematin formation brought about by MSG lipid bodies (76 ± 16 
kJ/mol) is not significantly different from that reported in acetate or benzoate buffer (84 ± 4 
kJ/mol) (90, 91). Thus the much faster rate observed in the lipid system arises from a much 
bigger pre-exponential factor, consistent with the idea that the interface is involved mainly in 
preorganizing heme and hence facilitating interactions between heme molecules. When adjusted 
for concentration of lipid per unit total volume, the concentration of lipid in the lipid-interface 
system is 384 times less than that of benzoic acid and 34,615 times less than acetic acid. Thus, 
the lipid particle/water interface is far more active in promoting beta-hematin formation than the 
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Scheme 3. The proposed mechanism of hemozoin formation.  Free heme (a) released as a result of hemoglobin degradation 
accumulates at the interface of the neutral lipid body within the digestive food vacuole of P. falciparum (b).  Nucleation occurs at the 
interface and elongation of the crystal extends along the interface (c) until curvature of the lipid body prevents further elongation of 
the crystal (d). The hydrophobic nature of the mature crystal (e) favors its transport into the lipid interior leading to a stack of aligned 
crystals.
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Other two systems and meets the requirement for physiologically relevant rates of formation. Its 
biological counterpart, the neutral lipid body-water interface, is thus likely to be the site of 
hemozoin formation in biology. 
 
 
Part II 
 
Heme Partitioning into Synthetic eutral Lipid Bodies (SLB) and the Mediation of Beta-
Hematin Formation by SLB 
 
 
 
 
Characterization of synthetic neutral lipid bodies  
Most eukaryotic cells contain cytosolic neutral lipid bodies which are hypothesized to 
participate in energy storage (92, 93).  However, the presence of neutral lipid nanospheres in the 
digestive food vacuole of Plasmodium as well as the association of NLBs with the digestive 
vacuole suggests that these neutral may have a role in hemozoin formation, a process that occurs 
within this organelle.  In this study, experimental data supports the hypothesis that neutral lipid 
nanospheres within the digestive food vacuole together with lipid bodies associated with the 
digestive vacuole are not only the location of in vivo hemozoin formation, but are also essential 
for the survival of the parasite by functioning as a time and site specific mediator of heme 
detoxification. Previous studies of synthetic neutral lipid droplets formed through sonication 
reported successful mediation of β-hematin formation (94). Recently, interfacial studies revealed 
crystal formation at a biologically compatible rate (t1/2 ≈2 min) (95, 96).  
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Characterization of Synthetic eutral Lipid Bodies 
SNLBs were formed by depositing an appropriate blend of neutral lipid onto an aqueous layer.  
Confocal imaging of samples extracted from just beneath the surface confirmed that this 
composition of lipids spontaneously organizes into an emulsion (Figure 11). Orthogonal 
projections of these lipid droplets demonstrate formation of spherical lipid droplets with 
continuous, not hollow interiors (Figure 11a), similar to our previously reported study using pure 
monoglyceride (97). Visually, the SNLBs exhibited a size distribution of a few hundred 
nanometers to few microns in diameter. In the current study, a neutral lipid blend in the ratio 
reported by Sullivan and coworkers to be present in the parasite 
(4MSG:2MPG:1DOG:1DLG:1DPG) (57) was observed to spontaneously assemble into an 
emulsion with the lipid dispersed in a form resembling lipid droplets. These SNLBs displayed 
physical properties (i.e. spherical droplets with diameters in the range of hundreds of nanometers 
to a few micrometers) similar to those of its in vivo counterparts (72, 73), rendering them useful 
for investigation of their role in hemozoin formation. The polarity of this lipid environment was 
found to lie between that of acetone and that of octanol as determined by the fluorescence 
emission peak maximum position of NR. 
To determine the uniqueness of the SNLB (differed from those of its individual 
components), differential scanning calorimetry (DSC) was performed on the lipid blend and its 
individual components. Ideally, if the heterogeneous lipid composition of the lipid blend 
provides better packing of lipids molecules through new bond formations, a detectable change in 
heat flux would be necessary to break these new bonds. Measured phase transitional peaks of the 
five neutral lipid samples were consistent with those of published values (98). Lipids containing 
saturated hydrocarbon chains (MSG, MPG, DPG) have a higher melting point than lipids with 
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Figure 11. Confocal micrographs of SNLB and zeta potentials of SNLB and its components. (a) 
Confocal microscopy of NR labeled SNLB composed of the lipid blend 4:2:1:1:1 
MSG/MPG/DOG/DLG/DPG demonstrates the presence of micron sized lipid droplets with 
continuous interiors. (b) Zeta potentials of the individual neutral lipids and SNLB are all close to 
zero as expected. 
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unsaturated chains (DLG and DOG). Upon heating of saturated lipids, MSG, MPG, and DPG, 
negative heat flow peaks were measured at 76, 74, and 74 ˚C, respectively (Figure 2a,b,c). These 
values matched those of published measurements (84) for corresponding melting temperatures. 
Cooling of the samples produced a positive heat flow at 69, 63 and 63 ˚C, corresponding to 
crystallization peaks of MSG, MPG, and DPG, respectively. In general, pure saturated 
asymmetric monoglycerides exists in three polymorphic forms, namely sub-α, α, and β (99). All 
polymorphs have a double chain length packing mode, characterized by a long spacing of about 
50 Å for MSG.  When monoglycerides, present in the α polymorph, are cooled 35-50 ˚C below 
the crystallization point of the α polymorph, they undergo a polymophric transition to a 
reversible sub-α polymorph. Further cooling of MSG and MPG samples produced positive heat 
flow peaks at 40 and 36˚C. These peaks are interpreted as the transition point (α to sub-α form) 
for MSG and MPG and are consistent to transition temperatures published by Gunston and 
Padley (100).  
Phase transition measurements for unsaturated diglycerides differed from those of 
saturated monoglycerides. Melting temperatures of 4.0 and 25 ˚C were measured for DLG and 
DOG, respectively (Figure 12d,e). Cooling of the samples produced positive heat flow peaks at -
5 and 14 ˚C, respectively. DSC plot of individual components of the lipid blend were normalized 
to the biological ratio (20) and overlayed (Figure 12f). When compared to the overlayed plot 
(Figure 12g), DSC plot of the lipid blend exhibited new melting peaks that shifted to lower 
temperatures (5, 20, 63 ˚C). Instead of 4 crystallization peaks, the lipid blend contained two new 
peaks at 5 and 45 ˚C.  In addition to DSC measurements, the zeta potentials of blend and its 
individual components were compared in order to explore the possibility that cations might 
accumulate around the head groups. However, true to its “neutral” lipid definition, no significant
 
 
48 
 
 
 
 
 
Figure 12. Differential scanning calorimetry of individual lipids and the lipid blend. The scans are for (a) MSG, (b) MPG, (c) DPG, 
(d) DOG, (e) DLG, (f) overlay of MSG/MPG/DOG/DLG/DPG normalized to the lipid blend ratio of 4:2:1:1:1, respectively, and (g) 
the lipid blend. 
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charge potential difference was observed for each individual component or the lipid blend 
composition (Figure 11b).  
The SNLB provides a unique crystallization environment that differs from that of its 
individual components. The melting properties revealed by differential scanning calorimetry of 
the lipid blend are not merely an overlay of the phase transitions of each individual component. 
The interactions of the five neutral lipids produce two new crystallization and three new melting 
peaks, suggesting that the heterogeneous lipid population of the lipid blend facilitated a new 
molecular organization of lipids. A melting temperature shift to lower temperature suggests that 
less interaction is occurring between lipid molecules in the SNLB than in homogenous samples. 
This is evident in a comparison of melting temperatures between mono- and di-glyceride. In 
saturated MSG and MPG samples, measured melting temperature is higher than that of 
unsaturated DLG and DOG.  This is likely a result of the presence of double bonds in the 
unsaturated lipids. These “kinks” will reduce the alignment of the hydrocarbon chains, producing 
a more fluid packing environment. Despite the lipid blend comprising of 2:1 monoglycerides to 
diglycerides, the presence of DOG and DLG reduced the primary melting peak. This lower 
melting point suggests that less stable or fewer interactions between lipid molecules are present 
in the SNLBs, which may result in a more fluid packing orientation.  
The new organization of lipids in the SNLB is not entirely unexpected given the diversity 
in head group and in the saturation of hydro-carbon chain of the components of the lipid blend. It 
has previously been demonstrated that the temperatures at which lipids undergo phase transitions 
is dependent upon the head group, the hydrocarbon chain length, and the degree and type of 
unsaturation present (98).  For example, the addition of double bonds, as in the case with DOG 
and DLG, reduces the hydrophobic interactions between lipid molecules thereby creating weaker 
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dispersion interactions. Berlin and Sainz’s DSC examination of phase transitions and molecular 
orientation in the liquid state of sonicated dispersions of neutral lipids reported that the 
positioning of acyl moieties in glycerolipids reduces the fluidity of dispersed lipid micelles (84).  
The authors attributed this restriction in mobility to the interactions between adjacent acyl 
chains. By the same reasoning, lipid droplets composed of homogenous monoglycerides (MSG 
or MPG) are likely to exhibit more surface rigidity than lipid droplets composed of a 
heterogeneous composition, such as the lipid blend.  The diversity in saturation of the 
components of the lipid blend will also contribute to the overall packing of the lipids in the lipid 
droplets, since unsaturated hydrocarbon chains do not pack as well as saturated chains. Together, 
DSC data demonstrates that the SNLBs are partly molten, a fact which may play a significant 
role in the biological function of the blend in hemozoin formation.  
 
Kinetics of β-hematin formation.  
Morphological, structural and spectroscopic analysis of the brown pigment formed by 
introducing soluble Fe(III)PPIX to the lipid blend emulsion unequivocally confirm the presence 
of β-hematin (Figure 13). SEM imaging of the product showed needle-like crystals resembling 
hemozoin in crystal habit (Figure 13c). TEM imaging of the largest face displayed electron dense 
crystals with a lattice spacing corresponding to the {100} face of hemozoin (Figure 13d). 
Infrared spectra exhibiting prominent peaks at 1662 cm-1 and 1210 cm-1, corresponding to the 
presence of the C=O and C-O stretching vibrations of propionate linked hematin dimers, 
confirmed the formation of β-hematin (Figure 13b). These findings are further supported by 
pXRD exhibiting the three characteristic diffraction peaks of beta-hematin (Figure 13a). 
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Together, these results definitively confirm the ability of SNLBs to mediate β-hematin 
formation. 
 SNLBs successfully promoted β-hematin formation under physiologically relevant 
conditions (37 °C, pH 4.8) with a half life (t1/2) 1.9 ± 0.01 min (Figure 14b).  The activation 
energy of hemozoin formation mediated by SNLBs and each of the individual components were 
determined from Arrhenius plots. An examination of activation energy revealed that 
monoglycerides exhibited energy barriers higher than those of diglycerides.  MSG and MPG 
have calculated values of 74.8 ± 5.3 kJ/mol and 60.4 ± 7.1 kJ/mol, respectively, while DLG, 
DPG and DOG showed lower values of 44.5 ± 15.4 kJ/mol, 35.2 ± 9.4 kJ/mol, and 37.7 ± 3.3 
kJ/mol, respectively (Figure14a). When the individual lipids are combined, the lipid blend 
revealed a much lower activation energy barrier of 27.8 ± 3.4 kJ/mol (Figure 14c). To evaluate 
the statistical significance of these relationships, t-test analyses were performed. Mean activation 
energies for the blend compared to those of MSG and MPG revealed 99.8% (p = 0.002) and 
99.3% (p = 0.007) confidence levels, suggesting the observed relationships between the blend 
and monoglycerides are statistically significant.  Similar observations were calculated for blend-
DOG and blend-DPG with 98% (p = 0.02) and 93% (p = 0.07) confidence levels respectively. T-
test evaluation for blend-DLG revealed an 86% confidence level (p = 0.14). The introduction of 
Fe(III)PPIX to the SNLB suspension successfully produced a brown pigment with a t1/2 of 1.9 ± 
0.01 min at 37 °C and pH 4.8, close to that reported for the malaria parasite DV(41, 42). This 
rate of heme conversion is well within the maximum half-life of 40 min previously estimated to 
be the maximum necessary to account for the observation that free heme in the parasite is limited 
to a maximum of 5% at 36 h in the lifecycle (95). Characterization using pXRD, FTIR, TEM and 
SEM clearly confirmed that the product was indeed β-hematin, demonstrating that SNLB-  
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Figure 13. Characterization of beta-hematin produced using SNLB suspended in citric buffer, pH 4.8, 37 °C. (a) pXRD, (b) FTIR, (c) 
SEM and  (d) TEM all show the characteristic features of beta-hematin. Fringes in the TEM in (d) exhibit the characteristic lattice 
spacing of the {100} face of beta-hematin.  
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mediated β-hematin formation is rapid and efficient under biologically realistic conditions. Such 
a rapid rate of heme conversion by the corresponding lipid blend in the parasite DV would 
therefore account for the fact that non-Hz Fe(III)PPIX is undetectable (i.e. makes up less than 5 
% of total Fe) in the Mössbauer spectrum of late trophozoite stage parasites (101). 
Kinetic studies revealed that the degree of saturation of the lipids influences the 
activation energy of β-hematin formation. SNLBs composed of just DPG, DOG, or DLG 
displayed lower activation energies than those of monoglycerides (MSG or MPG). The 
difference in molecular packing of the lipid molecules may be responsible for these measured 
differences. As explained above, DLG and DOG exhibit greater fluidity at the lipid body surface. 
This loosely packed surface may allow for faster organization of Fe(III)PPIX molecules, 
resulting in the measured lower activation energy. In the case of the lipid blend, the 
incorporation of a heterogeneous lipid population apparently alters the surface properties of the 
lipid body, with the differences in hydrocarbon chain length, degree of saturation and head group 
polarity all contributing to a more fluid and corrugated surface (84, 85) that is better able to 
template β-hematin formation. This surface may provide “pockets” for precursor heme dimers to 
intercalate in order to assemble, initiating hemozoin nucleation. Furthermore, the increase in 
packing fluidity may explain the complexity of the lipid blend associated with hemozoin in the 
parasite. If one type of lipid is sufficient to template hemozoin formation (58, 97), why does the 
parasite use a composition of five different lipid components? The answer is likely to be 
associated with the increase in surface energy associated with the template surface. This is 
evident in the observed lower activation energy. Further studies that include the examination of 
lipid packing are critical to further evaluate this hypothesis. Given that lipid peroxidation 
typically occurs at methylene groups adjacent to double bonds (102), making saturated lipids less 
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susceptible to oxidative damage than unsaturated lipids, the blend might also provide a means for 
the parasite to create an interface with hemozoin forming properties that resembles that of 
unsaturated lipids, while retaining a lipid mixture that is composed of almost 80% saturated 
lipids. In the strongly oxidative environment of the DV, this may reduce degradation of the lipid 
nanospheres and production of lipid peroxides. 
 
Fe(III)PPIX Partitioning into eutral Lipid Bodies 
The fluorescence spectrum of NR is solvatochromic, with more hydrophobic solvents 
producing a shorter maximum intensity emission wavelength (λem(max)) than do more 
hydrophilic solvents (103). Examination of λem(max) for a range of solvents exhibits a linear 
dependence of this parameter on the ET(30) of the solvent, a measure of microscopic 
hydrophobicity (Figure 15inset). The spectrum of NR in SNLBs (Figure 3) exhibits a λem(max) 
of 617 nm, corresponding to an ET(30) of 45 ± 4 kcalmol
−1. This is slightly more polar than 
acetone (42.2 kcalmol−1), but less polar than octanol (48.1 Kcal mol−1) (104). It also definitively 
demonstrates that NR is incorporated into the SNLBs and does not reside in the aqueous 
solution, confirming the observations of the microscopy studies. 
One leading hypothesis for hemozoin formation involves expitaxial nucleation at the 
lipid-water interface, extension of the crystal along the interface, and an interior movement of the 
hydrophobic crystal to the interior of the neutral lipid body (95, 96, 105). However, little is 
known about the partitioning of Fe(III)PPIX molecules into the lipid droplets. Using the unique 
selective neutral lipid staining property of NR, it has been possible to follow the partitioning of 
soluble Fe(III)PPIX into SNLBs (94, 103). Fluorescence calibration measurements reveal a 
linear relationship between the concentration of NR and measured fluorescence intensity (up to 1  
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Figure 15. A typical fluorescence emission spectrum of NR in SNLBs dispersed in aqueous 
solution (pH 7.4, 25 °C, 0.02 M HEPES buffer). The excitation wavelength is 540 nm. The inset 
shows the correlation (r2 = 0.94) between emission wavelength maximum of NR and the 
Dimroth-Reichardt hydrophobicity parameter ET(30) (104). The solvents are (from lowest to 
highest ET(30)): dodecane, toluene, ethyl acetate, chloroform, acetone, dimethylformamide, 
dimethylsulfoxide, isopropanol, pentanol, butanol, methanol and water.  
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µM in a conventional cuvette and up to at least 12 µM when using a 96 well plate attachment) 
(Figure 16a). In all experiments presented here, the concentration of Nile Red used in 
experimental measurements was well within the linear fluorescence range. The introduction of 
soluble Fe(III)PPIX to an aqueous emulsion of the lipid blend containing NR resulted in 
concentration dependent quenching of fluorescence. This quenching was found to conform to the 
Stern-Volmer relationship up to at least 60 µM Fe(III)PPIX, indicating that the decrease in 
fluorescence intensity is a result of dynamic (collisional) rather than static quenching (Figure 16b 
inset). The latter would be expected to give rise to an upward deviation from linearity (106). The 
slope of the Stern-Volmer plot, KSV, is dependent on pH of the aqueous medium (Figure 16c). 
Since KSV is the product of the fluorescence lifetime of the fluorophore (τ0) and the bimolecular 
quenching constant (kq), it is not expected to change as a function of pH, because the interior of 
the NR labeled SNLB is not likely to be altered by the pH of the aqueous medium. The most 
likely explanation for the increase in KSV with decreasing pH is therefore that the local 
concentration of Fe(III)PPIX in the SNLB particle increases with decreasing pH owing to 
increased partitioning of the partly protonated neutral form of Fe(III)PPIX into the hydrophobic 
lipid. Indeed, the data can be fitted to a protonation model with a single pKa of 4.62 ± 0.09, with 
a KSV of 0.021 ± 0.003 µM
−1 in the deprotonated form and 0.124 ± 0.007 µM−1 in the protonated 
form. Assuming that this difference arises solely as a result of increased Fe(III)PPIX 
concentration in the SNLB particle in the case of the protonated form, this indicates a 6 ± 1 fold 
accumulation of the protonated relative to the uprotonated form of Fe(III)PPIX in SNLB. 
Unfortunately, the absolute log Dlipid cannot be evaluated from these data. However, 
measurement of octanol-water portioning of Fe(III)PPIX at pH 7.51 where it is soluble in both 
 
 
57 
 
media indicate a log DOW of about 1.8. This suggests an approximate log P for Fe(III)PPIX in its 
neutral form of about 2.6.  
This quenching of NR was visually corroborated using confocal microscopy. Immediately 
following the addition of Fe(III)PPIX to NR labeled SNLBs under physiological conditions, 
fluorescent quenching was observed (Figure 17a). In fact, the rate of Fe(III)PPIX partitioning 
into the SNLBs was found to be pH dependent. Under pH conditions (2.3, 4.8 and 5.5) that 
include the expected range for the parasite DV (107-109), NR quenching observed at 50 s after 
the first addition of 500 µM Fe(III)PPIX was 74%, 78%, and 76%, respectively (Figure 17b). 
Interestingly, at pH 1.3, slightly less quenching was observed (26%), possibly because 
Fe(III)PPIX is entirely in its doubly protonated cationic form at this pH value. Likewise, 
significantly less quenching was observed (at 50 s) for pH 6.7, 7.3, and 8.1, respectively where 
the NR quenching was only 23%, 20% and 28%. At 150 s, the percent of total quenching for 
samples incubated in pH 2.3, 4.8, and 5.5 approaches their maximum value (90%, 92%, and 
94%, respectively). These values do not increase significantly at 200 s. For quenching at pH 4.8, 
a final heme concentration of 0.22 mM was required to quench the interior of the SNLB-NR. 
Note that this value reflects the overall amount of Fe(III)PPIX introduced to the SNLB solution 
and not the amount of Fe(III)PPIX localized within the SNLB.  
At 200 s, maximum quenching was observed for samples incubated at pH 1.3, 6.7, 7.3, 
and 8.1 of 80%, 89%, 87% and 57%, respectively. Location specific monitoring of fluorescence 
intensity during quenching experiments displayed selective localization of Fe(III)PPIX. Regions 
with no lipid present measured no significant changes in fluorescence. To ensure that the 
quenching effect was not due to photobleaching, the fluorescence intensity of labeled SNLBs 
was monitored. Mild quenching, specifically, a reduction of 2.0% in fluorescence intensity unit  
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Figure 17. Rate of Fe(III)PPIX quenching of Nile Red(NR) labeled synthetic neutral lipid droplet 
(SNLB). At pH similar to that of the digestive food vacuole of Plasmodium (pH 4.8), 
Fe(III)PPIX rapidly partitions into SNLB, indicated by quenching of NR (a).  At pH where the 
two propionate side group of Fe(III)PPIX is predominately unionized or ionized, the rate of NR 
quenching is slower (b). 
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was measured at after 50 s (Figure 17a) and 23 % at 200 s, suggesting that drastically decreased 
fluorescence intensities of SNLBs were indeed a consequence of the addition of Fe(III)PPIX and 
not photobleaching (Figure 17a). To confirm that the continual introduction of Fe(III)PPIX did 
not disrupt quenching measurements, Fe(III)PPIX was also added once to the SNLB-NR solution 
to produce a final Fe(III)PPIX concentration of 0.20 mM.  Maximum quenching of this sample 
was still observed at the 200 s; however, a slower rate of partitioning was observed. At the 50 s 
time point, only 40% quenching was observed. 
To explore the partition of Fe(III)PPIX into SNLBs, the hydrophobic dye, Nile Red, was 
employed. Conveniently, soluble Fe(III)PPIX was observed to be capable of quenching NR 
fluorescence. Linear Stern-Volmer plots indicate that this is a result of collisional quenching 
(106). These observations suggest about a 400-fold partitioning of the neutral form of 
Fe(III)PPIX into SNLBs relative to the aqueous medium. This phenomenon was visualized by 
confocal microscopy as a diminishing of fluorescence upon the addition of Fe(III)PPIX. In 
previous studies, TEM images of soluble Fe(III)PPIX introduced to SNLBs composed of MPG 
showed the localization of electron dense matter surrounding the lipid droplets (96). However, in 
the absence of elemental imaging, it could not be confirmed that this electron dense material was 
indeed heme.  In this study, confocal microscopic studies confirmed that Fe(III)PPIX 
spontaneously localizes to SNLBs under physiologically relevant conditions. Visually, a 
dramatic reduction in fluorescence intensity of NR labeled-lipid blend was observed upon 
introduction of Fe(III)PPIX (please refer to supplemental section for video imaging of the 
described event). Further addition of Fe(III)PPIX resulted in almost complete quenching of the 
droplet fluorescence.  This may be the first visual, real-time, evidence of heme partitioning into 
the neutral lipid droplets. Within the malaria parasite, heme is released as a consequence of 
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hemoglobin degradation in a continuous manner. The immediate localization of these heme 
molecules in the DV lipid nanospheres would be expected to encourage rapid crystallization of 
hemozoin. However, in vivo transport mechanisms remain unclear. No additional mediator was 
introduced to facilitate the trafficking of Fe(III)PPIX in the current study. However, the same 
spontaneous localization may not exist within the complex environment of the DV. 
The rate of Fe(III)PPIX partitioning into the SNLBs observed using confocal microscopy 
appears to be pH dependent and seemingly parallels conditions required for β-hematin formation 
(96, 110, 111). In the pH range that encompasses that which promotes β-hematin formation in 
vivo (pH ~2.3 to 6.5), Fe(III)PPIX molecules partition rapidly into the SNLBs.  Outside this 
range (pH 1.3, 6.7, 7.3, 8.1), the initial (50 second) quenching was dramatically lower. These 
observations can be attributed to the protonation state of Fe(III)PPIX (Appendix A). At low pH 
(<2.0), both propionates of Fe(III)PPIX are protonated and a water molecule is present as the 
axial ligand. In this environment, an overall charge of +1 substantially decreases the partitioning 
of Fe(III)PPIX into the SNLBs. Between pH 2.3 and 5.5, one propionate is presumably 
deprotonated, producing an overall neutral state which allows Fe(III)PPIX to enter the SNLBs to 
a greater extent. From pH 5.5 to 7.5, both propionates are likely ionized, with the water axial 
ligand remaining protonated and resulting in an overall charge of -1. Fe(III)PPIX again cannot 
easily partition strongly into the lipid. Above pH 7.5, the axial ligand is OH- and the overall 
charge is -2 further inhibiting Fe(III)PPIX from entering the lipid.  Interestingly, over a longer 
time period, there is a further increase in Fe(III)PPIX uptake under these conditions, indicating 
that the rate of Fe(III)PPIX partitioning is decreased. Only in the pH range of the digestive 
vacuole will released heme be able to rapidly enter the lipid droplets to a strong extent and 
convert to hemozoin, avoiding toxicity. This observed pattern of heme partitioning into the 
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SNLBs illustrates the ability of lipid droplets to control the site of hemozoin formation during 
heme detoxification. Similar pH trends of heme partitioning were observed for maximum 
quenching. Specifically, peripheral quenching, indicating that Fe(III)PPIX did not enter the 
interior of the SNLBs,  was observed at pH 1.3 and pH 6.7 and higher.  
 
Conclusions 
 
In this study, confocal microscopic studies confirmed that Fe(III)PPIX spontaneously localizes to 
SNLBs under physiologically equivalent conditions. Visually, a dramatic reduction in 
fluorescence intensity of NR labeled-lipid blend was observed upon introduction of Fe(III)PPIX. 
Further addition of Fe(III)PPIX resulted in almost complete quenching of the droplet 
fluorescence.  This may be the first visual, real-time, evidence of Fe(III)PPIX partitioning into 
the neutral lipid bodies. Within the malaria parasite, Fe(III)PPIX is released as a consequence of 
hemoglobin degradation in a continuous manner. The immediate localization of these 
Fe(III)PPIX molecules in the DV lipid bodies would be expected to encourage rapid 
crystallization of hemozoin. However, in vivo transport mechanisms remain unclear. No 
additional mediator was introduced to facilitate the trafficking of Fe(III)PPIX to the current 
study. However, the same spontaneous localization may not exist within the complex 
environment of the digestive vacuole. 
 
The precise mechanism of formation of hemozoin remains an unanswered question. 
Paradigms from the field of biomineralization suggest that the process involves the 
supramolecular preorganization of an organic matrix (e.g. lipids or proteins) that provides a 
foundation for the second order assembly for inorganic species (1).  In malaria, a growing body 
of evidence suggests that a lipid rich environment is essential for the formation of hemozoin (57, 
 
 
62 
 
73, 88).  However, previous experimental data for beta-hematin formation under physiological 
conditions could not account for the speed of hemozoin formation in vivo or provide details of 
the nucleation and crystal extension process. In part I, lipid bodies were synthetically produced 
to serve as a model for the neutral lipid bodies that exist within the digestive food vacuole of P. 
falciparum and to shed light on their possible roles during hemozoin formation in nature. 
Experimental evidence provided here supports the hypothesis that the nucleation and extension 
of beta-hematin is localized at the interface of neutral lipid bodies and water and that these 
bodies are responsible for the reproducibility of the structural morphology and size of hemozoin 
crystals observed in nature. Based on these observations, beta-hematin formation schematically 
represented in Scheme 3 is proposed. This model accounts for the orientation and formation of 
beta-hematin crystals with respect to these bodies. In particular, the model stems from the 
observation made during these experiments, which revealed the presence of (i) heme localization 
and nucleation at the lipid-water interface, (ii) crystal extension along the interface, (iii) 
orientation of mature crystals and (iv), crystal sizes that appear to be limited by the size of the 
lipid bodies. Finally, it should be noted that it is likely that the transport and delivery of heme to 
the lipid droplets in vivo will differ in several respects. The extent of heme accumulation may be 
much lower, since in the current experimental setup the entire quantity of heme was introduced 
to the lipid system at once, whereas in vivo hemoglobin degradation results in the continuous 
release of heme. In addition, it is possible that proteins may play a role in the delivery of heme to 
the lipid droplets.  
In part II, the partitioning of Fe(III)PPIX to the synthetic neutral lipid droplets at pH 
values close to those of the DV of P. falciparum was demonstrated. The neutral lipid blend 
reported to be present in the DV has unique properties which seem to strongly promote β-
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hematin formation by drastically lowering the activation energy of the process relative to lipid 
emulsions containing monoglycerides. In particular, despite being composed largely of saturated 
mono- and diglycerides, it lowers the activation energy to a level similar to, but even lower than 
the unsaturated diglyceride DOG. This suggests that the particular composition of the blend 
plays a critical role in its biological function. Collectively, these findings strongly support the 
hypothesis that hemozoin formation is brought about by lipid droplets (lipid nanospheres) in the 
DV. It is noteworthy that the time period reported for NLB production in vivo coincides with that 
of the blood feeding stage of the P. falciparum life cycle. The relative abundance and 
localization of lipid bodies are stage dependent (112, 113) with a large numbers of lipid bodies 
found in the late trophozoite and early schizont stages of the intraerythrocytic cycle (113, 114). 
In addition, microscopic observations of lipid bodies during the course of intraerythrocytic 
development have been reported to reveal tiny Nile Red fluorescent dots (<1µm) in the early ring 
stage.  These dots increase in size (~2µm) as development proceeds to later stages (113). The 
overlapping of neutral lipid body production and hemoglobin degradation are unlikely to be 
coincidental and may indicate that neutral lipid droplets are important in sustaining parasite 
viability via heme detoxification through mediation of hemozoin formation.  
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Chapter III 
 
ITERACTIOS OF EUTRAL LIPIDS AD FERRIPROTOPORPHYRI IX 
DURIG HEMOZOI FORMATIO I LAGMUIR-BLODGETT FILMS 
 
Fe(III)PPIX’s potential role in a number of pathogenic conditions has produced an 
increased interest in its behavior in physiological conditions (i.e aqueous solutions) (115). 
Abnormal release of Fe(III)PPIX from protein degradation has been implicated in atheogenesis, 
cancer, hemolysis, and inflammation (116-119). Within the human host, blood feeding parasites, 
such as the pathogenic helminth Schistosoma and the protozoan malaria Plasmodium, degrade 
large quantities of host hemoglobin in order to utilize the protein’s amino acids for maturation. 
As a consequence of this proteolysis, heme is released. In the “free” state, heme induces oxygen 
dependent free radical formation,(120, 121) lipid peroxidation(122, 123) and protein(124) and 
DNA(125) oxidation, all of which are deleterious to the parasite.  Several blood-feeding 
organisms, namely, the malaria parasite Plasmodium falciparum, the worm Schistosoma 
mansoni, and the kissing bug Rhodnius Prolixus,  have evolved efficient adaptations to 
circumvent the toxic effects of “free” heme (11). In these organisms, this process involves the 
crystallization of heme into hemozoin (126).  Despite hemozoin’s established role in the heme 
detoxification pathway, the precise molecular mechanism necessary for hemozoin formation 
remains unclear. 
Recent investigations implicate neutral lipids as the in vivo mediator of hemozoin 
formation (57, 58, 97). Specifically, electron microscopy imaging of P. falciparum, S. mansoni, 
and R. Prolixus provide irrefutable evidence that hemozoin formation occurs in close association 
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with lipid bodies. (57, 77) Using the hydrophobic probe, Nile Red, Tilley and colleagues showed 
that these lipid bodies are closely associated with the digestive food vacuole of P. falciparum and 
that this lipid population measured about a few hundred nanometers in size (73) Sullivan and 
colleague later identified the composition of these lipid bodies as a specific lipid mixture: 
monoglycerols monostearoylglycerol (MSG) and monopalmitoylglycerol (MPG) and the 
diglycerols dilinoleoylglycerol (DLG), dioleoylglycerol (DOG) and DPG (dipalmitoylglycerol) 
in a 4:2:1:1:1 ratio, respectively (herein referred to as the lipid blend) (57). In addition, in vitro 
studies showed that beta-hematin is produced at the lipid-water interface at a rate sufficient to 
avoid heme toxicity (58, 97). Although neutral lipids involvement in hemozoin formation has 
been demonstrated, the exact molecular mechanisms involved are not well understood.  
Works presented in previous chapters have demonstrated the biology realistic process of 
beta-hematin formation at the neutral lipid-water interface (58, 97). To better understand the 
molecular interactions of neutral lipids and heme, it is important to examine the lipid packing at 
the lipid-water interfaces. Traditional methods used to evaluate interface packing rely on 
concepts established in the early 1900’s by Irving Langmuir which remain popular today. The 
surface pressure-area isotherm (π-A) of a floating LB monolayer allows for the systematic 
examination of the 2D interactions of the lipid-Fe(III)PPIX that would otherwise be much 
difficult to do in the hydrated bulk environment. LB techniques have been successfully applied 
to the study of human diseases. For example, Leblanc and colleagues investigated the origin of 
Alzheimer’s Disease by examining packing properties of amyloids (127-129). Regen et al. (130) 
further examined oxysterol induced rearrangement of the liquid-order phase and its link to 
Alzhimer’s Disease. In addition, Chimote and Banerjee investigated mycobacterial cell wall 
lipids notable in tuberculosis (131). In this study, the hypothesis that nucleation of hemozoin 
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occurs via the interaction of Fe(III)PPIX and neutral lipid. The molecular interactions of neutral 
lipids and Fe(III)PPIX molecules are examined to better understand the in vivo mechanism of 
hemozoin formation in malaria. π-A isotherms of the lipid blend and of each of its individual 
components were measured to determine the packing stabilities at the lipid-water interface. The 
Fe(III)PPIX-lipid blend interactions were investigated by compressing lipid blend with various 
substituted protoporphyrin. The molecular corporation of antimalarial drug with the Fe(III)PPIX-
lipid interactions was examined using chloroquine.  This study provides further insight into 
molecular arrangement on the behavior of Fe(III)PPIX and neutral lipid at the interface. Details 
of Fe(III)PPIX and lipid interactions is a prerequisite to elucidation of hemozoin formation in 
nature and provides guidance for new anti-malarial drug design. 
 
Experimental Methods 
 
Langmuir Blodgett Theory 
A molecular film at the air-water interface is called a Langmuir-Blodgett monolayer. This 
type of monolayer provides a unique approach to determine the chemical and physical behavior 
of monolayer of amphiphilic molecules at the phase boundary. An important advantage of 
investigating Fe(III)PPIX-lipid interactions using the Langmuir- Blodgett monolayer approach is 
that the range of molecular areas known to occur in natural neutral lipid bodies can be 
investigated systematically while avoiding the complication associated with the bulk hydrated 
dispersions in vivo. An amphiphilic compound of interest is dissolved in a volatile inert solvent. 
The solution is then spread uniformly at the air-water interface between two movable barriers. 
After the volatile solvent evaporated, a single monolayer film of the compound is formed at the 
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surface. The hydrophobic interactions between hydrocarbon tails and intermolecular interactions 
between the polar head group and the water subphase facilitate the stability of the monolayer. 
The monolayer is treated as a 2D solution and the molecular interactions of the deposited 
molecules are based on additivity relations of the components mean molecular area at various 
surface pressures (π) at constant area as a function of their composition. When the molecules are 
compressed, the molecules experience an increase of interactions with their neighbors. 
Conventionally, an air-water interface measures a force energy per unit area of 72 mM/m at 
20˚C. The deposit of an amphiphilic molecule to the interface will lower the surface tension. 
This measured surface pressure is the force per unit length with which the monolayer expand 
relative to clean surface (129). These interactions are represented in a π-A isotherm, a plot of the 
change in surface pressure (π) with relative to area (A) available to each molecule at the air-
water interface (129). π-A isotherms are commonly recorded by measuring the surface tension γ 
directly (Wilhelmy plate method) or by measuring the difference π = γo- γ between the surface 
tension of the subphase and the surface tension of the subphase in the presence of a monolayer. π 
is then referred to as the film pressure or surface pressure. 
The regions of a conventional isotherm include the gas (G), liquid (L), and solid (S) 
phases and have been reviewed in detail (Scheme 4) .(132, 133) Briefly, when the molecules are 
positioned far apart, the film is said to be in the gaseous phase. In this state, no interactions occur 
between adjacent molecules. As the monolayer is compressed, the surface pressure rises and the 
area per unit molecule decrease, indicating the beginning of the liquid-expanded (LE) phase. 
During this phase, the hydrophobic tails begin to lift away from the subphase and weakly interact 
with adjacent tails. Under continued compression, the monolayer proceeds towards the liquid-
condensed (LC) phase which is associated with short-range molecular interactions between  
 
 
69 
 
 
 
 
 
 
 
 
Scheme 4. Langmuir monolayer compression surface pressure-area (π-A) isotherm.  When an 
amphiphilic lipid is deposited onto an aqueous surface, it is organized so that its polar head 
interacts with the water subphase and its hydrophobic tail oriented away from this subphase. As 
the barriers force the lipids together, a monolayer is formed. The lipid molecules go through a 
gas phase (G) in which minimal interactions occurs between neighboring molecules. Interaction 
between neighboring molecules occurs at the liquid phase. Maximum hydrophobic interactions 
occur when the hydrophobic tails are perpendicular to the subphase and lipid molecules are 
packed tightly together in the solid phase.   
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molecules.  In this state, the molecules are ordered with the hydrophobic tails oriented to 
optimize interactions with neighbors. Further compression results in the solid phase when the 
hydrocarbon tails are perpendicular to the aqueous surface and maximum molecule-molecule 
interactions occur.  Molecules in this phase have limited molecular motion and are packed into a 
rigid monolayer.    
 
Reagents 
All lipids were obtained through Nu-Check Prep Inc. (Elysian, MN).  The following neutral 
lipids were used: MSG – 1-monostearoylglycerol, MPG- 1-monopalmitoylglycerol, DOG – 1,3-
dioleoylglycerol, DLG – 1,3-dilinoleoylglycerol, DPG – 1,3-dipalmitoylglycerol, and TPG- 
tripalmitoylglycerol. The lipid blend refers to the established biological ratio (by vol.) of 
4:2:1:1:1 MSG:MPG:DOG:DLG:DPG, respectively.(57) A lipid blend stock solution of 3 mM in 
chloroform was prepared. A 3 mM stock solution of heme was also produced by dissolving 
appropriate hematin procine (Sigma-Aldrich) in DMSO.  The heme solution was sonicated to 
ensure that all products went into solution. For compression experiments, the stock solutions 
were used to prepare samples of 100 µM lipid blend and 100 µM heme to make a final 100 µL 
volume in chloroform.  50 mM citric buffer was used as the subphase at varying pH of 1.5, 3.0, 
4.0, 5.0, and 7.0. The buffers were filtered three times using 0.2 µm filter paper to remove 
impurities. This buffer does not promote beta-hematin formation and thus, is unlikely to disturb 
lipid and Fe(III)PPIX interaction18.     
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Scheme 5. The chemical formulas of the investigated compounds  
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Instrumental design 
π-A isotherms were determined with a LB Teflon trough (Nima Model 612D) with a 
maximum area of 600 cm² and two mechanically coupled barriers. The surface pressure was 
measured by the Wilhemly plate method, using a filter paper of 1 cm width and Nima software. 
Prior to the measurements, the paper was rinsed and pre-wetted with the citric buffer (50 mM) 
subphase solution. Before each measurement, the subphase cleanness was checked for possible 
adsorbed impurities by measuring the surface pressure in the entire area interval. This pressure 
remained lower than 0.3 mN/m. All deposition was done using a 100 µL microsyringe 
(Hamilton). Each compression was performed in triplicates to ensure reproducibility. 
 
Langmuir-Blodgett π-A Isotherm 
  For neutral lipid compression studies, a 10 µL solution of 100 µM MPG, DPG, TPG, or 
lipid blend (4MSG:2MPG:1DOG:1DLG:1DPG) was deposited onto the citric buffer subphase. 
In this study, all measurements of π-A were collected under barrier compression speed of 20 
cm2/min. To evaluate the interaction of the lipid blend-Fe(III)PPIX, a premixed solution 
containing 100 µM of Fe(III)PPIX and lipid blend was made in chloroform. Ample time was 
allowed for the spreading solvent, CCl3H, to evaporate before compression. To evaluate the 
effects of pH on the packing of lipid blend-Fe(III)PPIX, additional compressions were performed 
by spreading premixed solution onto citric buffer subphase at varying pH (1.5, 3.0, 4.0, 5.0, and 
7.0).  DMSO was employed to facilitate heme solubility. To investigate the molecular interaction 
of heme and lipid, compressions of the lipid blend and substituted protoporphyrin were 
performed.  A solution of 10 µL of 100 µM lipid blend and Fe(III)PPIX was deposited onto 
clean citric buffer subphase. 15 minutes was allotted for the spreading solvent to evaporate 
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before compressing. This experiment was repeated with the substitution of protoporphyrin IX 
(PPIX), and ferriprotoporphyrin IX dimethyl ester for Fe(III)PPIX(Frontier Scientific). To ensure 
that DMSO did not contribute to the packing of Fe(III)PPIX-lipid, a control study was performed 
by premixing 3.3% DMSO in chloroform. 10 µL of this solution was deposited onto clean citric 
buffer subphase and compressed. Less than 0.1 mN/m increase in surface pressure was observed, 
suggesting that minimal addition of DMSO did not disturbed packing properties of molecules 
under investigation.   
 
Antimalarial interactions 
  To examine the effects antimalarials drugs have on the lipid blend-Fe(III)PPIX packing, 
premixed solutions of 1:1:1 ratio of lipid blend:Fe(III)PPIX: chloroquine, all at 100µM, were 
compressed. Isotherms of lipid blend: anti-malarial were measured. Confocal analysis was 
employed to provide further insight into CQ mechanism of action at the lipid-water interface. 
Specifically, the hydrophilic dye Nile Red (NR)(73, 78) was used to determine the localization of 
CQ relative to the lipid surface. Synthetic neutral lipid bodies (SNLB) composed of the lipid 
blend was prepared by dissolving the proper ratio of lipid in a solution of 1:9 acetone to 
methanol (58, 97). 200 µL of this solution was deposited onto the surface of 5mL citric buffer 
(50mM, pH 4.8) within a 15mL BD Falcon conical tube. The lipids are incubated at 37˚C for 
approximately five minutes to allow for the spontaneous formation of SNLB. A 1 mM stock 
solution of Nile Red (MP Biomedicals) was prepared in acetone and used immediately. A proper 
volume of NR was then added to the SNLB solution to produce a 10:1 ratio of lipid to Nile Red. 
180 µL of the SNLB was transferred to a glass bottom microwell dish (35mm Petri dish and 14 
mm microwell dish, MatTek Corporation). A 1 mM CQ solution was prepared in water. 20 µL of 
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CQ solution was introduced to the SNLB-NR solution and imaged using a Zeiss LSM 510META 
upright confocal microscope (VUMC Cell Imaging Shared Resource) using the time series 
application with 63× oil(1.4) immersion objectives. Z-stacking was performed before and after 
quenching to ensure lipid bodies were not displaced during the experiment. Approximately 20 
seconds after the first CQ addition, another 20 µL of chloroquine stock solution was added. This 
was repeated every 20 seconds for a total of 300 seconds and 625 µM.   Images were prepared 
for publication using the LSM510 software. To confirm confocal data, fluorescence spectra were 
confirmed on the SNLB system. 20µL of a 1mM lipid blend in 1:9 acetone to methanol solution 
was added to water. 2 µL of a 1 mM NR in acetone was added to the SNLB system. 5, 10, 50, or 
100 µM of CQ was then added. The fluorescence spectrum was measured on a Varian Cary 
Eclipse fluorescence spectrophotometer.  Both excitation and emission slit widths were set to 5 
nm with a medium scan control and medium PMT detector voltage.  The sample was excited at 
590 nm and the emission spectrum was recorded from 650 nm. These fluorescence parameters 
for NR were previously reported by Greenspan (78).  
 
Results and Discussion 
 
eutral lipid isotherm 
A schematic representation of the lipid components is shown in Scheme 5. π-A 
isotherms, expressed by area (Å2) per lipid molecule, of mono-,di-,tri- palmitoyl glycerol and the 
lipid blend at physiological temperature (37˚C) revealed that the lipid blend packs more similarly 
to mono-glycerol than di-glycerol (Figure 18b). MPG forms a typical liquid-condensed (LC) 
monolayer with a relatively steep rising π-A isotherm curve. This isotherm curve is shifted to 
higher molecular area by about 473 Å2 /molecule for DPG and about 735 Å2/molecule for TPG. 
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More saturated molecules exhibited higher surface pressure maximums and a slightly steeper π-
A curve. Given that the hydrocarbon tail length is constant in all three samples, the packing 
differences observed are attributed to the degree of hydrocarbon tail saturation. Increased 
saturation leads to better packing efficiency as a result of increased non-covalent interactions 
between the hydrophobic tails. Under compression, these more saturated molecules come into 
contact with neighboring molecules, maximizing their interactions. These interactions are 
represented by a steeper isotherm curve at higher molecular area for DPG and TPG (Figure 18a). 
The lipid blend π-A isotherm exhibited an expanded LE phase with a maximum pressure of 32 
mN/m with a limiting area of 987 Å2/molecule, suggesting a disordered state with weak 
interactions between lipid molecules. Here, packing studies reveal that the lipid blend differs 
from its individual components. Differential scanning calorimetry (DSC) measurements of the 
lipid blend and its individual components may further corroborate the proposal that the lipid 
blend provides a unique hemozoin crystallization environment. By convention, the limiting area 
(Alim) values correspond to the extrapolation of the lowest compressibility region or best packed 
phase of the isotherm to zero surface pressure. In the case of neutral lipid compression, these 
values represent the area corresponding to the transition from LE to LC phase.  A linear trend 
was observed between glycerol saturation and corresponding Alim values; more saturated glycerol 
experienced a phase transition (LE-LC) at higher area/molecule than the less the saturated 
sample. Alim values of 840, 1313, and 1575 Å
 2/molecule were plotted against its corresponding 
lipid degree of saturation, MPG (1), DPG (2), TPG (3), respectively (Figure 18b). A linear 
relationship was observed for Alim and degree of saturation (y= 367x + 507, r
2 = 0.97). The 
isotherm of the lipid blend displayed a Alim value of 987 Å
 2/molecule. When this value was  
 
 
 
76 
 
 
 
 
 
Figure 18. (a) Surface pressure-area (π-A) isotherms and (b) limiting packing area (Alim) of 
mono-,di-, and tripalmitoyl glycerol (MPG, DPG, TPG, respectively) and the lipid blend. Alim of 
MPG, DPG, and TPG was dependent on the degree of saturation (MGP=1, DPG =2, TPG =3)(b).  
 
 
 
 
 
 
77 
 
extended to the established linear relationship, the lipid blend exhibited a 1.3 degree of 
saturation, suggesting that the predominate molecules in the lipid blend, mono-glycerols, 
exhibited more influences on molecular orientation as the extrapolated degree of saturation is 
closer to that of MPG than DPG (Figure 18b). 
            The lipid blend which possesses varying degrees of saturation and hydrocarbon chain 
length, packs less rigidly than those of its individual components as evident of the extended LE 
in its π-A isotherm (Figure 18). This is not unexpected given the diversity in its composition. The 
differences in hydrocarbon length and kinks and head group polarity give rise to a more fluid and 
irregular templating surface. This corrugated surface(134) can provide “pockets” for precursor 
Fe(III)PPIX dimers to intercalate in order to assemble, initiating hemozoin nucleation. 
Furthermore, the increase in packing fluidity can justify the existence of the lipid blend 
complexity. If one type of lipid is sufficient to template hemozoin formation,(58, 97) why does 
the parasite command a composition of five different lipid components? The answer is likely to 
be associated with the increase in surface energy associated with the template surface. Ongoing 
research is being performed to examine the kinetics of beta-hematin formation under lipid blend 
mediation. Comparison of the rate and activation energy associated with the lipid blend to that of 
its individual components may explain the use and the uniqueness of the lipid blend during in 
vivo hemozoin formation. 
 
eutral lipid-Fe(III)PPIX packing 
 While Fe(III)PPIX is insoluble in aqueous solutions, it is soluble in lipid environments. 
Investigation of beta-hematin formation under lipid mediation revealed that crystallization occurs 
at the interface of lipid bodies and water. Importantly, the rate of Fe(III)PPIX conversion at the 
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interface is rapid enough to account for Fe(III)PPIX toxicity.(58, 97) However, on a molecular 
level, little is known about the interactions that occur during this process, especially during 
crystal nucleation. To further examine the behaviors of lipid and Fe(III)PPIX molecules at the 
interface, LB compressions were performed deposits of lipid blend-Fe(III)PPIX. The 
introduction of Fe(III)PPIX to the lipid blend resulted in shift to higher molecular area of the π-A 
isotherm (~1085 to 1353 Å 2/molecule). This lipid blend-Fe(III)PPIX isotherm exhibited a much 
expanded LE phase (Figure 18). The transition from LE-LC of the mixed solution occurred at 
slightly higher area (1303 Å2/ molecule) than that of the lipid blend alone (1078 Å 2/molecule). 
However, lifting of the lipid blend-Fe(III)PPIX isotherm started at 2812 Å 2/molecule, suggesting 
that the introduction of Fe(III)PPIX encouraged weak interactions between the lipid molecules at 
high molecular area. The maximum pressure increased by 8 mN/m, from 32 to 40 mN/m upon 
the addition of Fe(III)PPIX. Here, the early transition to the LE phase upon the incorporation of 
Fe(III)PPIX is interpreted as the interaction of Fe(III)PPIX to the lipid molecules.  
Efficient interactions of lipid molecules and Fe(III)PPIX that promote crystallization 
favor a less organized lipid-Fe(III)PPIX packing state. This packing state is pH dependent 
(Figure 20). To examine the contribution pH to the packing of lipid-Fe(III)PPIX, compressions 
of premixed  Fe(III)PPIX- lipid blend on citric buffer subphase at varying pH (1.5, 3.0, 4.0, 5.0, 
and 7.0) were performed.  At pH 3.0-5.0, packing isotherms exhibited extended LE phase with a 
limiting area of roughly 824 Å 2/molecule (Figure 20), suggesting a loose ordered packing. 
Outside this pH range, pH 1.5 and 7.0, the isotherm curves shifted to the right with a limiting 
area of 940 Å 2/molecule. The maximum packing pressure for the samples at pH 1.5 and 7.0 were 
nearly twice  
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Figure 19. Pressure-area (π-A) of lipid blend  and protoporphyrin-lipid blend mixtures at 100 
µM. Introduction of Fe(III)PPIX to lipid blend created an extended liquid expansion phase at 
higher molecular area. The removal of the iron center of Fe(III)PPIX produced little change to 
this shift. However, the replacement of the propionic group produced a shift to lower molecular 
area. Unlike the isotherm plot of the LB which exhibited a distinct liquid condense phase, the 
isotherm plot of dimethlyester PPIX-lipid blend revealed a more liquid-expanded phase, 
suggesting that Fe(III)PPIX-lipid interactions occur via the propionic group of Fe(III)PPIX and 
polar head group of the lipid molecules.  
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as those of pH 3.0, 4.0, and 5.0. Rigid packing was observed for compressed monolayer at pH 
1.5 and 7.0. In conjunction to published in vitro studies of beta-hematin formation by 
monoglycerols that reported a pH bell-shape  dependence (~2.5-6.0) for crystallization,(91, 97) 
packing studies presented here suggest that weak interactions between lipid molecules is  
 necessary to template hemozoin formation.  Alim values of 894 and 888 Å
 2/molecule were 
extrapolated from π-A isotherms at pH 1.5 and 7.0. However, at pH 3.0, 4.0, and 5.0, Alim values 
were 718, 743, and 750 Å 2/molecule. At 1.5 and 7.0 pH, lipid molecules interact at higher 
molecular area, suggesting that at these pH, better packing existing between molecules.  The 
solutions exhibiting high disorder include those with a pH similar to that of the parasite’s 
digestive food vacuole (~4.8), the site of in vivo hemozoin crystallization.   Under low pH 
condition ( < 2), both propionic groups of Fe(III)PPIX are predominately un-ionized, giving the 
molecule an overall charge of +1. Under high pH (>6) condition, both groups are ionized, giving 
the Fe(III)PPIX an overall charge of -1. At pH 1.5 and 7.0, the charged molecules of Fe(III)PPIX 
are available to participate in electrostatic or salt bonding with the lipid molecules, resulting in 
stronger packed monolayer and LE-LC transition at higher molecular area.  Beta-hematin 
crystallization occurs optimally under conditions in which one propionic acid is predominately 
ionized and the other predominantly un-ionized (pH 2.5-6.5).(90, 91, 97) Under conditions in 
which both groups are predominantly un-ionized (lower pH) and both are ionized (higher pH), 
no beta-hematin is formed. Only at the pH range of the digestive vacuole (~4.8) will Fe(III)PPIX 
be able to interact with the lipid molecules to form hemozoin.(91, 97) 
To assess which component of the Fe(III)PPIX molecule interacts with the lipid bodies, 
π-A compression measurements were performed with the lipid blend and various substituted 
porphyrins. An isotherm similar to that of lipid blend-Fe(III)PPIX was measured for the 
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compression of lipid blend-PPIX (Figure 19). The molecular contact involved during 
Fe(III)PPIX-lipid blend interaction was preserved for the compression of PPIX-lipid blend, 
suggesting that the center iron does not interact with the lipid. However, the substitution of the 
dimethlyester group for the propionic group produced an isotherm shift slightly to the left of the 
lipid blend isotherm curve. The lipid blend-dimethylester isotherm displayed an expanded LE 
phase with a reduced pressure maximum of 16 mN/m, indicating that limited interactions 
between molecules only occur at low molecular area. The lipid blend-dimethylester PPIX 
isotherm is interpreted as limited or no interaction occurring between lipid molecules and 
dimethylester PPIX.  The removal of the propionic group disrupted this interaction, as evident 
with a strong shift of the isotherm curve to the left. Together, the substituted PPIX study 
proposed that lipid-Fe(III)PPIX interactions occur via the propionic group of the Fe(III)PPIX.  
In light of recent investigations of neutral lipid mediation of beta-hematin formation at 
the lipid-water interface, (97) the substituted PPIX compression study provides further details of 
molecular interaction involved during this crystallization process. Experimental data provided 
here suggest that crystal nucleation begins with the anchoring of a Fe(III)PPIX precursor to the 
lipid group at the lipid-water interface. In an aqueous environment, where competing hydrogen 
bonds occur, molecular dynamic (MD) simulations reveal that the beta-hematin precursors 
rapidly rearrange to form π-stacked dimer of H2O-Fe(III)PPIX (58). The formation of this beta-
hematin precursor involves an increase in the lateral shift between the porphyrins and 
electrostatic interaction of the negatively charged propionate of one H2O-Fe(III)PPIX with the 
positively charged Fe(III) center of the other. In this form, the propionate group interacts with 
solvent molecules rather than the  
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Figure 20. PH dependence of lipid blend-Fe(III)PPIX packing. Packing of Fe(III)PPIX-lipid 
blend is more ordered at pH 1.5 and 7.0. A more disordered packing was observed for pH 3.0, 
4.0, and 5.0. Limiting area is highest at flanking pH (1.0, 7.0). In conjunction with in vivo 
examination of beta-hematin formation,(97) packing studies suggest that beta-hematin formation 
favors a disorder arrangements of lipid blend-Fe(III)PPIX. 
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Fe(III) center. Within the aqueous environment, the hydrophobic tail of the neutral lipids will 
likely favor an organization that includes the hydrophilic head group exposed to the aqueous 
environment with the hydrocarbon tail towards the interior of the lipid body.  In this 
arrangement, the hydrophobic head group is available to anchor the precursor Fe(III)PPIX dimer, 
via the propionic group, to initiate crystal nucleation via the {100} or {010} faces (45, 89, 97). 
Conversion of the anchored dimer precursors to beta-hematin requires only a ligand exchange 
process with bond formation from the propionate O to Fe(III) with the displacement of the H2O 
from the opposite face of each porphyrin (58). In the presence of completing water hydrogen 
bond to the axial center of Fe(III)PPIX unit, these units cannot coordinate to form the hemozoin 
Fe-O dimer precursor, as demonstrated by Egan et al. using computational modeling (58). 
Instead, in the aqueous environment, Fe(III)PPIX units form π dimers with water molecules 
acting at the axial ligand. However, within the hydrophobic environment of the lipid layer, the 
hydrophobic Fe(III)PPIX is sheltered from the water molecules, allowing the dimers to come 
together to nucleate the crystal.  Crystal nucleation is likely to occur through seeding of anchored 
Fe(III)PPIX unit to the polar lipid head group. Crystal growth is then hindered by the geometry 
of the lipid bodies. The tapering off morphology and uniformity of hemozoin size in nature is 
likely a result of the curvature of these lipid bodies. This model, as depicted in Scheme 6, is an 
updated version of the model presented in chapter II (97). Though interfacial growth is a possible 
model, it seems unlikely in light of compression studies and Fe(III)PPIX partition data.  
 
Anti-malarial interactions 
          Traditional anti-malarials, such as chloroquine (CQ), a drug that is no longer effective as a 
result of drug resistance, function by thwarting hemozoin formation. This process is proposed to  
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Figure 21. Langmuir compression of premixed CQ, Fe(III)PPIX, and lipid blend. The addition of 
Fe(III)PPIX to the lipid blend increased the lipid molecules packing stability, as indicated by an 
isotherm curve shift to higher molecular area (b). Compression of lipid blend-Fe(III)PPIX in the 
presence of CQ produced an isotherm similar to that of just the lipid blend (c), suggesting that 
CQ disrupts the Fe(III)PPIX-lipid interactions Little interaction occurred between the lipid blend 
and CQ as indicated by the isotherm of premixed CQ and lipid blend resembling the isotherm of 
the lipid blend(d). 
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occur via formation of π-π complex between Fe(III)PPIX and these drugs in solution.(135) It is 
thought that CQ operates by intercalating its quinoline rings between the aromatic groups of the 
beta-hematin molecules and sterochemically capping onto the {001} surface of the crystal via 
(porphyrin) acid-amine (quinoline) salt bridge (45, 49). To examine the molecular interactions of 
CQ, lipids, and Fe(III)PPIX these samples were spread onto aqueous citric buffer subphase. The 
isotherm of the lipid blend-CQ displayed a slight shift to higher molecular area from the lipid 
blend π-A curve with a slight increase in maximum pressure (Figure 21). Interestingly, when 
Fe(III)PPIX was premixed with CQ and lipid blend, an isotherm identical to that of the lipid 
blend-CQ was measured. The compression of CQ and lipid blend produced an isotherm similar 
to that of just the lipid blend (Figure 21). These results suggest that the presence of CQ 
interrupted the interactions between lipid and Fe(III)PPIX and that minimal interactions existed 
between CQ and the lipid layer. Current proposal for hemozoin formation involves crystal 
formation in close association to lipid bodies within the digestive food vacuole of P. falciparum. 
Thus, for proper antimalarial functionality, CQ must partition into the lipid layer. To examine the 
localization of CQ to the lipid bodies, synthetic neutral lipid bodies (SNLB) were produced by 
depositing the lipid blend onto an aqueous buffer and were tagged with the hydrophobic dye Nile 
Red.  Confocal imaging showed that these SNLBs were identical in shape, size, and composition 
as those in nature (Figure 22b,c) (57, 73, 97).  The addition of approximately 625 µM CQ to this 
SNLB system produced no significant fluorescence change (Figure 22b,c). Fluorescence spectra 
of mixed CQ and SNLB explained confocal observation. In particular, the addition of CQ to the 
SNLB-NR system produced an increase in NR fluorescence intensity (Figure 22a). The 
introduction of 100 µM CQ to the SNLB-NR system resulted in an increase in fluorescence 
intensity by 43% (Figure 22a). Given the electron-rich structure of CQ, the close proximity of  
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Figure 22. Fluorescence spectra of synthetic neutral lipid body (SNLB) tagged with the 
hydrophobic dye, Nile Red (NR). The addition of CQ to 100 µM SNLB produced an increased in 
fluorescence intensity (a), suggesting the presence of an electron transfer from CQ to NR. 
Confocal imaging (b,c) confirmed fluorescence spectra analysis by demonstrating that the 
addition of 625 µM CQ over the period of 300 second (c) does not significantly quench SNLB-
NR fluorescence. 
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CQ and the π-acceptor NR, it is likely that a charge transfer from CQ to NR produced the 
observed fluorescence intensity increase. Here, the increased in NR fluorescence indicates that 
CQ spontaneous localizes to the SNLB. However, this scenario changed with Fe(III)PPIX was 
introduced to this system. When a premixed CQ and Fe(III)PPIX solution was added to the 
SNLB-NR, NR  quenching was observed (Figure 23), suggesting an energy transfer from NR to 
Fe(III)PPIX. Previous infrared spectroscopy examination of CQ during beta-hematin formation 
revealed that Fe(III)PPIX and CQ form complexes (136) with a 2 equivalent of Fe(III)PPIX to 1 
equivalent of CQ(137), preventing binding to Fe(III)PPIX from axial both face of Fe(III)PPIX. 
During the premixing stage, CQ and Fe(III)PPIX formed a complex that includes both axial face 
of Fe(III)PPIX capped by CQ (136, 137).  When this solution was introduced to the SNLB-NR 
system, the hydrophobic CQ-Fe(III)PPIX-CQ complex favored a localization with the 
hydrophobic lipid environment as evident in observed NR quenching. Despite the localization of 
Fe(III)PPIX to the lipid bodies, no beta-hematin was formed. This is not unexpected given that 
beta-hematin is thought to formed when two Fe(III)PPIX molecule complex to form a dimer. 
These dimers hydrogen bond with neighboring dimers to produce the macroscale crystal. In the 
presence of CQ, Fe(III)PPIX molecules are capped and cannot form the necessary bonds to 
initiate crystal nucleation. Together, compression studies of lipid and CQ in conjunction with 
fluorescence analysis provided further insight to CQ’s mechanism of action. Here, data suggest 
that CQ function in vivo by preventing crystal growth and not by direct interaction with lipid 
bodies. The interruption of Fe(III)PPIX-lipid interaction via CQ-Fe(III)PPIX-CQ complex, will 
inhibit crystal nucleation which leads to the accumulation of toxic Fe(III)PPIX, leading to the 
death of the parasite. 
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Figure 23. Fluorscence spectra of chloroquine (CQ) and Fe(III)PPIX and the Nile Red (NR) 
labeled synthetic neutral lipid body (SNLB) system. The introduction of CQ to SNLB-NR 
produced an increase in fluorescence intensity (a, b), suggesting that CQ spontaneously localized 
at the SNLB. The addtion of premixed CQ and Fe(III)PPIX decreased this fluroscence (c); 
however, this fluroscence intensity is still more than that of just SNLB-NR and Fe(III)PPIX. 
Together, these data indicates that CQ functions by hibiting hemozoin crystal nucelation. The 
pre-formed CQ-Fe(III)PPIX-CQ complex prevents Fe(III)PPIX molecules from assemblying by 
capping both axial face of Fe(III)PPIX.   
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Scheme 6. Proposed lipid-Fe(III)PPIX interaction during hemozoin formation. Precursor 
Fe(III)PPIX dimers are formed in the aqueous environment. In the absence of competing water 
molecules, hemozoin nucleation occurs when these dimers come together at the interface. Crystal 
growth occurs parallel to the interface.  
 
 
 
 
 
 
90 
 
Conclusion 
 
The examination of interfacial packing of the lipid blend, a lipid mixture associated with 
the formation of the malaria pigment in nature, has demonstrated the uniqueness of this mixture. 
Namely, the lipid blend packs into an extended liquid expanded state with weak interactions 
between lipid molecules. The lipid blend’s unique packing property is attributed to its complex 
composition. This high energy condition accounts for the low activation energy associated with 
in vitro synthesis of synthetic hemozoin, beta-hematin, under the mediation of the lipid blend by 
increasing the rate of crystal nucleation. In conjunction to reported studies of beta-hematin 
formation, less ordered packing of lipid molecules and Fe(III)PPIX is optimal for crystallization. 
This optimal packing occurs within the pH range of 3.0-5.0. Results from the substituted 
protoporphyrin IX (PPIX) study proposed that nucleation initiates via the anchoring of the 
propionic group of Fe(III)PPIX to the polar head group. Finally, this study provides preliminary 
details into the investigation of chloroquine interaction at the lipid-water interface. LB packing 
analysis reveals that minimal interaction exists between lipid and CQ and supports the current 
hypothesis that chloroquine functions by capping hemozoin extension (49, 135, 138). This study 
illustrates the effectiveness of LB techniques to investigate molecular interactions at the lipid-
water interface during hemozoin formation.  
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Chapter IV 
 
CRYSTAL EGIEERIG: SOLVET EFFECTS O BETA-HEMATI FORMATIO 
 
Heme (ferriprotoporphyrin IX - Fe(III)PPIX) is an ubiquitous and essential molecule 
which plays key biological roles in processes like oxygen transport, respiration, photosynthesis 
and drug detoxification (28, 139, 140). Despite this, heme is also capable to cause a number of 
cellular deleterious effects (141). Blood feeding organisms implicated in malaria, 
schistosomiasis, and Chagas’ disease , namely, the malaria parasite Plasmodium falciparum, the 
worm Schistosoma mansoni, and the kissing bug Rhodnius Prolixus, produces free heme as a 
byproduct of their digestion of large quantities of hemoglobin (Hb) to meet their nutritional 
requirements (15). It is believed that the same lipid composition is present in all model system. 
To circumvent heme toxicity, these organisms have evolved a detoxification mechanism that 
converts toxic heme into a non-toxic hemozoin (23, 142). Powder x-ray diffraction of this crystal 
revealed a triclinic unit cell with a space group of Pī (41). The macroscopic crystal is comprised 
of heme (Fe(III)PPIX) dimers formed through reciprocal iron-carboxylate bonds (42), where the 
propionic side chain of a porphyrin coordinates with the axial Fe of another. The dimers then 
hydrogen bond to form an extended network of dimers (41).  As previously previewed in chapter 
III, the significance of hemozoin lies in its association with antimalarial functionality. In 
Plasmodium, antimalarial key drugs such as chloroquine function by disrupting this heme 
detoxification pathway. Inhibition of heme conversion results in the accumulation of toxic free 
heme, which leads to parasite death. Understanding the molecular details of hemozoin formation 
may provide insight to future anti-malarial designs. 
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Due to the labor intensive process involved in obtaining hemozoin from model animals, the field 
of hemozoin research has relied heavily on synthetically produced hemozoin known as beta-
hematin. Chemically (42) and structurally (41), hemozoin and beta-hematin are identical. 
Various synthetic routes have been proven successful in crystal mediation, including benzoic 
acid (90), acetic acid (91), neutral lipids (58, 73, 97), detergents (143), and alcohol (87) –based 
systems. All these methods require the introduction of soluble heme to a crystal mediating 
system. However, limited data is available on the comparability of beta-hematin produced using 
these various system. Hemozoin found in nature possesses a conserved molecular structure. 
Crystal morphologies differ significantly among Plasmodium, Schistosoma, and Rhodnius. 
Crystals obtained from Plasmodium are very regular in shape with well defined crystal faces. S. 
manosoni hemozoin are heterogeneous in size, ranging from 50 nm to a few micrometer in 
diameter, with a spherical shape (44, 77). Hemozoin crystals from R. prolixus exhibit irregular 
surface topography and are generally much larger than crystals obtained from Plasmodium (44, 
144). The reasons behind this non-homogeneity in crystal morphologies remain unclear; 
however, it is likely related to the in vivo mediator of crystal formation.   
This study provides a systematic approach for investigating the mechanisms of chemical 
reactions in solutions that lead to beta-crystal nucleation. The works presented in this chapter 
were performed in a collaborative effort with Dr. Marcus Oliveira and Renata Stiebler from 
Universidade Federal do Rio de Janeiro (Brazil) and Dr. Timothy Egan from The University of 
Capet Town (South Africa). This study investigates the role of increased dissociation of acid 
heme precipitates by reducing the medium polarity plays a role on in vitro beta-hematin 
formation. The data presented here support the notion that reduction in medium polarity 
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increases the steady-state levels of soluble heme in acidic milieu, accelerating heme 
crystallization. In addition, beta-hematin crystal morphologies were correlated to solvents’ water 
miscibility and polarity properties. The controllability of crystal habits through the manipulation 
of solvent selection was also examined.  The ability to control crystal morphologies during beta-
hematin applications such as antimalarial drug screening (143, 145) and disease detection (146) 
may be advantageous. Solvent effects on crystal habits can be exploited to maximize molecular 
targets.  
 
 
Materials and Methods 
 
Materials 
             All materials used were of analytical grade or of the highest grade of purity available 
from commercial suppliers. HEPES, sucrose and Polyethylene glycol (PEG) (PEG 300; PEG 
3.350; PEG 6.000; PEG 8.000; PEG 20.000; PEG 22.000) were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). Pyridine, acetonitrile, dimethyl sulfoxide (DMSO), sodium acetate, 
sodium bicarbonate, sodium acetate, glacial acetic acid, and others reagents were obtained from 
(Merck, Darmstadt, Germany) and used without further purification. All other reagents were of 
analytical grade. All water used in the study was of ultrapure grade.  
For morphology studies, the following solvents were used: dimethyl sulfoxide (DMSO), 
dimethylformamide (DMF), tetrahydrofuran (THF), dichloromethane (DCM), acetonitrile 
(meCN), chloroform (CF), toluene, and hexane (Table 1).  For all beta-hematin morphology  
studies, 1 mg of hemin chloride (Sigma) were used unless otherwise stated. Citrate buffer (CB) 
at pH 4.8 and 50mM was used as the aqueous medium in crystallization studies. Previous studies 
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by Egan(58) have shown that this buffer does not mediate beta-hematin formation and will not 
accelerate crystal formation as does the widely used acetate buffer (91). 
 
Spectroscopy and electron microscopy studies 
In PEG-induced reactions, the final products were purified by using 0.1M sodium 
bicarbonate buffer, pH 9.1 washing steps as previously described.(49) FTIR spectra of undried 
material were recorded between 2000 cm−1 and 1000 cm−1 and were carried out as Nujol mulls in 
a Thermo Mattson Satellite FTIR. XRD measurements of pigments induced by DMSO-driven 
reactions, were performed in undried samples in a Huber Imaging Plate Guinier Camera 670 (58) 
in the 2theta range 4–30o using Cu-Ka radiation (=1.5418 Å) operating at 20 mA and 40 kV, 
with a step 75 resolution of 0.005o. For PEG-induced reactions, XRD analyses of purified dried 
pigments were performed using Cu Kα radition (λ = 1.541 Å), with data collection on a Scintage 
Instrument with vertical goniometer in the 2theta range 5-40˚ using a silicon sample holder. 
Scanning eletron microscopy (SEM) was used to investigate the external morphology of the 
beta-hematin produced. Finely ground samples were sprinkled onto aluminum stubs pre-coated 
with an almost dry carbon and glue mix. Excess sample was then removed before the samples on 
the stubs were sputter-coated with gold–palladium, and finally examined with a Leica S440 
Scanning Electron Microscope (for DMSO-induced pigments) and a Hitachi S-4200 (Japan) 
Scanning Electron Microscope (for PEG-induced pigments). 
 
Heme solubility in solvent: aqueous system 
The effect of different DMSO and polyethyleneglycols (PEG) on heme solubility was 
assessed by two different approaches: the first one by measuring the light absorption of Soret 
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band and the second one by using the alkaline pyridine method (147). For both methods, heme 
(100 µM) was added to sodium acetate buffer containing DMSO or PEG in polypropylene (1.2 
mL) tubes and were shaken for 10 minutes at room temperature. Then, the tubes were 
centrifuged for 10 minutes at 17.500 x g and the supernatants collected. For the first procedure, 
all the supernatants were analysed by light absorption wavelength scan between 300 nm and 800 
nm, which were carried out in a GBC-920 spectrophotometer (GBC, Australia). To quantify 
heme, an aliquot of 300 µL from supernatants were added to 700 µL of alkaline pyridine solution 
(20 % (v/v) of 1 M NaOH; 48 % (v/v) pyridine; 32 % (v/v) MiliQ water). The samples were 
analyzed by light absorption wavelength scan between 500 nm and 600 nm in a GBC-920 
spectrophotometer (GBC, Australia).  
The effect of different organic solvents on heme solubility was assessed by light 
absorption analysis.  Hematin porcine was added to 1:1 CB: solvent (by volume) to produce a 
100mM solution. The sample was centrifuged for 10 minutes and the supernatants were 
collected. UV-vis absorption as collected from 300-800nm using an Aligent 8453 
spectrophotometer. To quantify light absorption results, the effect of different organic solvents 
on heme solubility was further assessed using the alkaline pyridine method.(147) Heme (100 
mM) was added to CB containing DMSO, DMF, THF or MeCN (50% v/v) in polypropylene (1.2 
mL) tubes and was shaken for 10 minutes at room temperature. Then the tubes were centrifuged 
for 10 minutes at 17.500 xG and the supernatants were collected. To quantify unreacted heme, an 
aliquot of 300 mL from supernatants were added to 700 µL of alkaline pyridine solution (20 % 
(v/v) of 1 M NaOH; 48 % (v/v) pyridine; 32 % (v/v) MiliQ water). The samples were then 
analyzed by light absorption (500nm-600nm) on a GBC-920 spectrophotometer (GBC, 
Australia). Due to the presence of a biphase solution produced by toluene, DCM, and CF, 
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solubility measurement were performed only with water miscible solvents (DMSO, DMF, THF, 
and MeCN).   
 
Beta-hematin formation and characterization 
Spontaneous heme crystallization reactions under DMSO and PEG mediation were 
carried out in polypropilene tubes in the presence of 0.5 M sodium acetate buffer, pH 4.8, 100 
µM hemin, previously prepared in 0.1 M NaOH as 10 mM stock solutions, with a final volume 
of 1.0 mL. Tubes were kept for different times at 37oC. To evaluate the role of organic solvents 
on heme crystallization, different concentrations of DMSO, PEGs or acetonitrile were added 
previously to sodium acetate buffer before reactions were started. Then, the pH of all solutions 
were measured and adjusted to give an apparent pH 4.8, accordingly. The beta-hematin produced 
was determined by washing the pellet with “extraction buffer” (0.1 M sodium bicarbonate and 
SDS 2.5 %, pH 9.1), solubilizing it in 0.1 M NaOH and measuring the amount of heme 
spectrophotometrically at 400 nm (81). Kinetics of heme crystallization using Tween 20 were 
performed under the same conditions, at concentrations of 0.1 µM, 2 µM and 60 µM. 
Solvent effects on beta-hematin morphologies were investigated by adding 1mg of 
hematin porcine to a solution of 1:1 ratio of CB: solvent (by volume) in a glass vial. The sample 
was sonicated for 5 minute to help facilitate heme solubility and then placed in an incubator at 
37˚C for 12 hr. Products collected at the end of incubation period were characterized by Fourier 
transformed infrared (FTIR) spectroscopy of undried material as Nujol mulls. Powder X-ray 
diffraction (XRD) of the extensively washed dried product, and scanning electron microscopy 
(SEM) imaging of samples were also performed.  XRD was carried out using Cu Kα radiation 
(λ=1.541 Å), with data collection on a Philips PW1050/80 vertical goniometer in the 2θ range 5 
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– 40° using an Al sample holder.  Images of crystal products were obtained from a Hitachi S-
4200 scanning electron microscope (SEM). To access the temperature’s effect on crystal 
morphologies, 1mg of hematin porcine was added to 500 µL CB: 500 µL DMSO and allowed to 
incubate at room temperature (22 ˚C), 37 ˚C, or 80 ˚C for 12 hrs. Samples were washed and 
characterized as described above.  
The rate of beta-hematin formation under solvent mediation was examined by combining 
1mg of hematin procine with 500µL CB: 500µL solvent (DMSO, DMF, THF, or MeCN). The 
solution was sonicated and centrifuged for 10 minutes to remove amorphous heme. The 
supernatant was collected and used as a stock solution. Aliquots of 100µL were transferred to 
1mL glass vials and incubated at 37˚C.  The reaction was quenched at various time points by the 
addition of 20 µL of a 30% pyridine solution ( 30% pyridine, 40% acetone and 200 mM HEPES 
buffer (HEPES - 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.5)). The sample was 
then transferred to a 1.5mL polypropylene tube and centrifuged. 50 µL of the sample and 50 µL 
of water were transferred to a 96 well plate with read at 405nm on a Biotek Synergy HT multi-
mode microplate reader.  The percentage of beta-hematin conversion was calculated as 
previously described(79) and analyzed using GraphPad Prism 4 to obtain the half-life of each 
solvent. All data sets were performed in triplicate.  
For pH studies of solvent mediated heme conversion, similar experimental setup were 
performed for DMSO, DMF, THF, and MeCN. The final pH of the combined system was 
carefully adjusted using minimal solutions of sodium hydroxide (NaOH) and hydrochloric acid 
(HCl). The reaction was allowed to incubate for 12 hrs at 37 ˚C. Quenching and quantification of 
heme conversion was performed as described above.   
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Solvent surface tension measurements 
Surface tension of citrate buffer (pH 4.8, 50mM), and a 1:1 ratio of citrate buffer: solvent 
(by volume) was measured. Measurements for water miscible solvents, DMF, DMSO, THF, and 
MeCN were performed using a Sigma 700 produced by Gamry Instrument with wetting depth set 
at 6.0 mm. 
 
Osmolality measurement 
Solutions with 1 and 10 % of DMSO was prepared in acetic acid butter pH 4.8. 
Measurements were performed on a VAPRO 5520 vapor pressure osmometer (Discovery 
Diagnostics, Canada).  
 
Data analysis 
Kinetics of beta-hematin reactions were analysed by using linear least-squares fitting 
methods with the program GraphPad ©Prism 5.0. The data were fitted according to Avrami 
equation [34]:  
( )[ ]nzte−∞ −+= 10 ννν  
where ν  is the amount of beta-hematin formed (in nmols), ν ∞  is the amount of beta-hematin 
present at the beginning of the reaction, ν∞ is the amount of beta-hematin formed at completion 
of the reaction, z is the rate constant and n is the Avrami constant. For a process in which growth 
occurs along an interface between the two interconverting phases, as is likely to be the case for 
beta-hematin formation in this model reaction, n takes an integer ranging between 1 and 4. Water 
activity analyses were done by using the following equation (148):  
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aw = 1000/MWwater/(1000/MWwater + Cosm), 
 
where MWwater is the molecular weight of water and Cosm is expressed in Osmol kg−1. 
Comparisons between groups were done by the non-paired Student’s t-test or one-way ANOVA 
analysis of variance and a posteriori Tukey’s test for pairwise comparisons. The results were 
expressed as mean±standard error and considered significantly different at p < 0.05 as indicated 
in figure legends. Student’s t-test, ANOVA, Tukey’s test and correlation analysis were 
performed by GraphPad Prism 5.0 software. 
 
 
 
Results and Discussions 
 
 
Part I) Increase on the steady-state soluble heme levels in acidic conditions is an important mechanism 
for spontaneous heme crystallization in vitro 
Part II) Crystal Engineering: solvents effect on beta-hematin morphology 
 
Part I 
Increase on the steady-state soluble heme levels in acidic conditions is an important mechanism for 
spontaneous heme crystallization in vitro 
 
DMSO promotes heme solubilization and further crystallization into beta-hematin. 
It is well known that in vitro heme forms highly insoluble aggregates at acidic conditions, 
such as those found inside Plasmodium parasites food vacuoles.(49, 147) Among the physico-
chemical requirements for heme crystallization, a pH close to the heme pKa (4.8) is of foremost 
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importance (42, 91, 149). However, an interesting aspect related to heme crystallization reactions 
conducted in aqueous medium, is that amouphous heme precipitates are slowly converted into 
organized beta-hematin crystals, which presumably occurs by increasing heme solubilization (87, 
91, 150). In fact, Egan and co-workers recently demonstrated that heme and water spontaneously 
form a complex in aqueous medium, which depends on the interaction of the carboxyl group 
with the central iron of heme (90). Therefore, a proposed model suggested that, to produce beta-
hematin crystals, heme dimers bound to each other by means of reciprocal iron-carboxylate 
linkage, would require the displacement of the axial water molecule bound to the porphyrin.(58, 
91) Strengthening this proposal, alcohols accelerated spontaneous beta-hematin formation in 
vitro (87, 151) in reactions that depend on the hydrophobicity of these compounds and their 
ability to solubilize heme (87). However, spontaneous heme crystallization was also promoted by 
benzoic acid in a mechanism that does not involve solubilization of acid heme precipitates (90). 
Therefore, to assess whether reduction of the medium polarity would influence spontaneous 
heme crystallization, the effect of the aprotic solvent DMSO on heme solubility in acid 
conditions was investigated. For this sake, heme was incubated in the presence of different 
DMSO concentrations (4,6 % to 27,7 %) in sodium acetate buffer at an apparent pH 4.8 during 
10 minutes and then centrifuged. Figure 24a shows the UV-visible absorption spectra of the 
supernatant obtained after centrifugation of heme in the presence of different DMSO 
concentrations, acquired between 300 nm and 800 nm. UV-vis spectroscopy analyis 
demonstrated that DMSO increased the Soret absorption band of heme (around 400 nm) in a 
concentration-dependent manner, suggesting an increase of heme solubility in conditions of 
reduced medium polarity. In order to confirm this finding, quantification of heme in the 
supernatants by a more reliable method (the alkaline pyridin), indicated that DMSO increased in 
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about ten times the levels of soluble heme in acidic medium (Figure 24b). Also, a strong positive 
correlation (r2 = 0.6480, p < 0.0001) between the amount of solubilized heme and the DMSO  
 
 
 
 
 
 
 
 
Figure 24. DMSO promotes spontaneous heme solubilization. (A) Different concentrations of 
DMSO in  0,5 M sodium acetate buffer pH 4,8 and 100 µM heme were shaken for 10 minutes 
and centrifuged at 10.000 x g. for 10 min. The supernatants were analyzed by uv-visible 
spectroscopy between 300 nm and 800 nm. A magnification of the dotted box is shown in the 
inset. Dashed line black: control; dashed line gray: 4.6 % DMSO; pale gray: 8.3 % DMSO; dark 
gray: 15.1 % DMSO; black: 27.7 % DMSO. (B) Heme content in solution was quantified using 
the alkaline pyridine method. Data are expressed as mean ± SEM, of three different experiments 
in A and B. 
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concentration was achieved, strongly indicating that reduced polarity promotes heme 
solubilization in acid conditions. Next, ability of DMSO to faciliate spontaneous beta-hematin 
crystallization was examined. Figure 25a shows that incubation of heme for 24 h in the presence 
of 27.7% DMSO strongly stimulated (p < 0.0001) the formation of an insoluble heme pigment in 
vitro. FTIR spectroscopy analyses of this material show the transmission peaks at 1211 cm−1 and 
1664 cm−1 which designate the characteristics peaks of the iron-carboxylate bonds of beta-
hematin (Figure 25b). Additionally, XRD analyses of this material (Figure 25c) demonstrated the 
presence of sharp Bragg diffraction peaks corresponding to a crystalline material, which is 
structurally and chemically identical to beta-hematin.(152) SEM analysis of product revealed a 
crystal morphologies that are very regular (Figure 25d), which markedly resemble those of 
synthetic beta-hematin(77). Curiously, the crystals produced by DMSO are extremely large 
compared to those found biologically(77, 153) and reaching up to 55 µm in length (Figure 25d). 
These results unambiguously identify the product of heme preciptation induced by DMSO as 
true beta-hematin.  
 
DMSO accelerates spontaneous heme crystallization. 
 
In order to further understand how DMSO stimulated heme crystallization, kinetics of 
spontaneous beta-hematin formation reactions were carried out in the presence of different 
DMSO concentrations. Figure 26a shows that beta-hematin formation occurs through a 
sigmoidal shape curve in such a way that higher DMSO concentrations caused the most powerful 
effects on driving heme crystallization. No appreciable product was observed in the control or in 
lower DMSO concentrations (4.6 % or 8.3 %). In addition, about 50 % of heme was converted 
into beta-hematin at 27.7 % DMSO 15 h after reaction start time. The Avrami equation is  
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Figure 25. DMSO promotes spontaneous heme crystallization. (A) Spontaneous heme 
crystallization was performed from a 100 µM solution at different concentrations of DMSO  in 
0.5 M sodium acetate buffer pH 4.8, over 24 h at 28 ºC. Data are expressed as mean ± SEM, of 
three different experiments. (B) The final reaction products were then characterized by FTIR 
spectroscopy. The large Nujol peaks in the region between 1320 cm-1 and 1550 cm-1 are 
depicted in light gray whereas the key beta-hematin peaks are shown at 1664 cm-1 and 1210 cm-
1. (C) X-ray powder diffraction (XRD) was also used to confirm the identity of beta-hematin. 
(D) Scanning electron microscopy (SEM) was used to investigate the external morphology of the 
beta-hematin produced. 
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commonly used to model many different solid-state processes that involve nucleation and growth 
(91). In this equation, (see the methods section), the n values represent a function of the 
dimensionality of the growth process (assumed to be spherical, circular, or linear) and the type of 
nucleation (instantaneous or sporadic) (91). The exponent of Avrami is influenced by the type of 
nucleation, crystal morphology and the occurrence of secondary crystallization. Kinetics data 
from reactions with DMSO were fitted to the Avrami equation, and gives the r2 values for the 
four possible values of the Avrami constant (n = 1, 2, 3 or 4) indicating that heme crystallization 
performed in these conditions involves nucleation and growth. Considering the reactions with 
15.1 % DMSO, a reliable fit to kinetic equations was not possible. In the case of 27.7 % DMSO, 
the reaction has progressed significantly and the kinetics could be fitted to the Avrami equation. 
The fits of kinetic traces obtained for this condition was the following: n = 1, 0.8393; n = 2, 
0.9429; n = 3, 0.9682 and n = 4, 0.9863. Therefore, the best fit obtained was for n = 4, which 
indicates that DMSO promotes beta-hematin formation by sporadic nucleation (nucleation occurs 
throughout the process) and spherical (or 3-dimensional)  
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Figure 26. Increase in DMSO content promotes spontaneous heme solubilization and 
crystallization. (A) Kinetics of spontaneous heme crystallization were performed at different 
concentrations of DMSO with 100 mM over 24 h using 0.5 M sodium acetate buffer, pH 4.8 at 
28 ºC. Data are expressed as mean ± SEM, of least three different experiments. Open square: 
control; open triangle: 4.6 % DMSO; inverted gray triangle: 8.3 % DMSO; dark gray square: 
15.1 % DMSO; black circle 27.7 % DMSO. (B) Correlation of spontaneous beta-hematin 
formation at 24 h with heme solubilization at different DMSO concentrations (r2 = 0.8791). 
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growth from these nucleation points. This pattern is consistent with reactions induced by acetate 
and benzoic acid as previously reported (90, 91). The rate constant (z) for this condition is 3.2 ± 
0.3 × 10−5 h-4 (or 9.3 ± 0.9 × 10−14 min−4), proceeding in a very much slower way than with 4.5 
M acetate, where z = 2.3 × 10−10 min−4 at 37 °C (91) and even 0.050 M benzoic acid (4.8 × 10−12 
min−4 at the same temperature) (90). Therefore, these data strongly suggest that lowering the 
dielectric constant of water plays a significant role on the kinetic of heme crystallization. Just as 
a comparison, the rate constants obtained using total lipids extracted from regurgitates of adult S. 
mansoni females gave rate constants of 74 ± 18 h-2, but Avrami constant, n = 2. Finally, to 
establish a relationship between the initial heme solubilization and conrresponding heme 
conversion, a linear regression analysis was applied to measured beta-hematin formation. Figure 
26b shows that these two parameters are strongly correlated (r2 = 0.8791; p < 0.0001).  
 
Reduction in medium polarity by polyethers drives spontaneous heme crystallization. 
To gain insight over the physico-chemical requirements on spontaneous beta-hematin 
formation, we performed heme crystallization reactions in the presence of different polyethers, 
such as polyethylene glycols (PEGs) of six different side chains (300, 3.350, 6.000, 8.000, 
20.000 and 22.000), as well as the organic solvent acetonitrile, at 4.7 % (w/v) as final 
concentration. Figure 27a shows the FTIR spectra of pigments isolated after five days of 
reactions induced by PEG 300, 3.350, 6.000, 8.000 and 20.000. The characteristic beta-hematin 
transmittance peaks at 1210 cm-1 and 1664 cm-1 were seen in all PEGs-derived samples, with 
exception of PEG 300. Interestingly, this pattern was also observed in the XRD spectra of all 
these pigments, in which the 7.4o, 21.7o and 24.3o Bragg diffraction peaks characteristic of beta-
hematin are present in all PEG-derived pigments, but not in PEG 300 samples (Figure 27b). 
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Figure 27. PEGs are able to induce beta-hematin formation under acid conditions. Spontaneous 
heme crystallization was performed in the presence of 4.7 % of different PEGs with 100 µM, in 
0.5 M sodium acetate buffer pH 4.8, over 5 days at 28 ºC. Samples were centrifuged and the 
pellet washed in 0.1 M sodium bicarbonate buffer and 2.5 % SDS, pH 9.1, until the solution was 
almost clear. (A) Pellets were then characterized by FTIR spectroscopy. The large Nujol peaks in 
the region between 1300 cm-1 and 1600 cm-1 are obscured by the labels, but the key beta-hematin 
peaks are clearly seen at 1664 cm-1 and 1210 cm-1. (B) X-ray powder diffraction (XRD) confirms 
the identity of beta-hematin. 
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Similar to DMSO, polyethers with molecular weigth higher than 300 Daltons were able to trigger 
heme crystallization. Interestingly, morphological examination of dried product revealed crystals 
with a high frequency of brick-shaped crystalline structures in reactions performed in the 
presence of PEGs 3.350, 6.000, 8.000 and 20.000 and in a much lesser extent in PEG 300 
(Figure 28). Although some of the dried heme reaction products of PEG 300 resemble 
superficially to crystals, the XRD pattern shown in Figure 27b unambiguously demonstrate that 
this material is essentially amorphous. The surface appearance of these crystalline structures are 
quite similar, if not identical, to those exhibited by natural hemozoin(77) and beta-hematin.(77, 
91) Compared to the crystals produced by DMSO (Figure 25d), the size of crystals produced by 
PEGs was considerably smaller exhibiting the classical regular brick-shaped crystals and with 
lenghts ranging between 2.5 µm (for PEG 3.350) and 3.91 µm (for PEG 6.000). The density of 
regular brick-shaped crystals also varied between 5.7 crystals/field (for PEG 20.000) and 27 
crystals/field (for PEG 6.000). A kinetic investigation of PEG-induced beta-hematin formation 
was conducted over 7 days. Figure 29a show that in the absence of any additive (control), heme 
crystallization becomes evident only after five days of reaction. However, even after 7 days, the 
reaction has not proceeded far enough to allow a reliable fitting from kinetic equations. Also, 
four of the five PEGs investigated, were sufficient at promoting large quantities of beta-hematin. 
Interestingly, only polyethers with molecular weigth higher than 300 Daltons were able to induce 
significant (p < 0.05) heme crystallization. As demonstrated in figures 27 and 28, incubation of 
heme with PEG 300 did not result in substantial beta-hematin formation, and in figure 29a it is  
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Figure 28. Scanning electron micrographs of beta-hematin induced by PEGs. Scanning electron 
microscopy (SEM) was used to investigate the external morphology of the β-hematin crystals 
produced by different PEGs. Well formed crystals are seen in the presence of PEGs 6.000, 8.000 
and 20.000 which closely resemble hemozoin. Less regular crystals appear to be formed by PEG 
3.350 and few if any are formed in the presence of PEG 300. 
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evident that this polyether specifically inhibited the process. The amount of crystals after 7 days 
was significantly lower (p<0.05) than the control. In the case of PEG 3.350 the kinetics appear to 
conform to n = 3 or 4, as is the case in acetate, benzoate and aqueous DMSO (with the same 
interpretation as indicated above for DMSO). Since there is almost no difference in the fit of n = 
4 and 3, it is likely that the former is consistent with the other systems. The rate constants for 
beta-hematin formation in the presence of PEGs were the following: PEG 3.350 = 3.7 ± 0.8 × 
10−7; PEG 6.000 = 8 ± 1 × 10−4; PEG 8.000 = 4.7 ± 0.7 × 10−4; PEG 22.000 = 2.4 ± 0.6 × 10−4. It 
is important to note that direct comparison of the rate constants for reactions with different n 
values is not possible. The data show that kinetics in the presence of 4.7 % PEG 3.350 is 
considerably lower than in 27.7 % DMSO (z = 3.7 ± 0.8 × 10−7 h-4 vs. 3.2 ± 0.3 × 10−5 h-4). The 
other PEGs tested promote beta-hematin formation, showing best fits with n = 2. This result can 
be interpreted in two ways, being either instantaneous nucleation (all nucleation sites present at 
the beginning of the process) and two-dimensional (disc-like) growth, or sporadic nucleation and 
needle-like growth. The latter would seem more likely in this case because it is difficult to 
imagine that PEGs would provide direct nucleation sites for epitaxial growth (which is thought to 
happen with lipids).(58) In fact, the brick-shaped crystal stucture shown in figure 28 strengthen 
this concept. The reactions triggered by acetonitrile gives a best fit with n = 2, very similar to 
those found for three PEGs (please refer to part II of this chapter for more details on 
acetonitrile’s effect on beta-hematin formation). An important observation to consider in the 
kinetic studies is related to the autocatalysis of beta-hematin formation, which was proposed to 
be one of the mechanisms of crystal production, based on the observation that purified beta-
hematin could itself promote crystal growth as described in the literature.(48)  However, in all  
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Figure 29. Prior heme solubilization by PEGs and organic solvents promote spontaneous heme 
crystallization. (A) Kinetics of spontaneous heme crystallization were performed in the presence 
of 4.7 % of different PEGs with heme 100 µM over 7 days using 0.5 M sodium acetate buffer, 
pH 4.8 at 28 ºC. Data are expressed as mean ± SEM, of least three different experiments (* p < 
0.05, control vs. PEG 300; ** p < 0.01, control vs. PEG 22.000; *** p < 0.0001, control vs. PEG 
3.350, PEG 6.000, PEG 8.000). Black square: control; gray triangle: PEG 300; inverted black 
triangle: PEG 3.350; gray circle: PEG 6.000; gray square: PEG 8.000; black triangle: PEG 
22.000. (B) Heme content in solution was quantified by the alkaline pyridine method. Data are 
expressed as mean ± SEM, of three different experiments in A and B, (* p < 0.05, control vs. 
PEG 300, PEG 8.000, PEG 22.000).  (C) Correlation of spontaneous beta-hematin formation 
after 7 days and heme solubilization in the presence of different PEGs and organic solvents (r2 = 
0.8940). Black square: control; gray triangle: PEG 300; inverted black triangle: PEG 3.350; gray 
circle: PEG 6.000; gray square: PEG 8.000; black triangle: PEG 22.000; inverted gray triangle: 
acetonitrile; black circle: DMSO. 
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systems tested in this work (Figures 26a and 29a ) and in others (91, 149), the reactions become 
less efficient in later times, indicating that autocatalytic crystallization should play a negligible 
role in these conditions. DMSO solubility data indicate that the sufficieny of a promoter to 
faciliate heme crystalization rest heavily on its ability to promote heme solubility. To examine 
whether this holds true for PEGs, heme solubility within various PEG system was examined. 
Figure 29b shows that PEG 8.000 and 22.000 significantly (p < 0.05) increased the levels of 
soluble heme compared to control. Also, PEG 300 significantly (p < 0.05) reduced heme 
solubility in acidic conditions, re-inforcing the concept that previous solubilization is an 
important requirement to allow further heme crystallization in vitro. PEG 6.000 and 8.000 were 
the most potent compounds to promote heme solubillization. Figure 29c show a linear regression 
analysis indicating that, similarly to DMSO, beta-hematin formation and heme solubilization are 
strongly correlated (r2 = 0.8940; p < 0.0001).  
Previous evidence have demonstrated that beta-hematin crystals can absorb up to 14 % of 
its mass in water and the reversible crystal hydration affect the unit cells in such a way that 
rehydration results in a smaller cells (154). This suggests that water would participate on heme 
crystallization by providing the ordering of heme molecules, possibly between the layers of 
hemes. However, it is still unknown where water molecules are adsorbed, but these may include 
intercalation between the layers or adhesion to the crystallite surface (154). On the other hand, 
molecular dynamics simulations demonstrated that H2O–heme molecules interact quite fast, 
producing the beta-hematin dimer by means of reciprocal iron-propionate linkage between heme 
molecules.(58) Then, conversion of this precursor to beta-hematin dimer would require only a 
ligand exchange process with bond formation from the propionate to iron and subsequent 
displacement of H2O from the opposite face of each porphyrin. Since beta-hematin dimers 
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rapidly form hydrogen bonds between the protonated propionic acid groups, it seems unlikely 
that such interactions are expected to occur in water because of competitive hydrogen 
bonding.(58) Therefore, to gain insight over the role of water on heme crystallization, the 
medium osmolality in acetate buffers containing 1 % and 10 % DMSO were measured. In the 
absence of DMSO, osmolality was 86.6 mmol/kg whereas in 1 % and 10 % DMSO the values 
were 213,3 mmol/kg and 1448,6 mmol/kg, respectively. These values were used to estimate the 
water activity in these solutions as previously reported (148). In fact, the estimated water activity 
in 1 % DMSO was 0.9961 and 10 % DMSO was 0.9745 (data not shown). Finally, using 
reported water activity values of aqueous DMSO solutions at pH 7.4 (155), the degrees of heme 
solubility, the amount of beta-hematin produced was compared. Figure 30 shows that decrease in 
water activity is positively correlated with heme solubility (r2 = 0.9001, p<0.05) and beta-
hematin formation (r2 = 0.8317, p<0.05).  
Recently, Huy and colleagues (87) showed that promotion of heme conversion by 
alcohols is related with their degree of hydrophobicity and to their ability to solubilize heme, 
suggesting that dissociation of aggregated heme, and consequently the increase of heme 
monomers, are key physico-chemical factors in beta-hematin formation. In addition, alcohols can 
reduce the surface tension of a solution, thus lowering the energy barrier for creating a critical 
nuclei (87). Dorn and colleagues also observed that in acetate concentrations lower than 4.5 M, 
spontaneous beta-hematin formation was too slow to account for biological heme crystallization 
(138). This is probably because that acetate solubilizes hematin in acidic solution, and there is an 
indication that both the nucleation and linear growth rates of beta-hematin depend on acetate 
concentration (91). However, considering that acetate increase heme solubility, this would not 
reach the levels required to drive substantial beta-hematin formation since our kinetic studies  
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Figure 30. Heme solubility and beta-hematin produced in DMSO solution increase with reduced 
water activity. Values of heme in solution was obtained from Figure 24b and values of beta-
hematin produced was obtained from Figure 24a. Water activity was calculed based on values 
obtained in Dupont and Pougeois, 1983 (155). 
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demonstrates spontaneous crystallization only after five days of reaction (Figures 26a and 29a). 
Only compounds that reduce the water content in a given concentration in the medium exhibited 
clear inducible effects on beta-hematin formation in vitro. In fact, Mössbauer analysis of R. 
prolixus midgut four days after blood meal provides compelling confirmation that at least 97 % 
of all iron-containing species present in that compartent are hemozoin (149), strengthening the 
concept that physiological levels of “free” soluble heme are very low. Conceivably, once 
hemoglobin is digested by proteases, and heme molecules released, these must reach a critical 
concentration in solution to allow its further crystallization that is provided by an amphiphilic 
structures such as lipid droplets in S. mansoni (156) and in Plasmodium (57) or by phospholipid 
membranes in R. prolixus (14, 82, 149) These biological and chemical hydrophilic-hydrophobic 
interfaces would act by allowing heme accumulation at the surface of these structures which 
would then favours the contact between heme molecules in an environment chemically suitable 
to drive the nucleation of unit cells of beta-hematin. This CB:DMSO system was successful at 
mediating the crystallization of Mn(III)PPIX (Appendix B).  
 
Part II 
Crystal Engineering: Solvent effect on beta-hematin morphology 
 
A hallmark of hemozoin produced by Schistosoma and Rhodnius is the close association 
between crystals arranged into a larger roughly spherical structures composed of regularly 
shaped crystalline units.(77) At a magnified scale, these crystalline assemblies are composed of 
regular brick-shape crystals approximately 200 nm long. In Plasmodium, hemozoin morphologic 
shape varies between species. For example, P. falciparum hemozoin are closer in appearance to 
other mammalian Plasmodium species than in the avian Plasmodium species. Hemozoin from 
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mammalian Plasmodium species exhibit regular, brick-like features with smooth sides at right 
angles,(44) while crystals from P. vivax are larger and can be very thin.(44) It is possible that this 
discrepancy is hemozoin morphologies may be a result of in vivo crystallization parameters. To 
assess the morphological effects of crystallization parameters, various solvents were employed to 
evaluate beta-hematin crystallization. Changes in solvent composition is likely to changes the 
driving force for crystallization due to altered Fe(III)PPIX solubility and may influence crystal 
shape.  
 
Solvent promotion of Fe(III)PPIX solubility and spontaneous beta-hematin crystallization 
              Hemozoin is formed within the acidic aqueous (pH 4.8) environment of the digestive 
food vacuole of P. falciparum (20).  However, Fe(III)PPIX is insoluble in water at pH 4.8. Its 
dissolution is believed to be the rate-limiting step for beta-hematin formation (90).  Part I of this 
chapter has demonstrated the importance of Fe(III)PPIX solubility in beta-hematin formation. To 
assess the heme solubility properties in the presence of water miscible solvents (Table 1), heme 
was incubated in various mixture of solvent and aqueous citrate buffer (CB) at pH 4.8. The 
addition of solvents (DMSO, DMF, THF, and MeCN) to buffer containing Fe(III)PPIX increased 
Fe(III)PPIX solubility. Figure 31b shows the UV-visible absorption spectra (400nm) of the 
supernatant collected after centrifugation of heme in the presence of various DMSO 
concentrations in CB. The introduction of DMSO increased the Soret absorption band of heme in 
a concentration-dependent manner. In particular, the introduction of a 10% DMSO to a solution  
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Figure 31.  The addition of DMSO, DMF, THF, MeCN to a solution of aqueous Fe(III)PPIX 
increased heme solubility. This increased solubility was quantified using the alkaline pyridine 
assay(b)(147). Uv-visible spectra showing the solubility of heme in a CB:DMSO system as a 
function of DMSO concentration (b). 
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of Fe(III)PPIX in CB measured a Soret absorbance of 2.5 x 10-2 absorbance units (AU). 
However, when the volume of DMSO was increased to 50%, the Soret peak was increased by  
35X  to 8.9 x 10-2 AU. To quantify the degree of heme solubility, the percent of heme in solution 
was measured using the alkaline pyridine assay.(147) The addition of DMSO, DMF, THF or 
MeCN increased heme solubility to 46.5 ± 4.5 %,  33.7 ± 7.1 %, 93.8± 8.5%, and 3.7 ± 0.3%, 
respectively (Figure 31a). The percentage of soluble heme in the acidic CB, control sample, 
measured 1.5 ± 0.9 % heme was in solution (Figure 31b).  Due to the biphasic solutions that are 
formed with CB mixed with DCM, CF or toluene, heme solubility in these systems could not be 
measure. Together, these data suggest that the introduction of water miscible solvents promoted 
heme solubility within the solvent:CB system.  
 
Effects of solvent on beta-hematin crystal morphologies 
The 12 hr incubation of Fe(III)PPIX in the water-solvent system at 37˚C produced a 
water insoluble, brown product. These products were characterized morphologically by SEM, 
chemically by IR, and structurally by XRD (Figure 32).  SEM analysis shows that, in general, 
crystals formed processed a needle-like structure with tapered ends. However, 3D growth in 
these crystals varied with mediating solvents.  All samples exhibited prominent FTIR peaks at 
1210 cm-1 and 1664 cm-1, indicating significant formation of beta-hematin.(42) At the atomic 
level, the structures of crystals produced under the CB-solvent system exhibited the same XRD 
pattern as those of hemozoin which includes characteristic beta-hematin diffraction peaks at 7, 
22, 24 2ɵ.(41) Together, these results unequivocally confirmed the successful formation of beta-
hematin. 
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Figure 32. Product characterization of crystals formed under citrate buffer: solvent system. Crystals formed under DMSO (A), DMF( 
B), and MeCN (C) exhibited brick-like crystal habits (top row). Crystals formed under THF (D) and CF(E) displayed less thickness 
while crystal grown under CF(F) and toluene(G) are more smooth, plate-like. XRD (2, middle row) and FT-IR(3, bottom row) 
analysis unequivocally confirmed the presence of beta-hematin.  
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Unlike beta-hematin formed under other solvent systems,(157, 158) which produce homogenous, 
brick- like crystals resembling hemozoin from P. falciparum(44, 49), crystals produced in the 
current system exhibited morphologies that are dependent on solvent conditions. Crystals formed  
 Under DMF, DMSO, and MeCN mediation exhibited morphologies that are regular in shape 
with the longest dimension being a few microns (Figure 32). These crystals have tapered ends 
that parallel hemozoin extracted from P. falciparum as reported by Sullivan et al. and Noland et 
al
(49),(44).  Much less size homogeneity was observed for crystals formed under CF and toluene. 
The tapering effects are still present but less frequent. Overall, these crystals appear more plate-
like (Figure 32); however, crystals in the CB:toluene system appears to be much more thin than 
those from CB:CF system. Furthermore, SEM analysis of toluene mediated crystals showed 
structures that were nearly 6 times longer than those under mediation of DMF and DMSO. Beta-
hematin from the CB:DCM and CB:THF system both exhibits some level of crystal thickness 
with a smooth surface. No apparent organization was observed with the exception of beta-
hematin formed with THF. These crystals are organized into clusters with one end of each 
individual crystal sharing the same origin with other crystals in the cluster as if growth started at 
the center of the origin and elongated outward (Figure 31).  
    Interestingly, a relationship was observed between crystal morphologies and water 
miscibility of solvents. Solvents that are miscible in water (i.e. DMSO, DMF, and MeCN) 
produced crystals that resembled hemozoin from P. falciparum (Table 1). Hexane, a solvent that 
is immiscible with water was not able to mediate beta-hematin formation (Figure 31). As the 
solvent becomes less miscible (i.e. in decreasing order : DCM, CF, and toluene) the crystals 
become less uniform in sizes but smoother and more plate-like. In these solvent systems, 2D 
beta-hematin crystal growth is favored as a consequence of Fe(III)PPIX’s reduced exposure to 
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water. It is speculated that within these less water miscible system, crystal formation takes place 
at the interface.  These observations indicate that the presence of water is necessary to produce 
crystal with P. falciparum’s hemozoin morphologies.(157) Previous investigation of water 
behavior during hemozoin formation demonstrated that beta-hematin absorbs up to 14% of its 
mass in water and that reversible crystal hydration altered the unit cell of the crystal. Rehydration 
of these crystals produced crystals with a smaller unit cell(154) These observations suggest that 
water functions by ordering heme molecules; however, the molecular interaction of this 
phenomenon remains speculative. In fact, recent molecular dynamics simulations revealed that in 
the presence of water, two H2O-Fe(III)PPIX molecules spontaneously interact to form the beta-
hematin dimer(58). The conversion of this precursor to beta-hematin requires only a ligand 
exchange process with bond formation from the propionate O to Fe(III)and the displacement of 
H2O from the opposite face of each porphyrin. However, in the presence of competing hydrogen 
bonds in water, this interaction is unlikely. Within the solvent environment- away from water- 
the interactions of dimers can occur more readily. Furthermore, the formation of beta-hematin 
under DMF, DMSO, and THF at various pH exhibited a bell shape curve dependence, with 
pKA1 at 2.5 ± 0.2 and pKA2 at 6.5± 0 (Figure 33). Maximum heme conversion occurred at a pH 
similar to that of the digestive food vacuole, pH 4.5 ± 0.1. This observation can be explain by the 
protonation state of Fe(III)PPIX. At pH 4.8, the precursor dimer is likely to be a neutral (H2O-
Fe(III)PPIX)2 species with only one propionic acid group on each porphyrin ionized and the 
other not.(150) As a matter of fact, this neutral species is critical for dimerization to occur 
because only in the protonation state can Fe(III)PPIX precursor assemble to nucleate 
crystallization.(58) The observed effect of pH on solvent mediated beta-hematin supports this 
notion. 
 
 
 
 
 
 
 
 
Figure 33. pH effects of beta-hematin formation under DMF, DMSO, and THF. 
conversion occurs at approximately pH 4, with pKA1 at 2.5 ± 0.2 and pKA2 at 6.5± 0. This 
acidic environment parallels that of the digestive food vacuole, the site of hemozoin formation, 
within P. falciparum. At pH 4.8, the Fe(III)PPIX molecule is likely to be 
Fe(III)PPIX)2 with only one propionic acid group on each porphyrin ionized and the other not. 
Only at this protonation state can precursor Fe(III)PPIX assemble to initiate crystal nucleation. 
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Interestingly, the morphologies of beta-hematin formed under DMF mediation was not 
influenced by the temperature at which it was synthesized in DMF (Figure 34).  Beta-hematin  
formed at 22, 37, 80 ˚C all exhibited crystals resembling hemozoin crystals form in P. 
falciparum, suggesting that the observed morphological differences are likely to be a chemically 
derived rather than thermodynamically driven. In fact, Orlov proposed that the effect in crystal 
habit is likely to occur  if the dissolved substance reacts chemically with the solvent.(159) In 
aqueous DMSO, it is known that DMSO coordinates to Fe(III)PPIX.(160, 161) Resonance 
Raman data of Fe(III)PPIX solublized in neat DMSO revealed that the complexes formed are 
six-coordinate high-spin (DMSO)2Fe(III)Porphyrins.(162, 163) In light of Egan’s modeling 
study,(58) this process may involve a Fe(III)PPIX preformed dimer. The presence of water 
completing for the axial Fe will prevent Fe(III)PPIX dimers from assembling into beta-hematin. 
DMSO, a stronger Lewis base than water, is likely to displace water as the axial ligand.(160) 
Ligand coordination likely occurs between the axial site of the Fe(III)PPIX iron and the sulfonyl 
oxygen.(164) It is speculated that nucleation begins when the propionic group of another 
precursor unit displaces the axial DMSO.  As more monomeric units are assembled into the 
growing crystal, the rate of elongation decreases due to the lack of available monomers in 
solution. In the case of less miscible solvents, the crystals appear to be elongated and two 
dimensional. This suggests that within these systems, crystal growth occurs along the interface. 
In addition, coordination capabilities of the solvent will affect the rate of crystal formation. For 
example, in the toluene:CB system, coordination of the ligand most likely occurs through beta-
stacking of the aromatic toluene with the p-system of the Fe(III)PPIX. Coordination could also 
occur between the p-group and the Fe, however sterics would only allow an ada-1 interaction  
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Figure 34. Effect of temperature on beta-hematin morphologies. Using DMF as the model organic solvent, beta-hematin was 
synthesized at 22˚C (a), 37 ˚C (b), and 80˚C (c). Crystals formed under these temperature exhibited no observed differences.  
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rather than a more favorable ada-6 (i.e. ferrocene). Chloroform and DCM both are aprotic polar 
solvents that can coordinate only through their chloro groups. At the interface, these ligands can 
displace water when in high concentrations, allowing for the formation of the dimers and 
subsequent assembly. Because of their limited solubility, grown occurs fastest along the 
interface, resulting in elongated thin crystals. The polarity of the solvent may lead to preferential 
adsorption at selected face of the solute by altering the surface roughness of the growing crystal 
(87, 165). When the degree of polarity for each solvent, given in terms of dielectric constant, is 
compared between experimental solvents, crystals produced using solvent with high dielectric 
constants (Table 1). (MeCN, DMF, DMSO) closely resembled Plasmodium hemozoin (166). A 
similar finding was reported by Huy et al (87) who employed alcohol to demonstrate a 
correlation between alcohols’ degree of hydrophobicity and their ability to solubilized heme 
during beta-hematin formation, supporting the idea that heme solubility is a key physio-chemical 
factor in beta-hematin formation (157).  In addition,  the solvents effect on crystal habits, i.e., the 
ratio of growth rates of their various faces, is related to the changes of surface tension of the 
various faces (44). Huy et al. further demonstrated that reduction of surface tension facilitated 
heme conversion by lowering the nucleation energy barrier (87). Similar trends were measured 
for solvents used in this study. The measured surface tension of aqueous citrate buffer was 72.9 
±0.3 mN/m (Table 2). Upon the addition of the solvent (1CB: 1 solvent), this value was 
dramatically reduced.  The addition of DMSO or DMF to CB resulted in a surface tension 
reduction to 56.4 ± 2.4 mN/m and 46.3 ± 0.1 mN/m( Table 2). More drastic surface tension 
reduction of CB was observed for the addition of THF and MeCN, 29.2 ±0.3 and 33.1 ±0.1 
mN/m, reducing the energy barrier for nucleation. Not surprisingly, in the current system, the 
percentage of beta-  
 
 
127 
 
 
 
 
 
Table 1. Properties of solvents (DMSO, DMF, MeCN, THF, DCM, CF, toluene) used to 
investigate beta-hematin morphologies.  
 
 
 
 
 
 
 
Table 2. Measured surface tension of citrate buffer: solvent system 
 
 
Crystallization 
System 
Surface Tension (m/m) 
CB 72.8 ± 0.3 
CB:DMF 46.3 ± 0.1 
CB:DMSO 56.4 ±  2.4 
CB:THF 29.2 ±  0.3 
CB:MeC 33.1 ±  0.1 
 
 
 
 
 
 
 
 
 
 
Figure 35. Effects of solvent concentration of beta
DMSO in DMSO:CB system corresponded to increased percentage (%) of crystal formed within 
that system.  
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-hematin formation. Increased concentration of 
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hematin formed is dependent on the percentage of solvent (Figure 35). Measurements of heme 
Soret absorption showed that increased volume of miscible solvent in the crystallization system 
increased heme solubility (Figure 31). In addition, at higher concentration of solvent, the surface 
tension may be reduced even further. A 10% DMSO (by volume) system resulted in about 28% 
conversion. However, when the percent of DMSO was increased to 50%, beta-hematin formation 
was increased to 82%. Thus, the morphological variation observed among the various solvent 
systems is a consequence of solvent parameters.  
 
Effects of solvent on kinetics of beta-hematin formation 
To further evaluate the role of solvents have in heme conversion, the kinetics of beta-
hematin formation was measured under mediation of DMSO, DMF, THF, and MeCN. DMSO 
produced crystals with a half life (t1/2) of 139.8 ± 2.2 min (Figure 36). Reactions under DMF and 
MeCN produced similar t1/2 of 37.5 ± 2.1 and 30.9 ± 3.1 min, respectively. Beta-hematin 
formation under THF had the fastest rate of t1/2 of 13.3 ± 3.0 min These kinetic data strongly 
suggest that lowering of the dielectric constant (Table 1) of the solvent:CB system significantly 
increase the rate of beta-hematin. Of the four reaction conditions measured, DMSO has the 
highest dielectric constant of 47 also has the slowest rate of heme conversion. Likewise, THF, 
with a dielectric constant of 7.5, has shortest measured t1/2. Results from these kinetic studies 
further support the role of low dielectric mediator for hemozoin formation. As discussed above, 
the presence of water is necessary for the synthesis of beta-hematin crystals exhibiting crystal 
morphologies mirrored to those in nature. Despite THF’s miscibility in water, beta-hematin 
formed under its mediation does not have the same degree of thickness as crystals form under 
DMSO and DMF. However, THF dielectric constant is similar to that of CF, a less water  
 
 
 
 
 
 
 
 
 
 
Figure 36. Kinetics of beta-hematin formation under solvent: CB system. Solvents with low 
dielectric constant, such as THF, produced hemo
dielectric constant, such a DMSO. 
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zoin more rapid than solvents with higher 
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miscible solvent. Indeed, THF and CF crystals morphologies are practically identical, suggesting 
that the mediator polarity (i.e dielectric properties) plays an important role in deciding the 
morphology of the developing crystal. However, the introduction of soluble Fe(III)PPIX to water 
does not result in toluene, kinetic measurements of beta-hematin formation under these solvents 
were not successful. 
 
Controllability of Beta-hematin crystal habits 
To assess the controllability of beta-hematin morphologies, crystallization parameters 
containing mixed solvents were experimented. Successive additions of DMF (10%, 25%, 50%, 
75%) were premixed with toluene and added to amorphous heme. SEM analysis revealed that 
alterations of solvent condition were successful in changing crystal morphologies (Figure 37). At 
10% DMF, crystals exhibited morphologies that mirrored those of crystals formed in complete 
toluene (Figure 37a). These crystals are more plate-like and less regular than those at higher 
concentration (>50% DMF) (Figure 37c,d). At high concentration of DMF, crystal sizes are 
uniformly about 1 micron in length and exhibited more surface roughness. These results not only 
highlight the importance of synthesis design, but also hint at the crystallization parameters that 
controls hemozoin in nature. Beta-hematin synthesized with MeCN, DMF, and DMSO produced 
crystals that resemble P. falciparum hemozoin while THF, CF, and DCM produced more thin 
crystals similar to those in P. vivax. In the present study, the driving parameter that leads to these 
morphological differences appears to be related to the dielectric constant associated with the 
mediator. Likewise, the crystal morphology and organization discrepancy between the above 
mentioned organisms indicate that hemozoin formation in S. mansoni and R. prolixus differs
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Figure 37. Formation of beta-hematin using mixed solvents. SEM images of crystals formed with 10% DMF and 90% toluene (a), 
25% DMF and 75% toluene (b), 50% DMF and 50% toluene (c), and 75% DMF and 25% toluene (d). Crystal morphologies differed 
based on solvent condition. 
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from crystallization process that takes place in P. falciparum. For example, in S. mansoni and in 
R. prolixus, perimicrovillar membrane-derived vesicles present in the gut is proposed to provide 
attachment for free heme or a microenvironment in which heme remains soluble in an acidic 
milieu (77), a pre-requisite observed here for heme conversion. In addition, electron microscopy 
imaging of P. falciparum, S. mansoni, and R. prolixus provide irrefutable evidence that 
hemozoin formation occurs in close association with lipid bodies (57, 77, 156, 167). Specifically, 
hemozoin crystallization occurs at the interface of lipid bodies and water within the digestive 
food vacuole of the parasite (57, 58, 97). In fact, when Fe(III)PPIX is introduced to the interface 
of synthetic lipid bodies-water, beta-hematin is converted at a rate probably sufficient to account 
for heme toxicity within the parasite (97).  In light of the current study, it is likely that these low 
dielectric organic mediators serve the same crystallization function as solvents do: lowering 
energy barrier for hemozoin formation. On that note, the triple localization of hemoglobin 
degradation, lipid bodies, and hemozoin within the acidic digestive food vacuole within P. 
falciparum may not be merely coincidental. And that, perhaps, lipid bodies may be produced by 
blood feeding organisms specifically for the purpose of heme detoxification.   
 
 
 
Conclusion 
 
The present study provides a systemic approach to beta-hematin crystal engineering. The 
introduction of heme to aqueous systems containing water miscible solvents (DMSO, DMF, 
THF, or MeCN) or PEG increased heme solubility and promoted spontaneous beta-hematin 
crystallization.  The present study demonstrate that increase on the steady-state levels of soluble 
heme in acidic conditions, by reducing medium polarity, plays a critical role to determine 
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spontaneous heme crystallization in vitro. Morphological analysis of these crystals demonstrated 
brick-like structures, resembling hemozoin produced in P. falciparum. Less water miscible 
solvents (DCM, CF, or Toluene) formed beta-hematin exhibiting plate-like structures, similar to 
hemozoin found in P. vivax. Of significant, this study presents the first systemic approach for 
engineering of beta-hematin morphologies. Through the proper selection of solvents, the 
macroscopic crystal morphologies were successfully manipulated. These results demonstrate the 
success of controllability of beta-hematin morphology and illustrate the importance of beta-
hematin synthesis approach. The heme conversion pathway is a target for anti-malarial drug 
design and hemozoin can serve as an indicator for diagnostic detection. In both examples 
synthetic hemozoin is often used in experimental analysis. Hence, special career must be taken to 
properly select solvent conditions during pre-formulation to help maintain batch-to-batch 
uniformity to ensure reproducibility of results. These data represent a significant advance for 
understanding the mechanisms involved in heme crystallization and may open new perspetives 
for the rational intervention of this process. 
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Chapter V 
 
 
PHAGE DISPLAY APPLICATIO TO BETA-HEMATI 
 
 
 
The morphology of hemozoin (P. falciparum) and its synthetic counterpart, beta-hematin, 
consists of needle-like structure extended along the c-axis, exhibiting dominant {100} and {010} 
side faces, a less-developed {011} and minor {001} face.(41, 45) Modeling calculations of 
crystal face attachment energies, Eatt, of beta-hematin formation revealed that crystal growth 
occurs the fastest at the {001} face as reflected by the highly negative attachment energy ( Eatt = -
101.5 kcal/mol)(45). This face makes up the ends of the crystal and is speculated to be 
corrugated with O-H···O hydrogen bond between the propionic acid groups of neighboring 
molecules along the –a +c direction. It is believed that traditional antimalarials such as 
chloroquine, amodiaquine, quinine, and mefloquine, all of which are protonated at the 
nonprimary exocyclic amine, and are thought to target hemozoin. These compounds then 
function by intercalating its quinoline rings between the aromatic groups of the beta-hematin 
molecules (Figure 3) and sterochemically capping onto the {001} surface of the crystal via 
(porphyrin) acid-amine (quinoline) salt bridge.(45) In addition, π-π interaction between drug 
compound and the crystal {010} further limits crystal extension. Molecular analysis of 
chloroquine and beta-hematin interactions shows that optimal beta-hematin inhibition occurs at a 
2:1 chloroquine to heme interaction, suggesting that both axial face of the heme molecule is 
blocked from neighboring heme precursor by chloroquine.(137)    
The highly structured, repetitive crystal habits of hemozoin are exploited by chloroquine to 
inhibit hemozoin formation.  
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Chloroquine binding to the highly structured, repetitive crystal habits of hemozoin inhibits the 
crystal extension.(49) Likewise, hemozoin can serve as a substrate for protein recognition, 
making it a good candidate for phage display application. Phage display technology utilizes the 
self-assembly nature of the viral capsid structures of M13 bacteriophage. In this approach, M13 
viruses are reengineered to express select short peptides on their coat proteins. Generally, the 
peptide inserts are displayed on the virus PVIII or PIII coat protein. In the later case, the peptides 
are expressed on the outer surface of the phage, displaying five copies of the same peptide on its 
PIII coat protein. A phage library, comprising of ~109 peptide diversity, is then introduced to 
beta-hematin.  This high diversity of peptides will increase the probability of finding or 
“panning” for a short sequence that specifically recognizes a select beta-hematin crystal face. 
Phage that binds tightly to the crystal can be amplified by exploiting its virus nature by allowing 
it to infect E. coli. In this example, the DNA sequences of select peptides are genetically fused to 
the PIII gene. Thus recovery of the phage DNA allows the amino acid sequence of the selected 
peptide to be deciphered.  
Similar to chloroquine functionality, a peptide that selectively binds to the fastest 
growing face of beta-hematin may possess antimalarial properties. Likewise, peptides that 
specifically recognizes the {100} or {010} face may be a beta-hematin mediator by stabilizing 
the growing nuclei. In several phage display studies, researchers demonstrated that amino acids, 
such as aspartic acid, arginine, cysteine, glutamic acid, histidine, lysine, methionione, and 
tryptophan, selectively recognized certain inorganic substrates (168-170).  These identified 
peptides can function as template for inorganic crystal growth and nucleation(170). Studies have 
revealed materials-specific peptides that have preferential bindings (171), promote precipitation 
of nanoparticles(172, 173), and control the morphologies of these particles (174, 175). For 
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example, it has been demonstrated that tyrosine plays an important role in the reduction of Au3+ 
to Au0 by a number of tyrosine-containing peptides, though most are limited to simple dipeptides 
and tripeptides. By controlling the sequence of these peptides, the researchers were successful at 
manipulating the sizes, morphology, and irregularity of the growing gold nanoparticles.(176-
180) In addition, phage derived peptides were demonstrated to bind with high selectivity. For 
example, peptides panned against the {100} face of GaAs bound specifically to GaAs {100} but 
not to Si {100}. And in complementary fashion, peptides screened against the {100} Si surface 
showed poor binding to the {100} GaAs surface. Furthermore, panned peptides also promoted 
and control macroscale ordering of monomers. For example, the addition of poly(L-lysine) of 
greater than 100 residue inhibits spherical silica particle growth along the c-axis, forming 
hexagonal silica platelets (174).  
In this study, phage display technology was employed to pan for a 7-mononer peptide 
that recognizes beta-hematin crystal face. The specific binding of peptide to the fastest growing 
face of beta-hematin may inhibit the growth of the crystal and thus, may express antimalarial 
properties. On the other hand, peptides that bind to dominant beta-hematin crystal face may 
exhibit crystal mediating properties.  
 
 
Material and Methods 
 
 
Beta-hematin synthesis and characterization 
Beta-hematin was synthesized via dehydrohalogenation of hemin, as described by 
Bohle.(158)  Briefly, in an inert atmosphere, hemin porcine (Sigma) is dissolved in a minimal 
amount of 2,6-lutidine. A 50:50 mixture of anhydrous methanol: dimethylsulfoxide (DMSO) was 
added and the reaction vessel was sealed and protected from moisture and ambient light for 
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approximately three months. After the incubation time, the product was filtered and the 
precipitate was washed exhaustively with methanol, 0.1M sodium bicarbonate (pH 9.1) and 
deionized water. The purified product was dried under vacuum at 150˚C for 48 h and stored 
under desiccant. The cleaned product was characterized via infrared analysis (IR) and X-ray 
diffraction (XRD). The IR peaks of 1210 cm-1 and 1664 cm-1 and XRD peaks of 7, 22, 24 2theta 
confirmed the presence of beta-hematin. 
 
Beta-hematin Peptide panning 
Beta-hematin recognizing peptides were panned using a 7-monomer, PIII phage display 
library obtained from Dr. Mario Geysen from the University of Virginia (Charlottesville, 
Virginia). Panning experimental procedures are displayed in Scheme 7. 100 µL of stock phage  
 
 
 
 
 
 
Scheme 7. Beta-hematin phage display experimental procedure. A library of 7
incubated with beta-hematin crystal. Nonspecific viruses are washed away, leaving behind phage 
that binds to the crystal. The beta
amplified viruses are then subjected to several additional rounds of panning to ensure the 
selection of beta-hematin specific phage. DNA of phages from the final round of panning are 
sequenced to determine the beta-
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-hematin-specific phages are amplified overnight in 
hematin-specific peptide sequence.  
 
-mer phage was 
E.coli.  The 
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library was introduced to 2 mg of beta-hematin in 400 µL sterile PBS solution containing 0.5% 
Tween (PBST). The solution was incubated at 37 ◦C for 6 hours under gentle agitation. Beta-
hematin was previously blocked (1 hr) with a PBS solution containing 0.5% Tween and 2% 
BSA(PBST-BSA). After incubation, the beta-hematin was washed several times using PBST to 
remove nonspecific phages. Bound phages were eluted from beta-hematin crystals by the 
addition of 150 µL of an acidic glycine buffer (pH 2.2, 200 mM) for 15 minutes. The eluted 
phages were then transferred to a fresh tube and neutralized with a Tris buffer (pH 8.0, 2 mM). 
Eluted phages were amplified overnight via infection into Escherichia coli host cells to yield 
approximately 1011 copies of output phages. 100 µL of amplified phages was used for the next 
round of panning. In total, five (5) rounds were completed with each round containing more 
phage expressing peptides that are more specific for beta-hematin (Appendix C). To select for 
individual phage, a diluted solution of panned phage are plated on Luria Broth plates containing 
E. coli, 5’bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal, Fischer Scientific, Fair Lawn, New 
Jersey) and isopropyl –v-D-thiogalactoside (IPGT, Fisher Scientific, Fair Law, New Jersey) 
(Appendix D). Phage from the panning library produces a nonfunctional fragment of the β-
galactosidase enzyme.  In the presence of X-gal, this enzyme breaks X-gal into galactose and a 
byproduct, 5-bromo-α-chloro-3-hydroxyindole. The byproduct immediately oxidized into an 
insoluble compound that can be visualized as a blue pigment. E.coli used in this study produces 
another fragment of a nonfunctional β-galactosidase enzyme. The successful infection of E.coli 
by the phage with the 7mer insert will result in the assembly of a functional β-galactosidase 
enzyme. Selection for individual phage is then achieved by isolating individual blue colonies 
(Scheme 8). 
 
 
 
 
141 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme  8. Selection and amplification of individual phage. A diluted solution of panned phage 
are plated on Luria Broth plates containing E. coli, 5’bromo-4-chloro-3-indolyl-β-D-galactoside 
(X-gal) and isopropyl –v-D-thiogalactoside (IPGT). Phage from the panning library produce a 
nonfunctional fragment of the β-galactosidase enzyme.  In the presence of X-gal, this enzyme 
breaks X-gal into galactose and a byproduct, 5-bromo-a-chloro-3-hydroxyindole. The byproduct 
immediately oxidized into an insoluble compound that can be visualized as a blue pigment. 
E.coli used in this study produces another fragment of a nonfunctional β-galactosidase enzyme. 
The successful infection of E.coli by the phage with the 7mer insert will result in the assembly of 
a functional β-galactosidase enzyme. Selection for individual phage is then achieved by isolating 
individual blue colonies.  
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Confirmation of panned phage recognition of beta-hematin crystals using Quartz crystal 
microbalance (QCM) 
QCM techniques were used to confirm and quantify the recognition of panned virus to 
beta-hematin crystals. QCM is based on some materials exhibiting piezoelectric properties, the 
ability to generate an electric potential in response to applied mechanical stress. The quartz 
crystal naturally generates an electric field in response to an applied mechanical stress (181, 
182).  The QCM device operates by sending an electrical signal through a gold-plated quartz 
crystal, which generates a vibration at a specific frequency. The interaction of targeted molecules 
with the anchored probes will yield in a mass loading, detected by a decreased in frequency and 
increased in resistance by the QCM. The changes in frequency and resistance is used to calculate 
the mass loading or amount of antigen binding via the Saubery equation(1) (183).  In this 
equation, ∆ is the change in frequency (Hz),  is the sensitivity factor (various based on crystal 
properties), and ∆ is the change in mass.  
∆ = −∆ (1) 
When used as a biosensor, probes (i.e. protein, antibodies, chemical) specific for the target 
molecule are immobilized on the surface of the gold-plated crystal. Generally, an aqueous 
sample which contains the target molecules is flow across the functionalized crystal surface. 
Recognition of the target molecule by the anchored probe is detected as a decreased in oscillating 
frequency. The sensitive piezoelectric property of the QCM allows for the detection of 
monolayer surface coverage by small molecules, a useful advantage for working within the scale 
of biological recognition. The QCM acoustic system has many practical advantages over the 
more mainstream methods, including portability, low limit of detection, lower expense, moderate 
 
 
143 
 
degree of training, and label-free quantization (181). In addition, signal transduction by the 
piezoelectric mechanism operates well in complex, often optically opaque solution media.  
All experiments were performed using a Maxtek QCM system. Beta-hematin layer by layer 
assembly were produced on 5MHz QCM crystals, containing a gold deposit of 2,000Aº  in 
thickness. Crystals were initially cleaned three times using a piranha solution (3:1 solution of 
sulfuric acid and hydrogen peroxide) and dried under nitrogen. The assembly procedure for the 
beta-hematin layer by layer assembly production is illustrated in figure 38. Methods for 
producing poly (L-lysine) coated SAM were obtained from Frey and Corn (184). Briefly, 
cleaned crystals were immersed into a 1 mM ethanolic 11-mercaptoundecanoic acid (MUA) for 
at least 24 hr before being rinsed with ethanol and then soaked in water for 5 min. SAM crystals 
were rinsed with ethanol and dried under nitrogen prior to the addition of each new reagents. N-
hydroxysulfosuccinimide (NHSS) ester was formed by exposing of the MUA SAM to an 
aqueous solution of 75 mM 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochlorie 
(EDC) and 15 mM NHSS for 1 hour. These samples were then immersed in an aqueous solution 
of poly(L-lysine) (10mg/mL) for 1 hour. An aqueous solution of 100 mM beta-hematin was 
introduced to the SAM for an additional hour. Unbound beta-hematin was removed during 
ethanol washes. FTIR of beta-hematin functionalized QCM were obtained to confirmed presence 
of crystals. These beta-hematin layer by layer assembly were used for QCM measurements for 
determining the affinity of round five phages to BH crystals. Beta-hematin used in QCM studies 
was obtained from Bohle synthesis described above (158).  
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Figure 38. Beta-hematin self assembled monolayer. Beta-hematin crystals are functionalized on 
QCM crystals via a poly lysine layer. The assembly begins with the addition of a 11-
mercaptoundecanoic acid (MUA) monolayer. This MUA layer was converted to the active 
intermediate N-hydroxysulfosuccinimide (NHSS) ester. The addition of poly lysine to this 
intermediate formed a layer of poly lysine that is covalently attached to the crystal surface via the 
MUA. The incubation of the poly lysine SAM to beta-hematin formed a beta-hematin layer by 
layer assembly.  
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QCM measurements 
QCM measurements were performed using a Maxtek Quartz Crystal Microbalance 
system. 5MHz or 9MHz Matex crystals were used.  All reagents were introduced to a tubing 
system (0.25 mm) at a flow rate of 35µL/min. The crystal containing functionalized beta-hematin 
was first stabilized in TBS buffer (~1 hr), followed by flushing the system with 1mg/mL BSA in 
TBS until binding reaches an equilibrium. Unbound BSA was washed from the experiment 
chamber with TBS. Next, the phage solution was introduced to the sample chamber until binding 
reaches equilibrium. Unbound phage was washed away with TBS. This was repeated for each 
phage sample. To ensure that phage was bounded to beta-hematin crystal and not exposed poly-
lysine or BSA, phage solution was flowed over poly-lysine coated QCM chip. 
 
DA sequencing of phage from random peptide libraries 
Individual phage were selected from blue and white screen process from round 5 
samples. These individual viruses were isolated and amplified. Polymerase chain reaction (PCR) 
technique was used to amplified 7-mer peptide target region (on PIII coat protein). Purified PCR 
products were sequenced to determine the beta-hematin specific peptide sequence.   
 
PCR technology review 
PCR allows for the production of large quantities of a specific DNS from a complex 
DNA template of simple enzymatic reaction (185). Two oligonucleotide primers, short DNA 
fragment, are designed to be complementary to the ends of the targeted DNA sequence.  These 
primers will mark the beginning and end of the targeted region. The DNA template containing 
the targeted amplification region is then introduced into a buffer solution with the primers, DNA 
polymerase, and deoxyribonucleotides.  Immediate cooling then allowed the primers to anneal to 
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its complementary region on the single stranded template. The primers are positioned so that 
when each is extended by the action of a DNA polymerase, the newly synthesized strands will 
overlap the binding site of the opposite oligonucleotide (Figure 39). As the process of 
denaturation, annealing, and polymerase extension is continued the primers repeatedly bind to 
both the original DNA template and complementary sites in the newly synthesized strands and 
are extended to produce new copies of DNA. The end result is an exponential increase in the 
total number of DNA fragments that include the sequences between the PCR primers, which are 
finally represented at a theoretical abundance of 2n, where n is the number of cycles.(186, 187) 
In this study, the Qiagen RotorGeneQ 5-Plex thermocycler was used for DNA amplification. 
After PCR reaction is complete, electrophorese 3-5 µl of the 50 µl reaction on a 0.8-1.0% 
agarose gel, comparing PCR product using ssDNA template. The presence of an amplified 
fragment of approximately 240bp indicate the successful amplified of 7mer peptide insert. PCR 
products were purified using PCR purification kit from Promega. This step removes salts, unused 
primers, dNTPs, and enzyme for subsequent sequencing reactions. 
The following PCR conditions were used: 
 
1. D:A template:  Pick plaques using a wide-bore 200 l pipette tip  
2. Primers:   
                  Forward 5’- TTTTTTTAGGAGATTTTCAACGTG -3’ 
Reverse  5’- CCCTCATAGTTAGCGTAACG  -3’ 
PCR Reaction: 
Amount Reagent 
5.0 µl 5 µl of lysate 
4.0 µl Forward primer (5 µM) 
4.0 µl Reverse primer (5 µM) 
5.0 µl 10X reaction buffer 
1.0 µl dNTPs 10 mM each 
30.5 µl H20 
0.5 µl Polymerase 
50.0 µl   
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3. Thermocycle: 
 
 
 
 
 
 
 
 
 
Sequencing PCR samples 
 The forward and reverse primers, listed above, with the DNA template for PCR reaction was 
submitted for fluorescent dideoxy sequencing. Sequencing was performed by GenHunter 
Corporation (Nashville, TN). Sequencing results were identified my locating the forward primer, 
reverse primer, and signal sequence. The insert 7mer peptide is inserted following the PIII signal 
sequence. 
M13KE DNA sequence: 
                    Upstream DNA sequence 
…GCTCAGCGACCGAATATATCGGTTATGCGTGGGCGATGGTTGTTGTCATTGTCGGCGCAACTATCGG
TATCAAGCTGTTTAAGAAATTCACCTCGAAAGCAAGCTGATAAACCGATACAATTA 
    pIII forward primer 
AAGGCTCCTTTTGGAGCCTTTTTTTTTGGAGATTTTCAACGTGAAAAAATTATTATTCGCAA 
 
gIII DNA sequence: 
      pIII SIGAL SEQUECE     
 V  K  K  L  L  F  A  I  P  L  V  V  P  F  Y  S  H  S  A 
GTGAAAAAATTATTATTCGCAATTCCTTTAGTGGTACCTTTCTATTCTCACTCGGCCK 
       DA insert 
KKKKKKKKKGAAACTGTTGAAAGTTGTTTAGCAAAATCCCATACAG 
        -96 primer 
AAAATTCATTTACTAACGTCTGGAAAGACGACAAAACTTTAGATCGTTACGCTAACTATGAG 
 
GGCTGTCTGTGGAATGCTACAGGCGTTGTAGTTTGTACTGGTGACGAAACTCAGTGTTACGG 
TACATGGGTTCCTATTGGGCTTGCTATCCCTGAAAATGAGGGTGGTGGCTCTGAGGGTGGCG 
 
 
 
 
 
 
 
 
  
95oC 1.5 min  
94oC 30 sec  
50oC 30 sec   27-30 X 
68 or 72oC 30 sec  
68 or 72oC 1 min  
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Figure 39. Polymerase chain reaction (PCR) is a method to amplify select DNA sequence using 
cycles of repeated heating and cooling. In the first step, the sample is heated to denature the 
double stranded DNA template. Immediate cooling allows for the primers to anneal and mark the 
region to be amplified. The temperature is then heated again to allow DNA polymerase, an 
enzyme, to extend the primer. As PCR progresses, the DNA generated is itself used as a template 
for replication, setting in motion a chain reaction in which the DNA template 
is exponentially amplified.(186) 
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Synthesis of protein mimics 
All peptides were synthesized using standard FMOC solid phase synthesis methods using 
an Apex 396 peptide synthesizer (Aapptec). All peptides were synthesized using a Rink amide 
resin. The N-terminus of each peptide was acylated using DCM:acetic anhydride (1:1). Cleavage 
was performed by treating the functionalized resins with Reagent R (90:5:3:2 
TFA:Thioanisole:Anisole:EDT) and precipitating the peptides in cold ether. Purification was 
performed using a reverse-phase HPLC (Waters Prep LC 4000) with a Waters 2487 dual 
wavelength detector and C18 column. 
 
Identification of peptide functionality 
Stock solution of Fe(III)PPIX was made by dissolving 16.39 mg hemin chloride in 1 mL 
Dimethyl sulfoxide (DMSO). This sample was sonicated, vortexed and filtered through a 0.2 µm 
acetate syringe filter (Fisher Scientific). Stock solution of peptide was made in aqueous acetate 
buffer (2 M, pH 4.8) or citric buffer (50 mM, pH 4.8) at 1mM concentration. To determine the 
functionality of identified peptides, the detergent assay optimized in the Wright Lab by Dr. 
Melissa Carter and Rebecca Sandlin was applied to the peptides. 177.8 µL of stock Fe(III)PPIX 
solution was added to 20 mL of buffer solution and immediately used. 20 µL of stock peptide, 90 
µL Fe(III)PPIX solution, 90 µL diH20 was added to 96 well plates. Reactions containing no 
peptides and reactions using Nonidet P-40  (NP40) served as controls.  NP-40 has been 
previously demonstrated in the Wright research group to be very successful for the mediation 
beta-hematin formation. In NP40 reaction, 84.9 µL of manufactured NP40 solution 
(ThermoFisher, 10% solution) was added to 45 mL diH20. 18.4 µL of this solution was added to 
90 µL of Fe(III)PPIX, and 916 µL diH20 to make up the control reaction. The reaction was 
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incubated at 37 ˚C for 12 hr. In addition, three scrambled, random 7 amino acid peptides were 
generated to serve as control reactions. To ensure reproducibility, each reaction was performed 
in triplicates. These reactions are repeated in citric buffer. To determine if peptides had beta-
hematin inhibiting properties, 30.5 µM of chloroquine was added to 100 µM peptide and 100 µM 
Fe(III)PPIX in a 200 µL reaction volume. As control, NP40, Fe(III)PPIX and CQ was reacted. 
All reactions were performed at 37 ˚C for 12 hr in triplicate. 
 
Quantification of Beta-hematin formation 
To quantify percentage of beta-hematin form, pyridine assay reported by Egan et al. was 
used (79, 97).  Briefly, the introduction of an aqueous pyridine (5%, v/v, pH 7.5) to the reaction 
sample results in a low-spin pyridine-hematin complex. This complex does not form with beta-
hematin. Its absorbance obeys Beer’s law, making it useful for quantitating hematin 
concentration in hematin/beta-hematin mixtures.(79)  The reaction was quenched with the 
addition of 40 µL of an aqueous solution containing 30% pyridine, 10% HEPES buffer (2.0 M, 
pH 7.5), and 40% acetone (v/v). 
The percentage of unconverted Fe(III)PPIX was determined by performing colorimetric 
measurements of the samples. 50 µL of the sample and 50 µL of water were transferred to a 96 
well plate with read at 405nm on a Biotek Synergy HT multi-mode microplate reader.  The 
percentage of beta-hematin conversion was calculated as previously described(79) and analyzed 
using GraphPad Prism 4.0 to obtain the half-life of each peptide. 
 
Peptide orientations 
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To determine orientations of peptides in aqueous solution, dynamic light scattering (DLS) 
measurements were performed on 1µM and 10 µM peptide buffer solution. A 1M solution of 
acetate buffer adjusted to pH 4.8 was used. Measurements were performed in triplicates using the 
Malvern Zetasizer instrument. 
 
Results and Discussion 
 
 
 
Selection of beta-hematin specific phage 
Phage display techniques were successfully applied to beta-hematin crystal to select for 
beta-hematin specific peptide sequences. The first round of panning used a phage library that 
contained approximately 109  peptide diversity.  After five rounds of panning, the large phage 
library was reduced to approximately 200 potential viruses that demonstrated recognition of the 
beta-hematin crystal (Figure 40). Note, this does not translate to 200 different peptides. In fact, 
this 200 phage may be the duplicates of only a few distinct viruses. QCM analysis was used to 
confirm the specificity of these isolated phages. Beta-hematin crystals used for panning requires 
a three month synthesis, thus growing crystals directly onto the QCM crystal was not an option. 
Instead, beta-hematin were functionalized onto QCM crystals via a layer by layer assembly. The 
assembly of beta-hematin QCM chips was monitored real-time via QCM (Figure 41). The 
reaction began with a NHSS ester SAM pre-formed overnight on a QCM crystal. The flow of 
poly lysine to the SAM surface resulted in the binding of approximately 60 ng poly lysine 
(Figure 41a). Following a buffer wash, a solution of beta-hematin was introduced to the poly 
lysine SAM, resulting in a 25ng coating to the surface. Excess crystals were removed via another 
buffer wash. Maxtek QCM crystals used in this study have an estimated 3.42 x 107 µm2 available 
surface for surface assembly. The largest face of beta-hematin formed under Bohle 
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Figure 40.  Increased panning rounds reduces non-specific phage. Each green spot corresponds to one phage. Increased panning cycle 
reduced the number of unspecific phage particle. A) round one , b) round two, and c) round three.  
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synthesis(158)  are approximately 5µ x 1µ x 0.5µm. Theoretical values were calculated using 
beta-hematin density values(1.45g/cm3) estimated by Pagola.(41) If all crystals were to interact 
with the poly-lysine surface through its largest crystal face, {100}, a maximum surface coverage 
(100% binding efficiency) would equate to a mass loading of 0.25mg or 6.8 x 106 crystal. 
However, if all deposited crystals were aligned along its end, a maximum mass loading of 
2.478mg or 6.8 x 107 crystals is expected.  The experimental mass loading of 25 ng (figure 41) is 
estimated to be a less than 0.1% surface coverage. Despite this low coverage rate, reflective IR 
measurement of the crystal surface confirmed the presence of peaks at 1210 cm-1 and 1664 cm-1, 
confirming the attachment of beta-hematin to the poly-lysine surface (Figure 41b). 
To validate the success of the phage panning series, an isolated phage particle from round 
5 was amplified and QCM was used to quantify its beta-hematin recognition (Figure 42). The 
flow of aqueous poly-lysine over MUA functionalized QCM crystal resulted in approximately 
206 ng binding, suggesting strong anchoring of poly-lysine to MUA surface. Once poly-lysine 
loading leveled off, TBS buffer was used to wash off excess substrate.  Approximately 34 ng of 
beta-hematin crystals bound to the poly-lysine surface.  The introduction the solution of round 
five phage produced approximately 20 ng mass loading, confirming the ability of panned phage 
to recognize beta-hematin crystal surface. Based on a 930nm x 7nm M13 phage dimensions 
(188, 189), a theoretical maximum loading of 0.35mg was calculated for uniform attachment of 
phage virus laying on its side (not ends). A mass loading of 20 ng is about 0.05% binding 
efficiency. This was not unexpected given the low efficiency of beta-hematin binding onto the 
poly-lysine surface. To ensure that the phage used in QCM quantification was indeed binding 
with beta-hematin crystals and not exposed poly-lysine or BSA layer, a control was performed 
(Figure 43). Round 5 phage was introduced to the surface of BSA blocked poly-lysine layer.  
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Figure 41. Functionalization of beta-hematin crystal onto QCM chip.  Approximately 60 ng of 
poly-lysine covalently attached to the MUA SAM. Introduction of beta-hematin to poly-lysine 
surface produced a mass loading of approximately 25ng mass loading (a). The successful binding 
of beta-hematin to the poly-lysine surface was confirmed by the presence of FTIR peaks at 1664 
cm-1 and 1210 cm-1.  
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Figure 42. QCM quantification of round 5 phage recognition of beta-hematin surface.  
Approximately 34 ng of beta-hematin bound to the poly-lysine surface. The introduction of 
round 5 phage resulted in a mass loading of 20 ng, suggesting the successful recognition of 
panned phage and crystal.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 43. QCM measurements of round 5 p
control for phage recognition of beta
BSA blocked poly-lysine surface, suggesting that mass loading 
phage was a result of specific recognition for beta
binding.   
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hage and BSA-blocked poly-lysine served as a 
-hematin. No binding was detected for round 5 phage and 
(figure 42) detected for round 5 
-hematin and not a result of nonspecific 
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No significant binding was detected, confirming that previous observed binding of phage and 
crystal was a result of specific recognition by the phage particle for beta-hematin and not through 
nonspecific binding.   
 
Phage peptides functionalities 
Peptides are short, flexible amino acid sequences that can be quickly synthesized. Their 
ease of handling makes them a good candidate for a mediator or inhibitor of crystal growth. 
Approximately 200 phage viruses was identified from round 5 panning. These viruses were 
amplified and prepared for sequencing. Electrophoresis analysis of PCR product of isolated 
phage confirmed that DNA insert was 240bp (Figure 44). Purified PCR products were sequenced 
and 12 peptide sequences (Table 3) were identified. Three random, 7-mer peptides were 
generated to serve as control peptides. There is no observable trend in polarity and net charge for 
these peptides (Table 3). In fact, a wide range of hydrophilicity and net charge was exhibited. 
Pyridine quantification of beta-hematin formation under peptide mediation shows minimal 
conversion of heme with an average of 5% beta-hematin formation (Figure 45a). Three peptides 
expressed above average mediation at 10%, 17%, and 10%, EDKNNVA, ASDQEPS, and 
SITEDKN, respectively. FTIR and XRD characterization of product promoted by these peptides 
confirmed the successful formation of beta-hematin (Figure 46). Specifically, FTIR analysis 
exhibited beta-hematin characteristic peaks at 1664 cm-1 and 1210 , cm-1, denoting the presence 
of Fe(III)PPIX dimers. XRD measurements displayed peaks at 7, 22, 24 2theta, confirming the 
presence of beta-hematin unit cell. Together, these data unequivocally demonstrate the presence 
of beta-hematin. Analysis of EDKNNVA, ASDQEPS, and SITEDKN revealed that all peptides 
share similar hydrophilicity (EDKNNVA = 1.1, ASDQEPS = 0.9, SITEDKN =1) with a ratio  
 
 
 
 
 
  
 
 
 
 
 
 
Figure 44. Electrophoresis analysis of round 5 PCR products confi
DNA fragment. Purified PCR products were used to identify the DNA sequence of beta
specific 7-mer peptides.  
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rmed the presence of 240 bp 
-hematin 
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Table 3. 7 amino acid sequence identified through phage panning. * denote control peptide 
(random scrambling of 7 amino acid sequence). 
 
 
Sequence  MW 
Average 
hydrophilicity 
Ratio hydrophilic 
residues / total 
number of 
residues 
Iso-electric 
point 
et 
charge 
at pH 7.0 
TWHTRHW* 1064.2 -0.8 14% 14 2.2 
EDKVA 829.9 1.1 71% 7 0 
EPSRPSR 868.9 1.4 71% 12.4 2 
STFKKMD 897.1 0.7 57% 10.6 2 
DTSRPSR 858.9 1.3 71% 12.4 2 
PLGAAPG* 622.7 -0.4 0% 14 1 
NNVATFE 834.9 -0.2 43% 7 0 
KPSRPSR 868 1.4 71% 14 4 
TAHLRIW* 937.1 -0.8 14% 14 2.1 
ASDQEPS 773.8 0.9 71% 4.1 -1 
EDKKPIR 926.1 1.9 71% 10.6 2 
SITEDK 846.9 1 71% 7 0 
SIADQEP 799.8 0.6 57% 4.1 -1 
NNVKTFE 892 0.3 57% 10.1 1 
EDDQNNS 861.8 1.4 100% 3.7 -2 
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hydrophilic residues to total number of residues of 71%. Interestingly, four other peptides also 
possess a 71% hydrophilic residues, but do not exhibit above average percentage of heme 
conversion. All four of these peptides express a proline in the 5th position and a polar arginine in 
the 7th position, while three of the 4 peptides exhibit a serine in the 6th position. All four peptides 
promoted approximately 5% beta-hematin formation.  Both EDKNNVA and SITEDKN have 
only one nonpolar residue towards the outer region of the peptide, suggesting that a heavily polar 
residue is more favorable for crystal formation. However, EDDQNNS contains all polar residues 
but did not promote beta-hematin. Scrambled peptides, TWHTRHA, TAHLRIW, and 
PLGAAPG, promoted no beta-hematin. The NP40 control, at 30.5 µm, mediated 60 % beta-
hematin formations. When compared to NP40, peptides are weak mediator of beta-hematin 
formation. In contrast to assays performed in acetate buffer, beta-hematin formation assay in 
citric buffer (37 C, pH 4.8, 12 hrs) did not promote crystallization (Figure 44b). The ability of 
concentrated acetate buffer to mediate beta-hematin was previously reported by Egan et al.(91) 
Similar to the presented peptide assay, beta-hematin formation in 4.5M acetate(91) solution 
produced crystal formation that follows a sigmoidal growth curve. In the first scenario, the 
acetate is likely to act as a phase transfer catalyst or work in conjunction with the peptide to 
promote beta-hematin nucleation.  At a pH 4.8, the CB should have an overall negative charge, 
similar to acetate in this environment, suggesting that beta-hematin crystallization should 
proceed in both conditions. However, beta-hematin was only detected when acetate buffer was 
used in the assay. This result may be due to the amphiphilic characteristic of the acetate buffer at 
pH 4.8. In fact, lipid studies (chapter 1) and solvent studies (chapter 4) have demonstrated the 
importance of low dielectric environment during beta-hematin formation.  Though citric buffer 
has charged regions, the hydrophobic region is not accessible due to stearic hindrance.  
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Figure 45. Peptide mediation of beta-hematin formation in acetate buffer and citric buffer 
conditions. In acetate buffer (a), three peptides (EDKNNVA, ASDQEPS, and SITEDKN) 
exhibited above average crystal formation. However, when compared to NP40, peptides are 
weak mediator of beta-hematin formation. No peptide exhibited beta-hematin promotion 
properties in citric buffer (b). 
 
 
162 
 
Fe(III)PPIX restricted access to the hydrophobic region of citric acid may explain why no beta-
hematin is promoted in this buffer.  
Next, the ability of these peptides to inhibit beta-hematin formation was assessed by 
incorporating 25 µM chloroquine (CQ) to NP40 and peptides. Identified peptides do not exhibit 
beta-hematin inhibiting properties. The presence of the peptides did not prevent NP40 mediation 
of heme conversion. Furthermore, the percentage of heme conversion in the presence of NP40 
and peptide appears to have additive properties. Mainly, an increased percentage of beta-hematin 
formation was measured for peptide+NP40 reaction (Figure 47). This increased amount is 
approximately the amount of product produced by the peptides alone, suggesting that two 
independent mechanism of crystal formation occurred.   
 
Kinetics of peptide mediated beta-hematin formation 
 
Kinetics curves of heme conversion exhibited similar sigmoidal curve pattern as those of 
beta-hematin formation in detergent(143) and acetic acid(91). This is likely due to the acetate 
buffer system that all three approaches employed in their assay. Heme conversion for 
ASDEQPS, EDKNNVA, and SITEDKN reached maximum formation approximately 5 hr into 
the reaction (Figure 48). ASDQEPS reached 15% crystal formation at 5.4 hr with a half life (t1/2) 
at 5 hr. SITEDKN reached 12 % formation at 7.5 hr while EDKNNVA reached 11.5 % at 5.9 hr. 
When compared to the beta-hematin formation under NP40 mediation, the peptides heme 
conversion rates are nearly half as slow.  In conjunction to peptide+NP40 data (Figure 47), 
similar rate of reaction between NP40 and peptides suggest that two independent mechanism of 
crystal formation took place.  
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Figure 46. FTIR and XRD analysis of products form by EDKNNNVA. FTIR analysis(a) exhibit 
beta-hematin characteristic peaks at 1664 cm-1 and 1210 cm-1. XRD measurement of product 
displayed beta-hematin characteristic peaks at 7, 22, 24 2theta, demonstrating the successful 
promotion of synthetic hemozoin. 
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Figure 47. Peptides do not possess beta-hematin inhibiting properties. Incubation of NP40 and 
peptides with Fe(III)PPIX in acetate buffer did not inhibit crystal formation. Peptides that 
promoted (Figure 45) above average beta-hematin formation also promoted above average 
crystal formation the presence of NP40. 
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Orientation of peptides 
Histidine-rich peptides (HRP) and proteins, characterized by their rich histidine and 
alanine, have been discovered in the digestive vacuole of the human malarial parasite(190) and 
was previously implicated as the in vivo catalyst for hemozoin formation.(49)  HRP functionality  
extends beyond malaria as its roles in the biomineralization of heme,(49) copper, and zinc(191) 
have been established. However, studies using animal model with knockouts of the HRP genes 
concluded that HRP is a potent in vitro promoter of beta-hematin, but not the in vivo mediator for 
hemozoin formation.  Nevertheless, the application of HRP in in vitro synthesis of nano 
assembly is abundant. For example,  the HRP II epitope (AHHAHHAAD) is capable of 
stabilizing a variety of nanoclusters, including Au0 and Ag0 (192). Thus, it is surprising that none 
of the 12 peptides do not contain a histidine or alanine residue. In the epitope example, peptide 
ligands provide controllability of crystal morphologies by select ordering of residues at the bulk 
solution.(193) To examine the organization of peptides during beta-hematin synthesis in acetate 
buffer, dynamic light scattering (DLS) analysis was performed on dilution concentration (1 µM 
and 10 µM) of peptides (Figure 49). As predicted, ASDQEPS, EDKNNVA, and SITEDKN 
organized into aggregate bodies in the aqueous environment. All peptides appear to share similar 
aggregation trend. At low concentration, the size of peptide aggregation appears to be 
concentration dependent.  ASDQEPS (Figure 49a) measurements is dominated with aggregates 
of 1mm at 1 µM and 3mM at 10 µM. Both EDKNNVA(Figure 49b)  and SITEDKN (Figure 49c)  
produced smaller aggregates. At 1 µM peptide concentration, EDKNNVA measurements are 
dominated by peptide aggregates that are about 100nm in diameter, while SITEDKN 
measurements displayed a large population of peptide aggregates about 250 nm in size. 
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Figure 48. Kinetic of beta-hematin formation for ASDEQPS, SITEDKN, and EDKNNVA in 
acetate buffer. Heme conversion under all three peptide plateaued at approximately 5 hr into the 
reaction.    
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All peptides contain the 7 amino acids; however, the properties of these amino acids 
determine the degree of aggregation. EDKNNVA with an isoelectric point of 4.1 and an over 
charge of -1 at pH 4.8, produced the largest aggregation. This may be due to its largely charged 
ends. The first two residues on one end are glutamic-aspartic acid produces a 3 negative charges 
(carboxyl group of E and side chains of E and D). The other end of this peptide is predominately  
neutral and hydrophobic. At a pH 4.8, it is probable that this peptide organize with the 
hydrophobic region oriented inward with charged regions facing the bulk solution. This 
orientation will allow the negatively charged ends to Fe(III)PPIX molecules through ionic 
interactions. The polarized charge arrangement may increase aggregation size through static 
ionic interactions. SITEDKN’s charge distribution is also skewed to the ends with two negatively 
charged residues followed by a positive (EDK). However, the concentration of negatively 
charged residues towards one end is not as heavy in SITEDKN as in EDKNNVA. This charge 
distribution may be responsible for the smaller size in peptide aggregation for SITEDKN. When 
compared to EDKNNVA and SITEDKN, ASDQEPS exhibits more equally distribution of 
charged residues. As a matter of fact, the negatively charged residues are spaced every other 
amino acid with two flanking residues being hydrophobic and neutrally charged at one end. This 
even distribution produced an overall -2 charge with no polarized charged ends and thus, may 
limit peptide aggregation.  
The N-terminus of each peptide was acylated, producing an uncharged end. It is likely 
that, at pH 4.8, peptides are organized so that the N-terminus are oriented inward. EDKNNVA, 
SITEDKN, and ASDQEPS all possess a negatively charged C-terminus which can interact with 
the bulk Fe(III)PPIX solution through ionic interactions with the propionic group of Fe(III)PPIX 
molecules. Modeling studies of beta-hematin formation proposed that in the presence of water,  
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Figure 49. Dynamic light scattering (DLS) measurements of ASDQEPS (a), EDKNNVA (b), and 
SITEDKN (c). In aqueous environment, peptides spontaneously assembled into aggregated 
bodies. At 1 µM concentration, ASDQEPS formed aggregates larger than those of EDKNNVA 
and SITEDKN. 
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two Fe(III)PPIX molecules spontaneously dimerizes.(58)  Crystal nucleation begins when the 
dimers assemble to form the growing crystal. However, in an aqueous environment, water 
molecules will hydrogen bond with the center iron, preventing dimer assembly. When beta-
hematin crystallization occurs in an aqueous neutral lipid system, the lipid layer will eliminate 
water interactions, allowing crystal nucleation.(57, 58, 97) In the peptide system, this 
hydrophobic region is limited to only a few amino acid residues in length. This region may not 
be large enough to support continuous crystal growth, and thus, only a 10 percent beta-hematin 
formation was measured in the peptide system.   
 
Peptide alignment with Heme Detoxification Protein 
A budding proposal for hemozoin formation focuses on the Heme Detoxification Protein 
(HDP), a unique Plasmodium protein which is a potent beta-hematin promoter.(194) HDP 
investigation demonstrate that this protein is highly conserved across the Plasmodium genus, is 
extremely efficient in producing hemozoin, and is delivered to the food vacuole, the site of 
hemozoin formation, via a unique trafficking route.(194) Interestingly, when the phage peptides 
are aligned with the amino acid sequence of the HDP, EDKNNVA, SITEDKN, and ASDQEPS 
express high alignment.  All seven amino acid exhibit good consecutive alignment with amino 
acid sequence of HDP (below).  EDKNNVA, which is the best promoter of beta-hematin, 
exhibited the best alignment with HDP with all 7 amino acid possessing similar properties to 
those of HDP. Of those 5 amino acids, two are exact residue and five possess similar properties 
to its counterpart. SITEDKN and ASDQEPS exhibit two and one residues that are exact match, 
respectively. Scrambled peptide (control peptide), such as PLGAAPG, did not promote beta-
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hematin formation and exhibited poor alignment with HDP. Alignment can only be achieved for 
this peptide when residue matches are spaced many residues apart.  
 
: similar properties ,      . exact reside,         * exact match 
 
 
hdp             LKIFSNLLNHPTVGSSLIHELSLDGPYTAFFPSNEAMQLINIESFNKLYNDENKLSEFVL 120 
peptide         -------------------------------------------------EDKNNVA---- 7 
                                                                 :*:*:::     
 
hdp             LKIFSNLLNHPTVGSSLIHELSLDGPYTAFFPSNEAMQLINIESFNKLYNDENKLSEFVL 120 
peptide         ----------------------------------------------SITEDKN------- 7 
                                                              .: :*:*        
 
    
hdp             MKNRFYYNLIIKRLYTRSGGLRKPQKVTNDPESINRKVYWCFEHKPVKRTIINLIYSHNE 60 
peptide         -------------------------ASDQEPS---------------------------- 7 
                                            ::*.                             
 
hdp             LKIFSNLLNHPTVGSSLIHELSLDGPYTAFFPSNEAMQLINIESFNKLYNDENKLSEFVL 120 
peptide         ----------P-LG-------AAPG----------------------------------- 7 
                          * :*       :  *                                    
 
Conclusion: 
 
In this study, 7 amino acid peptides identified through phage display application to beta-
hematin crystal were demonstrated to be sufficient at mediating beta-hematin crystallization. 
However, the rates of heme conversion were limited to approximately 10%.  When compared to 
detergent (NP40) mediation, peptides are weak promoter of beta-hematin formation. The length 
and properties of the peptides may be responsible for the low conversion. Mainly, the absence of 
a longer hydrophobic region may limit the amount of crystal formed. A larger hydrophobic 
region is necessary to eliminate competing water hydrogen bound to allow crystal nucleation to 
being. This study provided a unique approach for biomineralization by integrating biomolecular 
recognition and material synthesis. Proof of concept demonstrating how biomolecularly 
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programmed components can provide the requisite building block for the assembly of new 
biologically inspired nanomaterials.  
 
Future Directions 
In this chapter, the proof demonstrating the application of phage display to beta-hematin 
crystal formation is presented. Initial virus screening and optimization of identified peptides 
suggest successful beta-hematin promotion by phage displayed identified peptides. The data 
presented here can serve as a stepping stone for understanding the molecular recognition 
involved during hemozoin formation. Future work for this project should investigate the 
controllability of beta-hematin morphologies based on peptide design.  Long peptide chain may 
produce crystal that differs in shape from those produced by longer chain length. In addition, 
peptides with amphiphilic characteristic may be more successful at mediating beta-hematin 
formation. To increase phage display detection using QCM analysis, optimization of beta-
hematin functionalization to QCM crystals must be performed.   
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APPENDIX A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 50. Confocal micrographs of NR labeled SNLB. in the presence of Fe(III)PPIX. The bottom panels show NR fluorescence 
from NR in lipid droplets prior to addition of Fe(III)PPIX. Careful addition of Fe(III)PPIX results in almost complete quenching of the 
NR signal at pH 4.8 (c) and 5.5(d), but incomplete or no quenching at pH 1.3(a),2.3 (b) 6.5(e), 7.3(f) and 8.1(g), top panel.
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APPENDIX B 
 
MN(III)PPIX Crystallization in Citric Buffer: DMSO System 
 
 
The CB:DMSO system presented in chapter 4 was applied to MN(III)PPIX in hopes to 
synthesizing manganese(III) substituted protoporphyrin IX crystals. Here, preliminary data are 
presented. 
 
Methods 
  Mn(III)PPIX was purchased from Frontier Scientific (Logan, Utah). 1mg of amorphous 
sample was dissolved in 1 mL solution of 1:1 50mM citric buffer (CB) to DMSO in a glass vial. 
The solution was immediately wrapped in foil and sonicated for approximately five minutes.  
Upon completion of incubation, the sample was washed with a solution of 0.1M sodium 
bicarbonate (pH 9). The dried sample was characterized with SEM, FTIR, and XRD (Figure 50). 
 
Preliminary Results 
Preliminary data demonstrates the success of Mn(III)PPIX crystallization using the 
CD:DMSO system.  SEM analysis revealed that these crystals are rectangular in shape; however, 
crystal dimensions are not consistent across all samples (Figure 50a,b). Mn(III)PPIX crystals 
resemble those of Fe(III)PPIX crystals that are produced in the same system. However, a 
molecular examination of these Mn(III)PPIX crystals revealed that they differed from 
Fe(III)PPIX (Figure 50, c,d).  FTIR analysis displayed distinct peaks at 1230, 1550, and 1720 
cm-1.  XRD analysis revealed peaks at 7 2 theta that is likely to correspond to the {100} dominate 
crystal face of the crystal. Another distinct peak is present at 22 2 theta which probably 
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correspond to the {010} crystal face. Preliminary data presented here demonstrates the 
successful mediation of Mn(III)PPIX using the CB:DMSO system. Further examination of this 
pathway is necessary to better understand solvent mediated crystallization. 
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Figure 51. Characterization of Mn(III)PPIX crystals produced in citric buffer: DMSO system. 
SEM analysis(a,b) reveal that Mn(III)PPIX crystal resemble those of Fe(III)PPIX. However, IR 
(c) and XRD (d) analysis demonstrate that these crystals differed at the molecular level. IR 
regions 1350-1500 cm-1 is obscured by nujol matrix. 
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APPENDIX C 
 
Phage Panning Protocol 
 
1. Place ~2mg of hemozoin in small, sterile tube. Add 1 mL of sterile PBS, sonicate and vortex 
the sample. Centrifuge sample at 3,000 RPM for 30 seconds. Decant supernatant.  
 
2. Add 400uL of sterile PBS and 100uL of stock phage. Incubate for 6 hrs at RT or 37C.. Wash 
unbound phage with PBST, 5X. 
 
3. Start e.coli liquid culture from plate: take a sterile loop and remove e.coli from plate to a 
50mL sterile tube containing 5mL of 2xYT broth. Store at 37C with gentle agitation. Do not 
tighten cap. 
 
4. After 6 hours incubation of hemozoin and phage, wash with sterile PBS. Add 1mL of PBS. 
Gentle agitation (flipping mixture on Jonas’ desk) for five mins. Centrifuge for 30 seconds at 
3,000 RPM. Decant the supernatant. And repeat 5 – 10 X. 
 
5. Remove supernatant from final wash. Elute with 150uL of PH2 and 0.2 M glycine for 15 
mins. at room temperature. Keep sample mixing. 
 
6. Add 30 uL of 1M Tris buffer for total of 180 uL. This is the phage output. 
 
7. Add 100 uL of solution in step 6 to 100 uL of e. coli in a 50 mL tube. Incubate for 30 mins. at 
37C to jumpstart amplification. After 30 mins. Add an additional 5mL of 2xYT + Kam 
(50um/mL) broth. Incubate at 37C overnight. 
 
8. Make top agar lawn (when starting wash). Refer to tittering protocol for steps on how to make 
top agar. Plate 10uL of phage (add the phage into the top agar solution and pour them together). 
 
9. Next morning. Spin down e.coli + phage amplification for 5 mins. at 3000 RPM. Save 
supernatant in cryo tubes (1.5mL each). Use this amplified phage to repeat steps 1-9. Repeat 4-5 
times. 
  
11. Plate amplified phage using tittering protocol. Count phage to determine concentration of 
amplified phage.  
 
 
Note) all PBS is sterile and contained magnesium and calcium. 
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APPENDIX D 
 
Phage Titering Optimized Protocol 
 
1. From a phage stock where the titer is expected to be 10^11 to 10614 pfus/ml 10-fold serial 
dilutions are made down 1 column of a 96 well microtiter dish. 
 
2. From either the 6th or 7th fold dilution (choose the 6th if you expect the titer to be low and the 
7th if you expect it to be high) make a series of 12 2-fold dilutions into PBS. 9I typically choose 
the 6th) 
 
a) Transfer 50 uL 10-fold into 50uL PBS for the first, change tips, mix 3x, transfer 50ul of this 
well into another 50 ul, change tips, mix 3x, etc. Because at this point the concentration is very 
low it is essential to change tips between wells. 
 
3. Plate 5 ul from each two fold dilution on the surface of a bacterial lawn, allow a few minutes 
for absorption, and incubate inverted over night at 37C. 
 
4. Count the phaques for each dilution  pfu/5ul and plot log9pfu/5ul) vs dilution # (disgard any 
dilution with fewer than 5 plaques because of sampling). The y-intercept of the trendline give the 
value at 0 dilution so the titer is determined by: 
 
Tier(pfu/ml) =10^b)(10^a)(200); 
 a is the 10 fold dilution used by to start the 2-folds  
 b is the y-intercept 
 
Note) the lawn is made using ~4mL 2xYT top agar at 55C, 20uL 1M IPTF, 20ul 10mg/ml 
Kanamycin, 80ul 2% XGAL, and 300uL e.coli cells from an overnight culture of XL1-blue. The 
reagents are vortexed quickly and poured onto the surface of a prewarmed 2xYT plate.  
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